Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.161791893769407,0.00284726900183568,0.156211246525809,0.167372541013005,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.147581720102951,0.00273339720430246,0.142224261582518,0.152939178623383,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,39858,-0.124470448070082,0.00415415747104997,-0.13261259671334,-0.116328299426824,5.77330157132298e-192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39477,-0.327008278419502,0.0116888724428678,-0.349918468407523,-0.304098088431481,4.31121682841789e-168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.074796291648541,0.00268294539531749,0.0695377186737187,0.0800548646233633,4.48755796856235e-167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.100273759287647,0.00384187197014551,-0.107803828349133,-0.0927436902261622,1.44934496172213e-146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.203971998957178,0.00787407779300922,-0.219405191431476,-0.18853880648288,1.87319944042412e-144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0761625607651197,0.00301001627217036,0.0702629288716658,0.0820621926585735,1.55525178249882e-138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37445,0.0624808336292305,0.00247612424408511,0.0576276301108237,0.0673340371476373,2.45167536747462e-137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,39908,0.0641934591179531,0.00255257510626052,0.0591904119096824,0.0691965063262237,6.48614462110468e-137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,39805,-0.0934280607115161,0.00383687418508613,-0.100948334114285,-0.0859077873087473,1.27876394776696e-128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.28468585445503,0.0117893372379133,0.26157875346872,0.30779295544134,1.36753764971103e-126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37021,-0.208494592644803,0.00887536613694421,-0.225890310273214,-0.191098875016393,1.4182708412597e-119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0740192961546471,0.00337697966798532,0.0674004160053959,0.0806381763038983,5.775884236469e-105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37445,0.107498588860159,0.00510730682773922,0.0974882674777901,0.117508910242528,8.31414163634058e-97
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.276183953231108,0.013353830869129,-0.302357461734601,-0.250010444727616,8.24411542597221e-94
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.110680087597629,0.0053673343182625,-0.121200062861423,-0.100160112333834,4.78471626844142e-93
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0711604534853029,0.00353500690981996,0.0642318399420558,0.07808906702855,7.9794090390543e-89
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0382891317403916,0.00205920348847872,0.0342530929029733,0.0423251705778099,2.2455178649039e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,37453,0.118161091122919,0.00638626011479381,0.105644021297923,0.130678160947915,1.66590279404786e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0537494812364414,0.00290707393760511,0.0480516163187354,0.0594473461541474,2.22747544819723e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.0518662188752081,0.00281187310828681,-0.0573774901674503,-0.046354947582966,3.45459568929837e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.0959276663431548,0.00520765437069656,0.0857206637765895,0.10613466890972,5.48789817770987e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.0734457467920304,0.00400202999792538,-0.0812897255879641,-0.0656017679960967,1.84254625254153e-74
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,39862,-0.0929318619124501,0.00509214075086643,-0.102912457784148,-0.0829512660407519,1.15392968167128e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0471628995812981,0.00259426540476927,0.0420781393879503,0.0522476597746459,4.06451336455452e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,39868,0.0823312672361251,0.00457086688084248,0.0733723681496738,0.0912901663225763,7.99616685541692e-72
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0825491929977137,0.00467601463399784,0.0733842043150779,0.0917141816803494,5.62593935032976e-69
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0332970043829097,0.00188916484497107,0.0295942412867664,0.036999767479053,7.04126401441824e-69
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.134411524367972,0.00769330205386306,-0.149490396393544,-0.119332652342401,1.00909559063049e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0611111151417394,0.00354118876730591,0.0541703851578198,0.068051845125659,3.91755988052458e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.110397947474871,0.00640819016268043,-0.122958000193725,-0.0978378947560178,6.38404772840277e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.144988038146381,0.00863597531304811,-0.161914549759955,-0.128061526532807,1.01902187933195e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.0734186968741138,0.00437715804927757,0.0648394670975298,0.0819979266506978,1.31610342641346e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0520886544762301,0.00316780969038362,0.0458797474830782,0.058297561469382,2.91734085237251e-60
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0452966523609402,0.00278749577832732,0.0398331606354186,0.0507601440864617,6.60054715959261e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.0559358807045643,0.00347791159741384,0.0491191739736332,0.0627525874354954,9.42247674071625e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0579483967219193,0.00362983454972857,0.0508339210044513,0.0650628724393873,7.43958752563435e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.0814827861544103,0.00512510559222334,-0.091527993115168,-0.0714375791936526,1.74898288038447e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.180160874354117,0.011549344888109,-0.202797590334811,-0.157524158373424,1.83941125101818e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0503405473689309,0.0032324358152042,-0.0566761215667311,-0.0440049731711306,2.74874688735541e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,36780,0.0652746203847969,0.00420571367645142,0.0570314215789521,0.0735178191906417,7.71679226613002e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40058,-0.0802929457796477,0.0051838090861229,-0.0904532115884486,-0.0701326799708469,9.9665439536962e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.076203780640739,0.00500258247760198,0.0663987189846391,0.0860088422968389,5.74673227261219e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.0801563574817295,0.00530865802901089,-0.0905613272185909,-0.0697513877448682,3.74359686777542e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.048326525629847,0.00321229422627805,-0.054622622313352,-0.042030428946342,8.31198288473189e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0787153649589876,0.00528055084385524,-0.0890652446129438,-0.0683654853050313,6.4737480956028e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37124,-0.0598030036134064,0.00401090457120633,-0.0676643765729708,-0.051941630653842,7.1771478727373e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40030,0.0238274648892098,0.00160338944235681,0.0206848215821905,0.0269701081962292,1.26074492587651e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37437,0.0387017591525401,0.00261839041656718,0.0335697139360684,0.0438338043690118,4.68955577872233e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0625204281639633,0.00423607154069487,-0.0708231283837252,-0.0542177279442013,6.60476361867892e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.0906066698915838,0.00623258198971612,-0.102822530591427,-0.0783908091917402,1.42491405497117e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0360693279508336,0.00248299787126601,-0.040936003778515,-0.0312026521231522,1.88780350138442e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.0731014330183859,0.005059951109582,-0.0830189371931666,-0.0631839288436052,5.12910578003869e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,39826,-0.140245523194017,0.00971610001619358,-0.159289079225756,-0.121201967162277,6.2124511077739e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,39885,0.0541102407926462,0.00376948941266559,0.0467220415438217,0.0614984400414708,1.92969852736376e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,39868,-0.0859307156929767,0.00598931939435312,-0.0976697817059088,-0.0741916496800446,2.14765452722848e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,39955,-0.0476832110962151,0.00334354588686343,-0.0542365610344674,-0.0411298611579628,7.25883540115108e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0468359281408542,0.00329748901965747,0.0403728496623255,0.0532990066193828,1.6350058939186e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,39931,0.0596517389304664,0.00421664307476582,0.0513871185039254,0.0679163593570074,3.65149658357299e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,39730,0.0386287071147783,0.0027377698513857,0.0332626782060623,0.0439947360234943,6.19887696920401e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,39749,0.0454690247746396,0.00323216072383911,0.0391339897559149,0.0518040597933642,1.11237549171166e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.0724793234596437,0.00518302446488889,-0.082638051410826,-0.0623205955084615,3.55849491497168e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,39749,0.0344109876178799,0.00246460484668148,0.0295803621183842,0.0392416131173756,4.83550887679382e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,39587,-0.106676816786196,0.00768276108722906,-0.121735028517165,-0.0916186050552271,1.4076956882151e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.021552080058713,0.00155732053910735,0.0184997318020626,0.0246044283153634,2.60825169765054e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.034516181105053,0.00252327592964763,0.0295705602829436,0.0394618019271623,2.32691430716279e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.041605595166296,0.00307922428559574,-0.0476408747660636,-0.0355703155665283,2.25732820103826e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0348988811662106,0.0025919495585965,0.0298186600313615,0.0399791023010598,4.24563210428961e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FURIN,Furin,39913,-0.0440871316327133,0.00328835992164834,-0.0505323170791441,-0.0376419461862826,9.11330140027237e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40009,0.0477741890095616,0.00356352270973013,0.0407896844984906,0.0547586935206327,9.15640220619812e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0414244668871279,0.0031045716212088,-0.0475094272646971,-0.0353395065095586,2.39741868025508e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.0610593957641259,0.00458584515661668,-0.0700476522710946,-0.0520711392571572,3.10223298204257e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,38721,-0.0506640664136653,0.00382416547240059,-0.0581594307395705,-0.0431687020877601,7.75361308535583e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,39858,0.0340935303039288,0.00258923855071855,0.0290186227445204,0.0391684378633371,2.16668607249205e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.049641069601595,0.00377327870655214,0.0422454433367528,0.0570366958664372,2.51643505114881e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37383,0.0238725016968899,0.0018144482842551,0.0203161830597499,0.0274288203340299,2.70768153491344e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,39866,0.043305469215007,0.00330591761959785,0.0368258706805952,0.0497850677494187,5.26878265954955e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0474153179428341,0.00361936811325983,-0.0545092794448234,-0.0403213564408448,5.71261807880965e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0419754217298527,0.00322855372415399,0.0356474564305109,0.0483033870291946,1.88216993575262e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.0811493748092578,0.00626020467163621,-0.0934193759656647,-0.0688793736528508,3.09430347449863e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,39906,0.0484087339631443,0.0037448918195452,0.0410687459968357,0.0557487219294529,4.93276849045065e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40012,0.0660557651244712,0.00511896332728478,0.056022597002993,0.0760889332459493,6.5669863146249e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,39908,-0.0227248807537505,0.00176783656638944,-0.0261898404238738,-0.0192599210836272,1.24238743138334e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.0637279709818335,0.00495965722413296,-0.0734488991411341,-0.0540070428225329,1.3457762569591e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0890325060022574,0.00700429476710588,0.0753040882587299,0.102760923745785,8.3200450177609e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.0760316513089614,0.00603585957000617,0.0642013665517493,0.0878619360661735,3.2602292106147e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0366439911503922,0.00291529875916458,0.0309300055824296,0.0423579767183548,4.62940486654994e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,39949,0.0337942361081091,0.00269291529999783,0.0285161221201133,0.0390723500961048,5.90896221352393e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37437,0.0452753047263169,0.00361133539075031,0.0381970873604463,0.0523535220921875,7.39877915041987e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.0872478690299432,0.00696996418991085,-0.100908998842168,-0.0735867392177179,9.42849155398655e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0309090251435688,0.00248896051087023,0.0260306625422631,0.0357873877448744,3.22269736881209e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.051002851428741,0.00412294124560977,-0.0590838162701361,-0.0429218865873458,5.43184613116881e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40030,0.0539324011712417,0.0043853442274019,0.045337126485534,0.0625276758569495,1.32026409624006e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0412533629539449,0.00335926464074452,-0.0478375216498041,-0.0346692042580856,1.64739814347331e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.0703734963011603,0.00575123460105793,-0.0816459161192339,-0.0591010764830868,2.85670879577274e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40058,-0.0327674104797326,0.00269339029502335,-0.0380464554579784,-0.0274883655014868,6.64147021707747e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.0737514817986641,0.00606596401652823,-0.0856407712710595,-0.0618621923262688,7.37634038502509e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.108909999080521,0.00895929698818435,-0.126470221177362,-0.0913497769836796,7.98019362081057e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37437,0.0685951993477204,0.00565372611054514,0.057513896171052,0.0796765025243889,1.05836778797294e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.100113511078804,0.00825887980088982,-0.116300915488548,-0.0839261066690604,1.1360601539132e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.0385245363781576,0.00319765036227742,-0.0447919310882213,-0.0322571416680938,2.77625833038638e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.0684287200797902,0.00570959536767083,-0.079619527000425,-0.0572379131591553,5.89598826768465e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0293317046809704,0.00246583521669019,0.0244986676562576,0.0341647417056831,1.71878857994206e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.0869892858383551,0.00731680777509205,-0.101330229077536,-0.0726483425991747,1.86192864748707e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40052,-0.0572688484884644,0.00484280321626467,-0.0667607427923432,-0.0477769541845857,3.90491597544496e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.049246671903606,0.0041682355227239,0.0410769302790672,0.0574164135281449,4.45823453706271e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37039,-0.0919317430808268,0.00778598080033362,-0.107192265449481,-0.0766712207121729,5.18541183453571e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.164772276894691,0.0140925785646147,-0.192393730881336,-0.137150822908046,1.88701455551872e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,39858,0.032337509068323,0.0027704628239053,0.0269074019334687,0.0377676162031774,2.36782631214916e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37124,-0.0326401051866841,0.00280327586944172,-0.0381345258907898,-0.0271456844825783,3.5088054207983e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37437,0.0448954264436788,0.0038562539269033,0.0373371687469483,0.0524536841404093,3.53461892167602e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0667245003824753,0.00574226027743787,-0.0779793305262536,-0.0554696702386971,4.36119054969027e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.0955158234009186,0.00822193399089406,-0.111630814023071,-0.0794008327787663,4.73402592634509e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40058,-0.033737310742389,0.00291222448104278,-0.0394452707252329,-0.0280293507595452,6.52095683797557e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0360231004075695,0.00310919727040281,0.02992907375758,0.042117127057559,6.84744347394426e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40003,-0.0216494544453494,0.0018785642157297,-0.0253314403081796,-0.0179674685825192,1.30862161796112e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0518282210038435,0.00450378974943374,0.0430007930949534,0.0606556489127336,1.59101183294911e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0348927658367063,0.00303353082185315,0.0289470454258742,0.0408384862475385,1.69056609840205e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.026781303554402,0.00233866685932147,0.022197516510132,0.0313650905986721,3.0342484492196e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.027206967223426,0.00237631395469735,0.0225493918722192,0.0318645425746328,3.10124750229974e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0353669308376237,0.00308914210711705,-0.0414216493675731,-0.0293122123076743,3.2809841060078e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0346019990405141,0.00302370792902334,-0.0405284665813998,-0.0286755314996283,3.31460396387829e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFM,Afamin,37453,-0.0210846580955502,0.0018476419862187,-0.0247060363885388,-0.0174632798025615,5.00930627303129e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.055269761467567,0.00484739973664244,-0.0647706649513861,-0.0457688579837478,5.36360973303807e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0282492540565727,0.00247938148018527,-0.0331088417577358,-0.0233896663554095,5.85525669763715e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.122502028523736,0.0107598891549861,-0.143591411267508,-0.101412645779963,6.79002474049932e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.0934150019370522,0.0082130179888296,-0.109512517195158,-0.0773174866789462,7.37005622064419e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0331559910521982,0.00291612850867527,0.0274403791751947,0.0388716029292017,7.68174840310628e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.0873749523125184,0.00773548156477297,-0.102536496179473,-0.0722134084455633,1.79098900613853e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,39788,-0.0510988590768033,0.00455484923640921,-0.0600263635801654,-0.0421713545734412,4.25025403844681e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,39862,0.0235369745782548,0.00211347571440191,0.019394562178027,0.0276793869784825,1.06101471687152e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0390229287168012,0.00351304816695844,-0.0459085031240397,-0.0321373543095626,1.45462528615557e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37388,-0.125679576688232,0.0113173177715912,-0.147861519520551,-0.103497633855913,1.57437210168156e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39489,-0.0540207824809681,0.00492783006645273,-0.0636793294112155,-0.0443622355507208,7.3202445068585e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40052,0.0283427577869369,0.00259292596221218,0.023260622901001,0.0334248926728727,1.02635757384046e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0307199017240986,0.00281099962700101,-0.0362294609930206,-0.0252103424551766,1.05607754911873e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0300621283704348,0.00275160210010516,-0.0354552684866409,-0.0246689882542287,1.13723780463917e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0323638629384719,0.00300060852866867,0.0264826702222813,0.0382450556546625,4.96543438990324e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0278093919137629,0.00258157332179837,0.0227495082030381,0.0328692756244877,5.76434545490832e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0414702440524096,0.00385860995515648,-0.0490331195645163,-0.0339073685403029,7.55093724990816e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0535339835526541,0.0049841530837439,0.0437650435085161,0.0633029235967922,8.07759473439141e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37056,0.0309948497547265,0.002895005990201,0.0253206380139325,0.0366690614955204,1.22291223381596e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0376214217409262,0.00353261607589561,-0.0445453492496816,-0.0306974942321708,2.13811288503795e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0281548752810445,0.00265097788036725,0.0229589586355247,0.0333507919265643,2.92416784965128e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0447348889771445,0.00422020165869703,-0.0530064842281907,-0.0364632937260983,3.62348159246603e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.103302438087583,0.00974692978091363,-0.122406420458174,-0.0841984557169925,3.72252453537444e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40058,-0.0265006545905586,0.00250405105346595,-0.0314085946553518,-0.0215927145257653,4.3424627849592e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.0556750159301131,0.00526081380345811,-0.065986210984891,-0.0453638208753353,4.36574783665102e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,39846,-0.0290417460878815,0.0027463981128062,-0.0344246863889816,-0.0236588057867813,4.7705506945791e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,39897,0.0370090373570822,0.00350014131081106,0.0301487603878926,0.0438693143262719,4.81330124694489e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,39899,-0.0306833410864502,0.00291296603429434,-0.0363927545136671,-0.0249739276592333,7.36378837781671e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,39585,0.0239517202223214,0.0022767348455749,0.0194893199249946,0.0284141205196482,8.49291483800605e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37411,-0.0455355072587666,0.00433069422583547,-0.0540236679414041,-0.037047346576129,9.29752643309596e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.0781629082261883,0.0074378116798916,-0.0927410191187758,-0.0635847973336007,9.58428248530212e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37420,0.0346885817560123,0.00330559310772057,0.02820961926488,0.0411675442471446,1.15550002927875e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.082631708004278,0.00792509693711048,-0.0981648980010145,-0.0670985180075415,2.26296786473904e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REN,Renin,39868,-0.0666961693082951,0.00641760787305862,-0.07927468073949,-0.0541176578771002,3.22025346872444e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0388052349326706,0.00374353490411615,0.031467906520603,0.0461425633447383,4.25056231200942e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,39866,0.0431845772234136,0.00417102376666776,0.0350093706407448,0.0513597838060824,4.84139536598141e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0380718428308734,0.00368387706312508,-0.0452922418745985,-0.0308514437871482,6.10670395576106e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0339280225385497,0.00329460478807281,-0.0403854479231724,-0.027470597153927,8.57883568978201e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0348983623000602,0.00338928757060183,-0.0415413659384398,-0.0282553586616806,8.71193307557048e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.0394404880893206,0.0038595950913611,0.0318756817102529,0.0470052944683884,1.94038586962778e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0224370044471901,0.00219597155841401,-0.0267411087016815,-0.0181329001926986,1.97020762721389e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.0570979381804196,0.00559218410712907,-0.0680586190303926,-0.0461372573304467,2.11390168543716e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,39847,0.0509260555055111,0.00499153429594698,0.041142648285455,0.0607094627255672,2.29517829053392e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MME,Neprilysin,39788,-0.0781750292234204,0.00766777329378442,-0.0932038648792379,-0.063146193567603,2.47250525392058e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.0618682813880552,0.00608441957382172,-0.0737937437527458,-0.0499428190233646,3.25332510253083e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0599796229920844,0.00590545524129773,0.0484049307191409,0.071554315265028,3.79829370274395e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,39949,-0.0305731604326464,0.0030280405081207,-0.036508119828563,-0.0246382010367299,6.73234494324804e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.0513029377793522,0.00510988508751702,-0.0613183125508855,-0.0412875630078188,1.19508555175563e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.0330325603744952,0.00330825779322751,-0.0395167456492211,-0.0265483750997693,2.07448927084621e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39315,-0.0391665819161005,0.00393205842260271,-0.0468734164244018,-0.0314597474077992,2.65861849257976e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0417208695015096,0.00419454231431624,0.0334995665654498,0.0499421724375694,3.05013463314111e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0378478283208106,0.00380666779443637,0.0303867594437153,0.0453088971979059,3.1836918908261e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0231686839956812,0.00233831932326617,0.0185855781220795,0.0277517898692829,4.46261762803285e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.0622035145087954,0.00629301289618586,-0.0745378197853197,-0.0498692092322711,5.80770752939664e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.0445207250900919,0.00452508636498064,-0.0533898943654539,-0.0356515558147298,8.91974321219407e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00857335898641969,0.000877159064478769,0.0068541272200413,0.0102925907527981,1.67995606702812e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0244196887899113,0.0025179942488281,0.0194844200622082,0.0293549575176143,3.62575598030214e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.034911895627851,0.00362642375131288,-0.0420196861804242,-0.0278041050752777,7.0338207770211e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0538514947955327,0.00559993118818568,-0.0648273599243766,-0.0428756296666888,8.03534654221353e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0258758063420286,0.00269251065152827,-0.031153127219024,-0.0205984854650332,8.50169691332938e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,39865,-0.0290077619355753,0.0030216790463736,-0.0349302528664676,-0.0230852710046831,9.16053251739555e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.0850648613374025,0.00886572450470395,-0.102441681366622,-0.0676880413081828,9.64360064474981e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0271851825546646,0.002860444307005,0.0215787117129348,0.0327916533963944,2.35863469113626e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.0890403083648907,0.00945780036940977,-0.107577597088934,-0.0705030196408475,5.51168670464663e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37124,0.020376873790772,0.00216806222384752,0.0161274718320309,0.0246262757495131,6.41896007430271e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37124,0.0460691921353931,0.00491672458396038,0.0364324119508307,0.0557059723199554,8.41797776220174e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0256768907142337,0.00274119298626273,0.0203041524611588,0.0310496289673087,8.43160203783211e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,39866,-0.0704031341240463,0.00752332463462876,-0.0851488504079186,-0.0556574178401739,9.18254448599329e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.051480339800401,0.00550426657972729,-0.0622687022966665,-0.0406919773041355,9.64130574434126e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0259978235124592,0.00278270159125411,0.0205437283936012,0.0314519186313173,1.06066550147965e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.0534821853004044,0.00572689432982414,-0.0647068981868597,-0.0422574724139491,1.09879431876393e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,39785,-0.0649831330637831,0.00696464144416565,-0.0786338302943478,-0.0513324358332184,1.19030050863727e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0296680592067025,0.00318220630558109,-0.0359051835656415,-0.0234309348477636,1.2726371063748e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0370839704134802,0.00400282958766424,-0.0449295164053021,-0.0292384244216583,2.20410731266256e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0310531362935435,0.00338750326002595,0.0244136299038927,0.0376926426831944,5.44445002597975e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,39908,-0.0299542338660543,0.00328098819659398,-0.0363849707313785,-0.0235234970007301,7.67534345574172e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.0947096887546188,0.0103892444552779,-0.115072607886964,-0.0743467696222741,8.69617831730896e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0272738214253413,0.00299692400878596,0.0213998503681209,0.0331477924825618,1.01639878350009e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0395472759731839,0.00434731396845395,-0.0480680113513536,-0.0310265405950141,1.06051464346376e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0498984866254079,0.00548841482810053,-0.060655779688485,-0.0391411935623309,1.11399932270936e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0462120496188399,0.00508731890794927,-0.0561831946784205,-0.0362409045592594,1.19636066307482e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0286963350418343,0.00316012214578972,0.0225024956360865,0.0348901744475822,1.22498514687441e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.021009623661761,0.00231830239742141,0.016465750962815,0.0255534963607069,1.41920200848896e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.0227258492539048,0.00250778470251087,0.0178105912369835,0.0276411072708261,1.42460621142578e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.060455637580647,0.00668299613763502,-0.0735543100104117,-0.0473569651508824,1.68560307571788e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0244806445248316,0.00272796818291534,-0.0298274621633457,-0.0191338268863176,3.1712009785157e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.10586483657191,0.0117977573014398,-0.128988440882732,-0.0827412322610877,3.26187317031459e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0322676250532553,0.00360135198713863,-0.039326274948047,-0.0252089751584635,3.60576954106952e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.0428282862816723,0.00479039600958499,-0.0522174624604589,-0.0334391101028857,4.28871343469077e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.0719113890755739,0.00804596321000198,-0.0876814769671778,-0.05614130118397,4.41556448943037e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,39846,0.156916230591016,0.0175920789071084,0.122435755933084,0.191396705248949,5.17268390546282e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.0577806695558218,0.00648752511500482,-0.0704962187812313,-0.0450651203304124,5.82992488500201e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0188632066822034,0.00211944328940417,0.0147090978349712,0.0230173155294355,6.27967248465056e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0233021492323882,0.00262262102048299,0.0181618120322416,0.0284424864325349,7.05462790653307e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,39585,-0.0455104444614133,0.00512529507286626,-0.0555560228042312,-0.0354648661185954,7.42484202379548e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,39868,0.0266984208947448,0.00301164412683208,0.0207955984061539,0.0326012433833357,8.43805566633547e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.033763099952991,0.00381813899495375,0.0262795475228816,0.0412466523831003,1.02911645212599e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,39868,-0.0545455382804861,0.00617283481160807,-0.066644294511238,-0.0424467820497343,1.08972536203751e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0209408865854206,0.0023719870115468,0.0162917920427888,0.0255899811280523,1.16988131516506e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.0481789222288445,0.00545900362944527,-0.0588785693425573,-0.0374792751151318,1.20017268830548e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0435382774239766,0.00494129965186042,-0.053223224741623,-0.0338533301063302,1.36445245344726e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,39839,-0.041608941869004,0.004724496088582,-0.0508689542026247,-0.0323489295353833,1.41442476036109e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0365750270268264,0.00415771649159608,-0.0447241513503547,-0.0284259027032981,1.54626185326152e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0342876091157859,0.00390356451149523,0.0266366226732552,0.0419385955583165,1.74014980106793e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.0193611274479323,0.002214196930163,0.0150213014648128,0.0237009534310517,2.46633610970214e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0446198732379259,0.0051121999446123,0.0345999613464857,0.054639785129366,2.84107838521451e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,39758,-0.0649115975966187,0.00744726732859275,-0.0795082415606605,-0.050314953632577,3.15786864606732e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37043,-0.0549938224282786,0.00632377454619414,-0.0673884205388191,-0.042599224317738,3.82888438611878e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0354155339887345,0.00407677528122225,-0.0434060135399301,-0.0274250544375389,4.07734032546115e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0305743614516737,0.00352621643700363,-0.0374857456682008,-0.0236629772351466,4.71081709442468e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0243720270048185,0.00281114368473804,0.0188621853827319,0.029881868626905,4.7332151585174e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0217026521169823,0.00250800633304411,0.0167869597042158,0.0266183445297487,5.55914261715668e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.0230198246965693,0.00266466118453915,0.0177970887748725,0.028242560618266,6.30097357960419e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0276505527235557,0.0032015509636316,-0.0339255926122736,-0.0213755128348378,6.32433883706026e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0546672419906772,0.00633327325672479,0.0422540264074966,0.0670804575738578,6.60552112006576e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0200228507747282,0.00231993167456683,0.0154757846925772,0.0245699168568791,6.65726653245974e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.0458149892251604,0.00531211127047832,-0.0562267273152979,-0.0354032511350229,7.03586005691326e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0237670930894656,0.00275915699191028,0.0183591453853214,0.0291750407936097,7.85272259080427e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0236283796645229,0.00274887469853839,-0.0290161740736582,-0.0182405852553877,9.17685870671745e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0506611104498794,0.00590804234763465,-0.0622408734512433,-0.0390813474485155,1.08091837779248e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0485459378382423,0.00568922265752547,-0.0596968142469922,-0.0373950614294924,1.55153892217728e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,39843,-0.0280619115654602,0.00329075764533753,-0.0345117965503218,-0.0216120265805987,1.62775812741374e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0227087540194851,0.00267323569406418,-0.0279482959798508,-0.0174692120591193,2.15407389800784e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,39973,-0.0443403670762359,0.00522030497981565,-0.0545721648366746,-0.0341085693157972,2.17187945044125e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.0593497226305912,0.00701843266938038,-0.0731058506625767,-0.0455935945986056,2.9986144682122e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0275646728465557,0.0032621071828631,0.021170942768144,0.0339584029249674,3.16403987859686e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.027007944421937,0.00320181939517425,0.0207323784073955,0.0332835104364785,3.63808700803483e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0358323164679274,0.00425584877751612,0.0274908528639958,0.044173780071859,4.10479608983388e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASN,Vasorin,39642,0.0224361228259719,0.00266608632791411,0.0172105936232603,0.0276616520286836,4.24858253552003e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,39891,0.0228042046896947,0.00272342031385549,0.017466300874538,0.0281421085048515,6.05727989707444e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0720753931065614,0.00861109872248378,0.0551976396104932,0.0889531466026296,6.23021411182121e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0246029475845744,0.00294244526733232,-0.0303701403085457,-0.018835754860603,6.70275100744435e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,39866,-0.0264614438518597,0.00316551591020377,-0.032665855035859,-0.0202570326678603,6.82336465704944e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.0625572024021298,0.00749004945487335,-0.0772376993336816,-0.0478767054705781,7.35712211541436e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37309,-0.0204083949880877,0.00245801379394277,-0.0252261020242156,-0.0155906879519599,1.11327143688696e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,39788,-0.0557082699319042,0.00671655275841613,-0.0688727133383998,-0.0425438265254086,1.17998875013389e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPTC,Opticin,39788,0.0356812592089771,0.00430421588940051,0.0272449960657521,0.044117522352202,1.22361990575118e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,39858,-0.0289922394807359,0.00350725104787758,-0.035866451534576,-0.0221180274268959,1.48835493543806e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,39931,-0.0413123140129798,0.00500641131265299,-0.0511248801857797,-0.03149974784018,1.67899740743886e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0255316131971033,0.00309648232094468,0.0194625078480517,0.0316007185461549,1.77194122452078e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0328076140193515,0.00397952049635839,0.0250077538464891,0.040607474192214,1.79141034714154e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,39858,0.0365951807659718,0.00447214769469478,0.02782977128437,0.0453605902475736,2.97739286720819e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0520594262713043,0.00637675230794053,-0.0645578607948678,-0.0395609917477409,3.48254881733571e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.069201892750364,0.00850099686159215,-0.0858638465990846,-0.0525399389016434,4.28046877022081e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0238482865323845,0.00293433037950235,0.0180969989885599,0.0295995740762091,4.70274935877897e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.0686884623149075,0.00847167488783461,-0.0852929450950634,-0.0520839795347517,5.51674219512342e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.016500207594414,0.0020458821153666,0.0124902786482955,0.0205101365405326,7.94737980604078e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.0557815196664938,0.00693698862485054,-0.0693780173712008,-0.0421850219617867,9.63077711319392e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0383867363329708,0.00478253334879112,-0.0477605016966013,-0.0290129709693402,1.08736865311157e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.021218339666405,0.00264648015264289,-0.0264054407655851,-0.0160312385672249,1.16844547140618e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0484898884830909,0.00605510219102634,-0.0603578887775026,-0.0366218881886793,1.24444285688268e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0260604986572781,0.00326525842161383,0.019660592150915,0.0324604051636413,1.54645504615041e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37437,-0.0204892570886004,0.0025701025453826,-0.0255266580775503,-0.0154518560996505,1.683212996611e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0403072736764616,0.0050685568302299,0.030372902289211,0.0502416450637122,1.95054531047488e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0353795162206032,0.00445727832995538,-0.0441157817473158,-0.0266432506938907,2.19936847320548e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FST,Follistatin,39908,0.0395731944494822,0.00501040546535723,0.029752799737382,0.0493935891615823,3.01171744040877e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0196153692196811,0.0024909427020964,0.0147331215235721,0.02449761691579,3.63409018641479e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,39858,-0.0250010337691812,0.00317941169473971,-0.031232680690871,-0.0187693868474914,3.97513721751455e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.0400561524031667,0.00509532780935125,-0.0500429949094952,-0.0300693098968383,4.03868090490062e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37411,-0.0392029764575568,0.00499442930452007,-0.0489920578944162,-0.0294138950206975,4.49486533207866e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0228903156901868,0.00293828329168658,-0.0286493509418925,-0.0171312804384811,7.09126768469054e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40009,-0.0282075901165326,0.00362484688685049,-0.0353122900147595,-0.0211028902183056,7.5846365324471e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0314457627815207,0.00404533380135628,-0.0393746170321791,-0.0235169085308624,8.10487553822115e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.0974032295125615,0.0125635962693194,-0.122027878200428,-0.0727785808246954,9.52030518416668e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.0477637468526676,0.00617448436594,0.0356617574954253,0.05986573620991,1.08998547487704e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0445783731083295,0.00576671629213005,-0.0558811370409044,-0.0332756091757546,1.13578626649318e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,39858,0.0193029019459797,0.00250384166001318,0.0143953722923538,0.0242104315996055,1.33902501502252e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0191665783834353,0.00248842214139263,-0.0240438857805648,-0.0142892709863057,1.41428003984658e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0447580328943295,0.00582296904614266,-0.0561710522247691,-0.0333450135638899,1.60049668561085e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0367579574276392,0.00478735987512801,-0.04614118278289,-0.0273747320723883,1.70700418062158e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0173372401416816,0.00226698367086427,-0.0217805281365755,-0.0128939521467876,2.1831241506733e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0241975279116888,0.00317355117447288,-0.0304176882136556,-0.0179773676097219,2.58031386168612e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0290240057187641,0.00381185986386756,-0.0364952510519445,-0.0215527603855837,2.80183012130787e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.0174919250487803,0.00231030690749398,-0.0220201265874685,-0.0129637235100921,3.89752952168775e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37043,0.0482963229397008,0.00639501755136532,0.0357620885390248,0.0608305573403768,4.56164843864404e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0260434325293865,0.00346334287230004,0.0192552804996784,0.0328315845590945,5.77618602804932e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0293797889364882,0.00390743159975883,-0.0370383548720155,-0.0217212230009609,5.81400194404774e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.020399371626654,0.00271357516008903,-0.0257179789404285,-0.0150807643128795,5.87735442593161e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.0488169614889663,0.00650785565227047,-0.0615723585674165,-0.0360615644105162,6.6501780741478e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.046204714380135,0.00616652204348959,-0.0582910975853746,-0.0341183311748954,7.09194349789075e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0346931334732355,0.00463183581969382,-0.0437715316798354,-0.0256147352666356,7.31451687286288e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,39913,-0.0283101968181666,0.00379202555512693,-0.0357425669062154,-0.0208778267301178,8.70926263216964e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0216245923496878,0.00290289955684783,-0.0273142754811095,-0.0159349092182661,9.9564470657749e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.041447139534396,0.00556710100869097,-0.0523586575114303,-0.0305356215573617,1.02799028192299e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0380238350609745,0.00510848440333819,-0.0480364644915174,-0.0280112056304317,1.04158550430588e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0333165235266522,0.00447715697028977,-0.0420917511884202,-0.0245412958648843,1.04642251472393e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.025238856886477,0.00339467016148124,-0.0318924104029802,-0.0185853033699738,1.09980816246537e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0423965075155966,0.00571274930849164,0.031199518870953,0.0535934961602402,1.21659955516171e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0451127749849723,0.00607912628582967,-0.0570278625051985,-0.0331976874647462,1.22285084122341e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0340191332911742,0.00459889386763882,-0.0430329652717462,-0.0250053013106021,1.472245469997e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.057441762059576,0.00777636869649975,-0.0726834447047155,-0.0422000794144365,1.59283575415205e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0258586016121921,0.00350465356648164,-0.0327277226024961,-0.0189894806218881,1.68146245964901e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.0323736009610829,0.00440546432016211,0.0237388908935651,0.0410083110286006,2.10070908781532e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0272047756037338,0.00371242921871492,-0.034481136872415,-0.0199284143350525,2.44595282083188e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0274538515828531,0.00375342731318632,-0.0348105691166983,-0.0200971340490079,2.70757116291204e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40009,0.0210710279371624,0.00288111564293202,0.0154240412770156,0.0267180145973091,2.72486435078108e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.0201741805899294,0.00276573923898212,0.0147533316815244,0.0255950294983343,3.14303709391176e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.0461275715421923,0.00633693614667622,-0.0585479663896777,-0.0337071766947069,3.51343233120691e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0254693493850229,0.00350090709982828,-0.0323311273006863,-0.0186075714693594,3.6240059101186e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40030,-0.0385841755738852,0.00534502849238274,-0.0490604314189553,-0.028107919728815,5.48184067119404e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.0164948793231563,0.00228682733341867,0.0120126977496558,0.0209770608966569,5.71765843121917e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.013935436025392,0.00193286622590455,0.0101470182226191,0.0177238538281649,5.85824773295233e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37138,0.0148789523267793,0.00206806573112862,0.0108255434937672,0.0189323611597914,6.59931398947465e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0382646200135663,0.00532483208617626,-0.0487012909024718,-0.0278279491246608,6.97096181422134e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37411,-0.0301646219499838,0.0041985121022479,-0.0383937056703897,-0.0219355382295779,7.09261149320151e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.0238078945027532,0.00331624158152009,0.0173080610029738,0.0303077280025325,7.32116199883994e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.039633474681964,0.00555545046001437,-0.0505221575835922,-0.0287447917803359,1.0151809284583e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0308872548886454,0.00434475900007087,0.0223715272485065,0.0394029825287843,1.21705930838506e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0263392816677001,0.00371002126795911,-0.0336109233528999,-0.0190676399825002,1.30484923954753e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40058,-0.0233815164228152,0.00329775413850555,-0.0298451145342861,-0.0169179183113443,1.39514763445341e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0332436601249114,0.00469696065403757,-0.042449703006825,-0.0240376172429978,1.52764088012734e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0278978912765033,0.00394496875478294,-0.0356300300358778,-0.0201657525171287,1.59302725119829e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.0673834279677415,0.0095315058613749,-0.0860651794560363,-0.0487016764794467,1.61893475128608e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37437,-0.0767858309628272,0.0108672353694522,-0.0980856122869536,-0.0554860496387009,1.67465956493994e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39489,-0.0355902372694534,0.00504114962573377,-0.0454708905358915,-0.0257095840030152,1.73580601756148e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0162608310481937,0.00230428035958321,0.0117444415434106,0.0207772205529768,1.77366940958407e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0300835795349653,0.00426595344991311,0.0217223107731356,0.038444848296795,1.83554208957238e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0340974418085252,0.00484063289314349,-0.0435850822790865,-0.024609801337964,1.94416262920198e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,39868,-0.0240727119716903,0.00342247130056351,-0.0307807557207948,-0.0173646682225858,2.09234445932281e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.0546236258167623,0.0077738466828191,-0.0698603653150877,-0.0393868863184368,2.22032099512781e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0214971102316342,0.00306196645542278,-0.0274985644842629,-0.0154956559790056,2.31590195485052e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.018937013212453,0.00269856129540646,-0.0242261933514497,-0.0136478330734563,2.36715942510706e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,39868,-0.0453517228653115,0.00647898741670446,-0.0580505382020522,-0.0326529075285708,2.66472792170759e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0243855252818885,0.00348369928847218,-0.031213575887294,-0.017557474676483,2.68184708310685e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0268824965240146,0.00384281119645957,0.0193505865789538,0.0344144064690754,2.74600571383881e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.023196163635101,0.00331914538922484,0.0166906386722203,0.0297016885979817,2.88608458746977e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0236587043097014,0.00339093945479825,-0.030304945641106,-0.0170124629782969,3.13294846953164e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0199335298937637,0.0028582888229623,-0.0255357759867698,-0.0143312838007576,3.20231401692674e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,37453,-0.0148718486748253,0.00213232385725518,-0.0190512034350455,-0.0106924939146052,3.21195915312177e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37186,0.119663947167788,0.0171826754216341,0.0859859033413849,0.153341990994191,3.4571020547147e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0290663046162039,0.00417455196211961,0.0208841827704495,0.0372484264619583,3.46704811280173e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0259508796754475,0.00372945130439369,0.0186411551188359,0.0332606042320591,3.57660892727343e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.0238986699080011,0.00343816284875385,0.0171598707244435,0.0306374690915586,3.76686760148112e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0205671407366814,0.002960104545589,0.014765335827327,0.0263689456460359,3.87140898859926e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.024548939713789,0.00354073947398481,-0.0314887890827992,-0.0176090903447788,4.27097936942106e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0354863700930341,0.00512012085181331,-0.0455218069625882,-0.0254509332234801,4.34543502442787e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0280349421987207,0.00408342529032526,-0.0360384557677582,-0.0200314286296832,6.86715891788046e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0357049713863163,0.00520617125210263,-0.0459090670404374,-0.0255008757321951,7.2284662998153e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.030662669612841,0.00447260695167316,-0.0394289792381204,-0.0218963599875616,7.35513842386345e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,39858,0.0127809107975224,0.00186457527418837,0.00912634326011322,0.0164354783349316,7.41270068837318e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCN,Decorin,39585,0.0144998313684215,0.00211616760196336,0.0103521428685733,0.0186475198682697,7.55652156209669e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0412381682718505,0.00602039257033347,0.0294381988339969,0.0530381377097041,7.66761773403193e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0191807135549904,0.00280183610590954,0.0136891147874077,0.0246723123225731,7.87991903382506e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.0275972996890419,0.00403448079616129,0.0196897173285657,0.035504882049518,8.2420618491465e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.033147983292667,0.00484990183175098,-0.0426537908828989,-0.0236421757024351,8.50992684562604e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0178931605670292,0.00261830776812903,-0.0230250437925621,-0.0127612773414963,8.56270256191677e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0175251468381481,0.002565785785225,-0.0225540869771891,-0.0124962066991071,8.77423917493424e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0143570794912985,0.00210251696765767,-0.0184780127479076,-0.0102361462346895,8.88716069848744e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0142321548064635,0.00209100292721321,0.0101337890691256,0.0183305205438014,1.03705062368893e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0176840050206238,0.00259888859437629,0.0125901833756463,0.0227778266656014,1.05814606291068e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.0392361909940159,0.00577465742927665,-0.0505545195553981,-0.0279178624326337,1.12455842691524e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELL,L-selectin,37453,0.0150045835476091,0.00220984592074839,0.0106732855429422,0.0193358815522759,1.16888202847831e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0251648911882108,0.0037104343563165,0.0178924398498305,0.0324373425265911,1.225593781416e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0327088153630395,0.00483460736021452,-0.04218464578906,-0.0232329849370191,1.37360482789032e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,39866,0.0278896459945271,0.0041229843071997,0.0198085967524157,0.0359706952366385,1.38469540613254e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.0132686157820854,0.00196350217283329,0.0094201515233322,0.0171170800408387,1.45089623977171e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,39897,-0.0175074199404545,0.00259208356614071,-0.0225879037300903,-0.0124269361508187,1.48573424194104e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0174140664476886,0.00257956671668361,-0.0224700172123885,-0.0123581156829888,1.52099149388452e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RETN,Resistin,39790,-0.0268384257506166,0.00397834945779102,-0.034635990687887,-0.0190408608133462,1.57079277093213e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,39858,0.0156743296590349,0.00232439402066191,0.0111185173785376,0.0202301419395323,1.60013674061919e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.0254757783248617,0.00378547888857981,-0.0328953169464782,-0.0180562397032453,1.75622445979245e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37043,-0.0397186650596109,0.00590375433090814,-0.0512900235481909,-0.028147306571031,1.79487363573192e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.0113672429245065,0.0016957165535149,0.00804363847961734,0.0146908473693957,2.10292818441723e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0180162195191544,0.00268989575254023,-0.0232884151941333,-0.0127440238441756,2.18793813608993e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0354769400684549,0.00529976858115101,-0.0458644864875109,-0.0250893936493989,2.24199418818401e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.0201415010645795,0.00301112401057191,0.0142396980038586,0.0260433041253004,2.33644688233058e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.0581848302666246,0.00870144467378555,-0.0752396618272443,-0.0411299987060049,2.35704864574592e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,37453,-0.0130388305728678,0.00195009034241963,-0.0168610076440103,-0.00921665350172534,2.37869648238296e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.0177854610835938,0.00266158801349655,0.0125687485771405,0.023002173590047,2.42934732798105e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.0440317782428024,0.00659009542652907,-0.0569483652787993,-0.0311151912068054,2.44492436357454e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.0384026106990085,0.00574974311163566,-0.0496721071978144,-0.0271331142002026,2.48685750571107e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,39846,-0.0188602451730412,0.00282478452504548,-0.0243968228421304,-0.0133236675039521,2.5242605998087e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.0594254824134907,0.00890144000847701,-0.0768723048301057,-0.0419786599968758,2.53703234623026e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,39913,-0.0262885869170068,0.00394324766716917,-0.0340173523446583,-0.0185598214893552,2.70082620102076e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.0122354999972035,0.00183757152258054,0.00863385981294569,0.0158371401814614,2.87251828293304e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.0460563389498896,0.00691841842438398,-0.0596164390616822,-0.032496238838097,2.88665721341635e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37056,-0.0293951201998923,0.00441884554097038,-0.0380560574601943,-0.0207341829395904,3.00094632052226e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0191538755757267,0.00288005191732447,-0.0247987773336826,-0.0135089738177707,3.03552236117444e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,39713,-0.0395291975460151,0.00594488568751433,-0.0511811734935432,-0.027877221598487,3.04156977918746e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0345718773582095,0.00520916500191633,-0.0447818407619655,-0.0243619139544535,3.32929606750634e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37430,-0.0364121370908693,0.00549716759083371,-0.0471865855689034,-0.0256376886128353,3.63271671401887e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0205631322470061,0.00310564881728175,-0.0266502039288783,-0.0144760605651339,3.69839237606455e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,39749,0.0269819762053797,0.00409296999354856,0.0189597550180246,0.0350041973927349,4.46786648936569e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0334384170204457,0.00507897612920166,-0.043393210233681,-0.0234836238072104,4.73286672703298e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0419655003937831,0.00637868110096854,-0.0544677153516815,-0.0294632854358848,4.91501586594094e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0433113104451048,0.0066013853159788,-0.0562500256644232,-0.0303725952257863,5.50900508857712e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0173877983713531,0.00265411645485426,-0.0225898666228674,-0.0121857301198387,5.88376652532412e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0495204853752638,0.0075627383927051,-0.0643434526249658,-0.0346975181255618,6.04354690274747e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.0166203665430233,0.00253821228441769,-0.021595262620482,-0.0116454704655646,6.0448522885449e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0191868517585651,0.00293275870664286,0.0134386446935451,0.0249350588235851,6.24312656602365e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.0181152173004092,0.00277127213288962,0.0126835239199456,0.0235469106808729,6.51537302970957e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0299208568062804,0.0045796552199007,-0.0388969810372858,-0.020944732575275,6.62174709421981e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.016374232029076,0.00251061498513946,0.0114534266582027,0.0212950373999493,7.18308098143498e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.0145529267017193,0.00223230646850971,0.0101776060234402,0.0189282473799983,7.31656488247986e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.0664420892770663,0.0102008794339435,-0.0864358129675956,-0.046448365586537,7.56885695750266e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.0724748631573649,0.0111322708705803,-0.0942941140637022,-0.0506556122510275,7.7223086713661e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.022405166505451,0.00344263247033973,0.0156576068635851,0.0291527261473169,7.83425718937539e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37437,-0.0477666409731086,0.00735314382815673,-0.0621788028762958,-0.0333544790699215,8.53106866025522e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0107928133748222,0.00166874864332503,-0.0140635607157392,-0.00752206603390512,1.02971823851962e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,39789,-0.0472565461829717,0.00732640963538813,-0.0616163090683324,-0.032896783297611,1.14948715817655e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0353804285135912,0.00550061566045595,-0.0461616352080848,-0.0245992218190975,1.29521938655451e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.047112411652747,0.0073304193291706,-0.0614800335379214,-0.0327447897675726,1.34656863620695e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0378726317776018,0.00590132729774492,-0.0494392332811818,-0.0263060302740217,1.42293153218529e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39314,-0.0574460455364832,0.00896016484995454,-0.0750079686423941,-0.0398841224305723,1.48498024079831e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.0175764113555347,0.00274389920816375,0.0121983689075338,0.0229544538035356,1.53907796214526e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.0567403793530236,0.00891686671063352,-0.0742174381058653,-0.0392633206001819,2.03852068793493e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0228124851800794,0.00359021715562026,-0.0298493108050951,-0.0157756595550636,2.15360127930779e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37043,-0.0374869708695636,0.00592002938346931,-0.0490902284611635,-0.0258837132779638,2.4948780620183e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0380143531785985,0.00600753821999168,-0.0497891280897822,-0.0262395782674149,2.5678176217126e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0216650914876305,0.00342466192813939,0.0149527541084773,0.0283774288667837,2.59396461164616e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37445,-0.0138444063100173,0.00219113990114913,-0.0181390405162696,-0.00954977210376503,2.72605094012629e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0172274958377417,0.00273186015520835,-0.02258194174195,-0.0118730499335333,2.93582605078399e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.038705979900171,0.00614021245872899,-0.0507407963192798,-0.0266711634810622,2.99654391425701e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0348666578526436,0.00554125155228941,-0.0457275108951309,-0.0240058048101564,3.2261195881093e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0275550747058157,0.00438235508248459,-0.0361444906674855,-0.0189656587441459,3.30492638250694e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEP,Leptin,39868,-0.0414176781867538,0.00661078865785406,-0.0543748239561477,-0.0284605324173598,3.81949786639958e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0239349975433277,0.00382263035401685,-0.0314273530372007,-0.0164426420494546,3.91326258803948e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0273623120134554,0.00437802650409451,-0.0359432439614806,-0.0187813800654301,4.23303564072771e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0359610913441817,0.00576674674225553,0.0246582677293608,0.0472639149590025,4.60476817870662e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.042671723223433,0.00684643851132633,-0.0560907427056326,-0.0292527037412334,4.7246644098411e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.0665261882444514,0.0107027897792452,-0.0875036562117719,-0.0455487202771308,5.25698357778285e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,39868,-0.0260343158704623,0.00418997175733334,-0.0342466605148357,-0.017821971226089,5.31047664785907e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.0555369879505717,0.0089396049181681,-0.0730586135901811,-0.0380153623109622,5.34514408652637e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.051274373742236,0.00825517750264833,-0.0674545216474267,-0.0350942258370453,5.38943578958714e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0371443655757568,0.00598079388203804,-0.0488667215845514,-0.0254220095669622,5.41160305766931e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37088,0.0186751033103639,0.00300996710279844,0.012775567788879,0.0245746388318488,5.65359802940625e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0448284856670999,0.00723689540246077,-0.059012800655923,-0.0306441706782768,5.992357239614e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.0259618272933675,0.00419129710347801,-0.0341767696161844,-0.0177468849705506,6.03179731974027e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0361226846135753,0.00583520979116385,-0.0475596958042565,-0.0246856734228942,6.17196933909737e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0367599154467899,0.00595129058588461,0.0250953858984561,0.0484244449951238,6.72808682462898e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNST,Consortin,39868,-0.065020655152357,0.0105397154785428,-0.0856784974903009,-0.0443628128144131,7.03269932485651e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,39858,0.0189235592579917,0.00307282523379421,0.012900821799755,0.0249462967162283,7.52590650840318e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0499026217040609,0.00810463581130428,-0.0657877078942173,-0.0340175355139045,7.57671607301462e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0264783851944403,0.00430147379345337,-0.0349092738296089,-0.0180474965592717,7.65594965008397e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLN,Promotilin,39866,-0.053499253418072,0.00869459819501542,-0.0705406658803022,-0.0364578409558418,7.77619791340982e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0141496604212008,0.00230089182921777,-0.0186594084064677,-0.009639912435934,7.94887706430874e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0313551744496777,0.00510687832331317,-0.0413646559633715,-0.0213456929359838,8.45558044822549e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.040949795650852,0.00668114920432059,-0.0540448480913203,-0.0278547432103836,9.04053703516067e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0414342024748366,0.0067714737973151,-0.0547062911175742,-0.028162113832099,9.68071680789382e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00863981042701616,0.00141346182735159,0.00586942524540704,0.0114101956086253,1.00763141988299e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.0507343733763448,0.00830276095086968,-0.0670077848400494,-0.0344609619126402,1.02090873815039e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.0655976329633136,0.0107387899463608,-0.0866456612581808,-0.0445496046684464,1.02972306082881e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.0499862831984598,0.00819237354231236,-0.066043335341392,-0.0339292310555276,1.07904104295327e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,39908,0.0182191599405528,0.00298827519304801,0.0123621405621787,0.0240761793189269,1.10633783162767e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0201200719233575,0.00330436200833975,-0.0265966214597034,-0.0136435223870116,1.16227659296333e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0188260666906108,0.00309924973972757,-0.0249005961804768,-0.0127515372007448,1.27268367281453e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.034970311875905,0.00575702324901389,-0.0462540774439723,-0.0236865463078378,1.27797855600775e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0260297715556935,0.0042855404065069,-0.034429430752447,-0.01763011235894,1.28224023412789e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0504795815007913,0.00832040589702067,-0.0667875770589518,-0.0341715859426308,1.33359155892415e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.0511196754310549,0.00842612524365897,-0.0676348809086265,-0.0346044699534833,1.33415540499271e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0153817118148733,0.00253943420129831,-0.020359002849418,-0.0104044207803286,1.41682897282281e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.0453650957509794,0.00749004761425027,-0.06004558907491,-0.0306846024270489,1.41997963164101e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37056,-0.04994843139954,0.00827015700101,-0.0661579391215196,-0.0337389236775604,1.58650785103546e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0251135420137301,0.00416010505077825,0.0169597361142047,0.0332673479132555,1.61465702036811e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0153938675129169,0.00255128009964921,0.0103933585176045,0.0203943765082294,1.6432866983429e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELN,Elastin,37437,-0.0198007495424431,0.00328228087942361,-0.0262340200661134,-0.0133674790187728,1.65517881372658e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0243906540649434,0.00404733131748371,-0.0323234234472115,-0.0164578846826753,1.71377878134664e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0235231346587853,0.00390797558645004,0.0158635025093432,0.0311827668082274,1.79037027873117e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.0434501225756547,0.00722938711744292,-0.0576197213258429,-0.0292805238254666,1.89334966565474e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37124,-0.0269590497735168,0.00449287817244196,-0.0357650909915031,-0.0181530085555306,2.01966659184168e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37445,-0.0155413655882638,0.00259095879438977,-0.0206196448252677,-0.0104630863512599,2.04451175791651e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0365314339181615,0.00609497635992105,0.0245852802527162,0.0484775875836067,2.10522574373022e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,37453,-0.012018001583513,0.00200568286055005,-0.0159491399901911,-0.00808686317683494,2.12549595535174e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0225074073960901,0.00375704516029128,-0.029871215910261,-0.0151435988819192,2.14217121169475e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,39720,-0.0161668157324969,0.0027005196460466,-0.0214598342387482,-0.0108737972262455,2.18950123009925e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0331651453069673,0.00554020607647008,-0.0440239492168486,-0.0223063413970859,2.19298890456738e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0370497722220515,0.00619646109026258,0.0249047084851369,0.0491948359589662,2.29042379218925e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0413269299767331,0.00691200957032144,-0.0548744687345631,-0.027779391218903,2.29364260800633e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.0726726872774758,0.0121595002433289,-0.0965053077544003,-0.0488400668005512,2.3267651269366e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0166428916937588,0.00279138724590168,0.0111717726917915,0.022114010695726,2.53989413331861e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,39862,0.0128655811292135,0.00216112842218803,0.00862976942172501,0.0171013928367021,2.68482909065136e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.0236844472060401,0.00398047498578445,0.0158827162339026,0.0314861781781776,2.73476822929223e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.0440339956297043,0.00740238395793064,-0.0585426681872483,-0.0295253230721602,2.75973198262647e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,39749,0.0192385485508855,0.00323727294840738,0.012893493572007,0.025583603529764,2.86008156424592e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37411,0.0261272415268798,0.00439649979580411,0.0175101019271038,0.0347443811266559,2.871843941816e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.0578551376945705,0.00973871854042227,-0.0769430260337981,-0.0387672493553428,2.90728468867435e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,39885,0.0187496654964182,0.00315951689459599,0.0125570123830101,0.0249423186098264,3.01101189294392e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.042581139069586,0.00719427790897449,-0.056681923771176,-0.028480354367996,3.3105474453491e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.0555481604539882,0.00939163575112522,-0.0739557665261937,-0.0371405543817828,3.39313549369194e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37124,-0.0305179456677249,0.00516320629973567,-0.0406378300152068,-0.020398061320243,3.49113112540817e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0164529258231043,0.00278797073162832,0.0109885031891128,0.0219173484570958,3.67689895292214e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0236313053274499,0.00400497226504604,-0.0314810509669401,-0.0157815596879596,3.69703743702528e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0325670045909269,0.00552276124048343,-0.0433916166222744,-0.0217423925595793,3.77919527712134e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37124,-0.0397293799350966,0.0067437862893435,-0.0529472010622098,-0.0265115588079833,3.92560591402782e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0128903344864908,0.0021894881101955,-0.017181731182474,-0.00859893779050765,4.00250129671735e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0142014355679761,0.0024154792996647,0.0094670961406333,0.0189357749953189,4.19994259958424e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0291068884027932,0.0049575063199764,-0.0388236007899469,-0.0193901760156394,4.41226645566079e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0224272843300638,0.00382990385415101,-0.0299338958841998,-0.0149206727759278,4.84162995782601e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.0534243060686136,0.00912479543594921,-0.0713089051230741,-0.0355397070141532,4.8678908828741e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0205365370511328,0.00351507619081665,0.0136469877171322,0.0274260863851334,5.2455244810726e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0349922353990151,0.00599424486896449,-0.0467409553421855,-0.0232435154558447,5.39718792814455e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0148847812195637,0.00255344571312963,-0.0198895348172978,-0.00988002762182964,5.67295571387056e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.020155152511041,0.00345814188880707,-0.0269331106131028,-0.0133771944089791,5.72580926710404e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0362644270768505,0.00622979311583403,-0.0484748215838852,-0.0240540325698158,5.95981014812308e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.0605651888662131,0.0104041103067293,-0.0809572450674025,-0.0401731326650238,5.97251830907524e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,39587,0.0168378169462026,0.00289433823968911,0.011164913996412,0.0225107198959933,6.08943243836021e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0257521993598898,0.00442727683417507,0.0170747367649066,0.0344296619548729,6.11575929736021e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37437,-0.012996364743346,0.00223658988285621,-0.0173800809137442,-0.00861264857294782,6.35718009500071e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0492043569457037,0.0084877604998427,-0.0658403675253954,-0.032568346366012,6.87434584576855e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0167057696193104,0.00288387223443274,-0.0223581591987986,-0.0110533800398223,7.05058264124107e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0195897458838133,0.00338251907340053,0.0129600084999482,0.0262194832676783,7.10830914591121e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0324094968231363,0.0056090025254153,-0.0434031417729503,-0.0214158518733223,7.6953741957206e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.0463332344623113,0.00801877227315499,-0.0620500281176951,-0.0306164408069275,7.72172762562606e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0205420588123482,0.00356366514730046,-0.0275268425010571,-0.0135572751236393,8.3515102779584e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39504,-0.0278820295017091,0.00484170328722246,-0.0373717679446651,-0.0183922910587531,8.63433223718191e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0260796685713776,0.00453172090793952,-0.0349618415509391,-0.0171974955918162,8.83111222413107e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0210154706746475,0.00365560810278105,-0.0281804625560983,-0.0138504787931966,9.14869855451856e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0229092767432491,0.00398558188063865,0.0150975362571974,0.0307210172293009,9.19119892018062e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,39587,-0.0267070404772147,0.00465143559207326,-0.0358238542376783,-0.0175902267167511,9.54735344541445e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F3,Tissue factor,39931,0.0152122033990662,0.00264989880967191,0.0100184017321093,0.0204060050660232,9.60024320002728e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0200220175346747,0.0034898062123485,0.0131819973584717,0.0268620377108778,9.8265973459146e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0156915006857338,0.00274162568304686,-0.0210650870245056,-0.010317914346962,1.06245199158609e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0243380317598894,0.00426220607528276,-0.0326919556674436,-0.0159841078523352,1.14858402655867e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0274527986072928,0.00480971557512309,-0.036879841134534,-0.0180257560800515,1.16537679433308e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0279560322908659,0.00490876417370387,-0.0375772100713255,-0.0183348545104063,1.25446481480309e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.035297489320179,0.00620192099130556,-0.0474532544631379,-0.0231417241772201,1.28223703189966e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0217769800124655,0.00382639451777845,0.0142772467576198,0.0292767132673113,1.28293537105378e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37056,-0.0514965699074947,0.00904827514337369,-0.0692311891885071,-0.0337619506264823,1.28748308791061e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37388,0.0205873517684367,0.00362012088466047,0.0134919148345022,0.0276827887023712,1.32024158923833e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.0569778600655228,0.0100226708653268,-0.0766222949615634,-0.0373334251694823,1.33596271385501e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.0117137018312686,0.00206087212075754,0.00767439247458386,0.0157530111879534,1.34463976864552e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.015686168863652,0.00276918241783098,0.0102585713247033,0.0211137664026007,1.50430666104429e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0312710021076419,0.00552211371147675,-0.0420943449821363,-0.0204476592331475,1.51466227584594e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0347027537272072,0.00613004537483269,-0.0467176426618793,-0.0226878647925352,1.52992474003565e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0384902314156712,0.00679984811474169,0.0251625291107775,0.0518179337205649,1.53560815143702e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0143895672215961,0.00254227767533421,0.00940670297794107,0.0193724314652512,1.54430779418231e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,39788,-0.0282493071889613,0.00499224482798056,-0.0380341070518032,-0.0184645073261194,1.5520458469334e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0129570770075677,0.00229243347911868,-0.0174502466266403,-0.00846390738849508,1.61164443617262e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0124158357146204,0.0021968679468467,-0.0167216968904399,-0.00810997453880083,1.62227706661e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.04755771269031,0.0084172349352684,-0.0640554931634361,-0.031059932217184,1.63727845340676e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,39913,-0.0313102009056803,0.00554550425199314,-0.0421793892395868,-0.0204410125717737,1.66953788730126e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.0147519057533763,0.00261341984387588,0.00962960285937961,0.0198742086473731,1.68275241051943e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0176094211525739,0.00312399794744455,-0.0237324571295653,-0.0114863851755826,1.76104691457714e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0283468254060382,0.00503156505473289,-0.0382086929133147,-0.0184849578987618,1.79321947706717e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37299,0.0156601761129741,0.00277979389721607,0.0102117800744306,0.0211085721515176,1.80055004132555e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.012330089575203,0.00218875528747667,-0.0166200499386572,-0.00804012921174868,1.80219736425705e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.0137474965165304,0.0024409886039526,0.00896315885278333,0.0185318341802775,1.81731665349473e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0086092969431175,0.0015290735800577,0.0056123127262044,0.0116062811600306,1.82775669432135e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0203016840444527,0.00360887715265119,-0.027375083263649,-0.0132282848252564,1.88083363253982e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.0505037084065388,0.00899621613252085,-0.0681362920262797,-0.032871124786798,2.01119736664814e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,39713,0.0259383684204775,0.00462149931104183,0.0168802297708356,0.0349965070701195,2.02712207370232e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,37453,0.0165735408436339,0.0029624685953681,0.0107671023967124,0.0223799792905554,2.25526077877018e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,39720,0.0170946357903744,0.00305663138163253,0.0111036382823747,0.0230856332983742,2.27335881195307e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0276340019127161,0.00494232290018934,-0.0373209547970872,-0.017947049028345,2.29742811316269e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.016768258684365,0.00299927909509381,0.0108896716579811,0.0226468457107489,2.29766328828137e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0144911705713342,0.00259209785832719,-0.0195716823736554,-0.00941065876901287,2.30092086208924e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0162946277726311,0.00292507697132538,-0.0220277786364289,-0.0105614769088334,2.57870437687342e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,39788,0.0157025740274171,0.00284089297035556,0.0101344238055202,0.021270724249314,3.30231498715983e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0419292453610983,0.00759586275545265,0.0270413543604111,0.0568171363617855,3.4424613076148e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0160408318741078,0.0029063861943276,-0.0217373488149899,-0.0103443149332257,3.45884448153877e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0190914139764968,0.00346106652681243,-0.0258751043690492,-0.0123077235839445,3.52104484745194e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.0124344761981623,0.00225882031890129,0.0080071883731158,0.0168617640232089,3.75194934116025e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0308593033458511,0.00561114040942581,-0.0418571385483257,-0.0198614681433765,3.86336133519322e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.0467022096930974,0.00849263453111472,-0.0633477733740822,-0.0300566460121125,3.8765130938985e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.022457447760654,0.00408510975458081,-0.0304642628796324,-0.0144506326416756,3.91275057553239e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40030,-0.0214496709242369,0.00390704049523584,-0.0291074702948991,-0.0137918715535746,4.07975352048804e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.032567746170821,0.00594620944902379,-0.0442223166909076,-0.0209131756507344,4.39127702778052e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39489,-0.0346887581849692,0.00633544096349308,-0.0471062224734156,-0.0222712938965227,4.43380886349004e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39448,0.0636297283436714,0.0116343386497101,0.0408264245902396,0.0864330320971032,4.59207884553387e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,39788,0.00802913119997676,0.00146910831347717,0.00514967890556151,0.010908583494392,4.69042329561675e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0174234832795788,0.00318860610302478,0.0111738153176502,0.0236731512415074,4.73139222851402e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.0206816065275236,0.00379461410622963,-0.0281190501757337,-0.0132441628793136,5.10431527671296e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0297007270079905,0.00545339603032859,-0.0403893832274345,-0.0190120707885465,5.21923347887862e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,39868,-0.0185826794423733,0.00341271085123615,-0.0252715927107961,-0.0118937661739504,5.2528048901293e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0215891697513719,0.00396913240419454,0.0138096702391506,0.0293686692635932,5.42891614764816e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37241,-0.0124302583446788,0.00228687345333477,-0.016912530313215,-0.00794798637614269,5.56063192832202e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0270449396509424,0.0049820655363999,-0.0368097881022862,-0.0172800911995986,5.78524169446143e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0374462245112064,0.00690049457573144,-0.05097119387964,-0.0239212551427728,5.84518718407506e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40052,0.0161310397235856,0.00297579749532294,0.0102984766327527,0.0219636028144186,6.02005177684824e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0343574603959917,0.00635286493986394,-0.046809075678125,-0.0219058451138584,6.45768995392636e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0372164608656489,0.00688954593073459,-0.0507199708898887,-0.0237129508414091,6.68970777256574e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0366607508547943,0.00678786923739746,-0.0499649745600933,-0.0233565271494953,6.74201720751718e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0265826160447216,0.00492835595253492,-0.03624219371169,-0.0169230383777531,6.99823912979117e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0309914016733656,0.00574958994034862,-0.0422605979564489,-0.0197222053902823,7.14042144421314e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0420249479146746,0.00781245105723447,-0.0573373519868542,-0.0267125438424951,7.60857408443754e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37422,-0.0243356170924146,0.00453487660824056,-0.0332239752445661,-0.0154472589402631,8.16790572418953e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39397,0.0338329690549468,0.00631246444140894,0.0214605387497852,0.0462053993601083,8.4546169873859e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.0467362341936106,0.00873842470843996,-0.063863546622153,-0.0296089217650683,8.9985895308963e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,39749,-0.0219857939969953,0.00411514124494477,-0.030051470837087,-0.0139201171569035,9.28557433239615e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0245329595375916,0.00460462742050999,-0.0335580292817912,-0.015507889793392,1.00703052496061e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0393135125621068,0.00739697316802741,-0.0538115799714406,-0.0248154451527731,1.08457364325614e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39489,0.0381674013848788,0.00718357089044212,0.0240876024396122,0.0522472003301453,1.09223040945633e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0276750242430797,0.00520938779675317,-0.0378854243247159,-0.0174646241614435,1.09561896303209e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.0442117233159345,0.0083223790910901,-0.0605235863344711,-0.0278998602973979,1.09670548015658e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0398297437170368,0.0074987638908713,-0.0545273209431446,-0.0251321664909291,1.10183066676798e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0283188611748968,0.00533619041359102,-0.0387777943855352,-0.0178599279642584,1.13001860573645e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0365231719861817,0.00688617616372323,0.0230262667052842,0.0500200772670792,1.15178944952658e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0227943144011575,0.00431443565802096,-0.0312506082908786,-0.0143380205114364,1.28565971860151e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.0563095665403196,0.0106819588515034,-0.0772462058892662,-0.035372927191373,1.37425601762283e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40052,0.0137780142524739,0.00261587410929786,0.00865090099825008,0.0189051275066977,1.40385406894302e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0298060521667197,0.0056596031051158,-0.0408988742527467,-0.0187132300806927,1.40925444533385e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0367824241500043,0.0069910169892351,-0.0504848174489051,-0.0230800308511035,1.44804370445708e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0206253691438935,0.00392653391468574,-0.0283213756166775,-0.0129293626711094,1.5168565565444e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0290111979888902,0.00552749040286879,-0.039845079178513,-0.0181773167992674,1.55694800505587e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0212939445157806,0.00405835654348798,-0.0292483233410171,-0.0133395656905442,1.57030425809706e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.035040246373822,0.00667952511904766,-0.0481321156071554,-0.0219483771404886,1.57496701499211e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.058621661121142,0.0111827931985545,-0.0805399357903088,-0.0367033864519751,1.61125362045444e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0264699359509967,0.00505494914569315,-0.0363776362765553,-0.0165622356254381,1.66219034208668e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNC,Tenascin,39931,0.0240513551810717,0.00459552542236477,0.0150441253532368,0.0330585850089066,1.68288313842259e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.021747732326421,0.00415814774499073,0.0135977627462391,0.0298977019066028,1.7149793767512e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0197338134711886,0.00378036814132031,-0.0271433350281764,-0.0123242919142008,1.81557271211634e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,39731,0.0146240895485858,0.00280281009780126,0.0091305817568953,0.0201175973402762,1.83485225968864e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.048363535638169,0.00927221737661921,-0.0665370816963426,-0.0301899895799953,1.85144169969705e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.0396512354682061,0.00760501303075137,-0.0545570610084787,-0.0247454099279334,1.87703332599886e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0730418950095915,0.0140229443140422,0.0455569241540687,0.100526865865114,1.92904660244845e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0343123283191942,0.00659671056377734,-0.0472418810241978,-0.0213827756141906,2.00729085840335e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0169870117646423,0.00327817064568961,-0.0234122262301939,-0.0105617972990907,2.22357697493119e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0157218058418635,0.00304481161179969,0.00975397508273608,0.0216896366009909,2.45939339246276e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0411370518748928,0.00797181392856232,-0.056761807174875,-0.0255122965749107,2.49484758262138e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0210689961192619,0.00409254645979321,-0.0290903871804566,-0.0130476050580672,2.66181495048822e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.0362874422599688,0.0070653611311879,-0.0501355500770971,-0.0224393344428405,2.83970998641223e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0251200502080956,0.00489311311307921,-0.0347105519097309,-0.0155295485064604,2.87413557493252e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0249463778318231,0.00486471136803574,0.0154115435504731,0.0344812121131732,2.96838852834676e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0198127175792436,0.00386754951658146,-0.0273931146317433,-0.0122323205267439,3.0524198419896e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0216954436139202,0.00423532902808174,-0.0299966885089605,-0.01339419871888,3.05738660710142e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_E,,39866,-0.0136632426195738,0.00267405658046331,-0.0189043935172819,-0.00842209172186571,3.2663083319748e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37257,0.0536388925344014,0.0105053233235177,0.0330484588203067,0.0742293262484961,3.33779818684663e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.0488574024386996,0.00956968082766446,-0.067613976860922,-0.0301008280164773,3.345048829991e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0362218380258469,0.00710906971017666,-0.0501556146577932,-0.0222880613939007,3.53151109447662e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0099053427232144,0.00194528657295308,-0.0137181044062024,-0.00609258104022637,3.58395157530813e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39344,-0.0380555864190231,0.00747624084500443,-0.0527090184752318,-0.0234021543628145,3.61871303095552e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0106136797095765,0.00208805644797315,-0.0147062703476039,-0.00652108907154914,3.76402341281545e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0295907312830133,0.0058324813431014,-0.041022394715492,-0.0181590678505345,3.95142333756638e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40030,0.0219146382131789,0.0043218862081449,0.0134437412452149,0.0303855351811429,4.0090671899169e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0183802043193542,0.00362514001947905,0.0112749298811752,0.0254854787575331,4.0193382959222e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0378291748153621,0.00746236788280802,-0.0524554158656658,-0.0232029337650583,4.04481804815445e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.0148702869755404,0.00293378074236328,0.00912007672050839,0.0206204972305725,4.05111279414185e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37043,-0.0369232953634718,0.00730005961472279,-0.0512314122083284,-0.0226151785186151,4.29495857134214e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.0163018017303096,0.00322347115063776,0.00998379827505963,0.0226198051855597,4.30095984867967e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0169834537525624,0.00335966203738956,0.0103985161592789,0.0235683913458459,4.34915916051589e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.0407930260329798,0.00808313932136104,-0.0566359791028475,-0.0249500729631122,4.5550396823872e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRN,Agrin,39931,-0.0160431707004949,0.00318010953279374,-0.0222761853847706,-0.00981015601621915,4.58829971022731e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0168231714578298,0.00333585361687593,-0.0233614445469066,-0.0102848983687529,4.63090334069501e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,39788,-0.0504464860870784,0.0100389155255358,-0.0701227605171286,-0.0307702116570282,5.08640712840535e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.0407130995851531,0.00810222287780591,-0.0565934564256527,-0.0248327427446536,5.09031116856956e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0180887907992914,0.00360083866675556,-0.0251464345861323,-0.0110311470124505,5.14050623682184e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.0192465052715655,0.00383401251779575,-0.0267611698064452,-0.0117318407366858,5.23464796348376e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0320033719880436,0.00638210913705041,-0.0445123058966624,-0.0194944380794248,5.38453188494104e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0416734644677402,0.00831359555635134,-0.0579681117581888,-0.0253788171772916,5.42491053293837e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.0232860282517379,0.00465591188899768,0.0141604409493024,0.0324116155541733,5.76291686793097e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.027233320038525,0.00544623514311888,-0.037907940919038,-0.016558699158012,5.78189293611377e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.0478907517051918,0.00958093034004899,-0.0666693751716878,-0.0291121282386957,5.83734812514478e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.0518641155022994,0.0103815027001155,-0.0722118607945257,-0.0315163702100731,5.92039844101197e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0315593898131063,0.00632476541638755,-0.0439559300292259,-0.0191628495969867,6.10881334442252e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0340482897649513,0.00682385568071243,-0.0474230468991477,-0.0206735326307549,6.11560682401947e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.0359463306273043,0.00720710893483887,-0.0500722641395885,-0.0218203971150202,6.17835304752709e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0123364395535211,0.00247368849237914,-0.0171848689985842,-0.00748801010845797,6.19463779918059e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0317998768144751,0.00638553157862754,-0.0443155187085851,-0.0192842349203651,6.42524093418522e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37169,-0.0626480747699459,0.0125793055226271,-0.087303513594295,-0.0379926359455969,6.42985654201154e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0306095161925145,0.00617216848273256,-0.0427069664186703,-0.0185120659663587,7.16130719403456e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.0130456455428995,0.00263076529054688,0.00788934557342766,0.0182019455123714,7.16191446348525e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,39713,-0.0386195607306416,0.00779146281944802,-0.0538908278567597,-0.0233482936045235,7.24591401039043e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,39795,-0.021987269802215,0.0044372934055431,-0.0306843648770794,-0.0132901747273505,7.30315737265662e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0188164984619644,0.00380337139394442,-0.0262711063940955,-0.0113618905298334,7.61643533825592e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.0549020794769984,0.0110978457448949,-0.0766538571369924,-0.0331503018170043,7.62500528129841e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0172535578775502,0.00349152228271616,-0.0240969415516739,-0.0104101742034265,7.82841478961853e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.016594992024002,0.00336099777789906,-0.0231825476686841,-0.0100074363793198,7.99234494650644e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,39587,-0.0207657789835422,0.00420593855842441,-0.0290094185580541,-0.0125221394090304,8.0043190761766e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.0365723983184371,0.00741100296253639,-0.0510979641250084,-0.0220468325118658,8.11744091874658e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0175612891439188,0.00355902722029714,-0.0245369824957012,-0.0105855957921364,8.12750165664033e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,0.00848596440361952,0.00172017241340281,0.00511442647335002,0.011857502333889,8.18478059980834e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0295904690282826,0.00600561949647388,-0.0413614832413714,-0.0178194548151938,8.43001171256505e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0253421074977702,0.00514492134674972,-0.0354261533373996,-0.0152580616581407,8.49323926816834e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.0498808265439281,0.0101463579619876,-0.0697676881494238,-0.0299939649384324,8.914564635758e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.0398088909574878,0.00809838730300921,-0.0556817300713859,-0.0239360518435897,8.93834706126887e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40058,-0.0217550506331797,0.0044380680303793,-0.0304536639727231,-0.0130564372936363,9.58234595357951e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0178138548956313,0.0036413113439982,-0.0249508251298678,-0.0106768846613949,1.0072534117491e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39477,-0.0222080418028753,0.00455386351573589,-0.0311336142937176,-0.013282469312033,1.08910922062287e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.0525224707820841,0.010780564142322,-0.0736523765010352,-0.0313925650631329,1.11761413630625e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.0130404699496406,0.00268056106678393,0.00778657025874413,0.0182943696405371,1.15642516687285e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40009,-0.0290118312631878,0.00596682199787445,-0.0407068023790217,-0.0173168601473538,1.17185375885419e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37437,0.0143575458174843,0.00295464206538791,0.00856644736932397,0.0201486442656446,1.1910668315733e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0131767350175135,0.00271209382076144,-0.0184924389062059,-0.00786103112882106,1.19624220591744e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0362634666933248,0.00746668551347314,0.0216287630869174,0.0508981702997321,1.20490535064284e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0134299880372163,0.00276778191814841,-0.0188548405967872,-0.00800513547764544,1.23221610986023e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.0345214750608023,0.00712758110433655,-0.0484915340253019,-0.0205514160963026,1.28858197592201e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.012268511709046,0.00253673450936894,-0.0172405113474091,-0.00729651207068285,1.33707954096359e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0351345090922498,0.00731130907673691,-0.0494646748826541,-0.0208043433018455,1.55773703736363e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,39952,0.0185023300475893,0.00385043633933038,0.0109554748225018,0.0260491852726769,1.55948331717307e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0457136156117625,0.00951496996375978,-0.0643629567407316,-0.0270642744827933,1.56633986596255e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0137433251187604,0.00286215012955726,-0.0193531393726927,-0.0081335108648282,1.58964261094602e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0246340332726458,0.00513124223127691,-0.0346912680459486,-0.0145767984993431,1.59726416808076e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0245297349278078,0.00511342223590164,-0.034552042510175,-0.0145074273454406,1.62418766040719e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0287241485985165,0.00598878463964047,-0.0404621664922118,-0.0169861307048212,1.63319856582896e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0271160499393381,0.0056558047303344,-0.0382014272107935,-0.0160306726678827,1.64636713601408e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37388,0.0174511816019389,0.00364769734674111,0.0103016948023264,0.0246006684015515,1.73513315842481e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0404695411105193,0.00847814660444401,-0.0570867084552295,-0.023852373765809,1.82743280553909e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0373462006999968,0.00782567194293462,-0.0526845177081487,-0.022007883691845,1.84118647036038e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.026905041114858,0.00564041745588678,-0.0379602593283961,-0.0158498229013199,1.85838308368521e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.0319597352681741,0.00671255091995486,-0.0451163350712857,-0.0188031354650626,1.94441202218346e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0247866026888963,0.00521653324930845,-0.0350110078575409,-0.0145621975202518,2.03632400828872e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0259665597592156,0.00546827738185691,0.015248736090776,0.0366843834276551,2.06605274867335e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,36543,-0.0113714917020974,0.00239475161564462,-0.0160652048687609,-0.006677778535434,2.07167614898659e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.033764604823069,0.0071235138942125,-0.0477266920557255,-0.0198025175904125,2.16080197470424e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0230776312864897,0.00487027504440259,-0.0326233703735188,-0.0135318921994606,2.17206577922561e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0269020022484316,0.00567702332185407,-0.0380289679592656,-0.0157750365375976,2.17223563055656e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,39882,-0.0425963560199794,0.00898956580745425,-0.0602159050025897,-0.024976807037369,2.17237872696873e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.0408806978760195,0.00862821220869749,-0.0577919938050666,-0.0239694019469724,2.1800434153962e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,39749,-0.066952478855648,0.0141368369197717,-0.0946606792184005,-0.0392442784928954,2.19828628299504e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0205330145280521,0.00433745728903212,-0.029034430814555,-0.0120315982415491,2.22164555669436e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0223470947559775,0.00472757798203987,-0.0316131476007757,-0.0130810419111794,2.30201034094735e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0275219136822344,0.00582467795181331,-0.0389382824677885,-0.0161055448966803,2.31993041523038e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0378483680510321,0.00801917752668816,-0.0535659560033409,-0.0221307800987233,2.38513161342312e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0262569391194453,0.00556401649878989,-0.0371624114570735,-0.0153514667818171,2.38933318750206e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.00988409583140778,0.00209684857148045,-0.0139939190315095,-0.0057742726313061,2.45180020265843e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,36879,-0.0321317025104898,0.00682160863263422,-0.0455020554304529,-0.0187613495905267,2.49929802926108e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0223438874745329,0.00474720757593709,-0.0316484143233696,-0.0130393606256962,2.53815809713708e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0170484633598986,0.00362297233368346,-0.0241494891339181,-0.00994743758587898,2.55552299786399e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.042238792322452,0.00897756302645035,-0.0598348158542947,-0.0246427687906093,2.560782298608e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0122751718922496,0.00260958677969679,-0.0173899619804553,-0.00716038180404385,2.5741579806376e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37437,-0.0128572295962399,0.00273720430008667,-0.0182221500244098,-0.00749230916807004,2.6632104786325e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.0141321764376419,0.00300939952075243,-0.0200305994983167,-0.00823375337696718,2.6788419344686e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.0434076745131418,0.00924509523472518,-0.0615280611732031,-0.0252872878530804,2.68514288119163e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,39866,-0.0437465930562677,0.00932033436073348,-0.0620144484033053,-0.0254787377092301,2.70567089620374e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.043248730002819,0.00923541854337045,-0.0613501503478251,-0.0251473096578129,2.85155799822554e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0314635961557938,0.00672186253065022,-0.0446384467158682,-0.0182887455957193,2.88624864866149e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.0554241751173416,0.0118414363274573,-0.0786333903191578,-0.0322149599155254,2.88986834169748e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0446633010041623,0.00958672881523105,-0.0634532894820152,-0.0258733125263095,3.20984994180726e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0374083750606054,0.00803133314548068,-0.0531497880257475,-0.0216669620954633,3.22148115963947e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0429813120963505,0.0092359325985952,-0.0610837399895971,-0.0248788842031039,3.28627726852446e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40030,0.0206386834881663,0.00443809606724669,0.0119400151963627,0.0293373517799698,3.34000134962882e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0170894299956315,0.00367668678729734,-0.0242957360987343,-0.00988312389252875,3.37759183486614e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37420,0.0161931026593643,0.00348523964948121,0.00936203294638109,0.0230241723723474,3.4129469180056e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLU,Clusterin,37453,0.0144612854071263,0.00311371613618363,0.00835840178020639,0.0205641690340462,3.442934100742e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.0123915039651633,0.00267492479857635,-0.017634356570373,-0.00714865135995369,3.64187963652931e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,39725,0.022217917338768,0.00479912588824569,0.0128116305978065,0.0316242040797296,3.69320105968656e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0361428919025393,0.00781199038884288,-0.0514543930646713,-0.0208313907404073,3.75186073892591e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0234528996355095,0.00507622978359791,-0.0334023100113614,-0.0135034892596575,3.86460135601494e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40009,-0.0156000936533708,0.00337909148774281,-0.0222231129693467,-0.00897707433739487,3.92982488102668e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0135118049877177,0.00292714764218785,-0.0192490143664059,-0.00777459560902952,3.94188438667214e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,39619,-0.0190955393060021,0.00414028283301704,-0.0272104936587155,-0.0109805849532887,4.01690745234056e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0161002165553414,0.00349670490564634,-0.0229537581704083,-0.0092466749402746,4.1743103368736e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39489,-0.0320766378633445,0.00697469604597398,-0.0457470421134536,-0.0184062336132355,4.27850879981216e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,39673,-0.0148132086104061,0.00324498056078119,-0.0211733705095372,-0.00845304671127492,5.0335234578372e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0266843013518757,0.00586118793663303,-0.0381722297076765,-0.015196372996075,5.34327198386104e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.0291960398330527,0.00642618503233229,-0.041791362496424,-0.0166007171696814,5.57853993448393e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0282185304879952,0.006215490212306,-0.040400891304115,-0.0160361696718755,5.67434829544832e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0134766721895672,0.00297104222580528,-0.0192999149521456,-0.00765342942698887,5.77471472589346e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.0104074245361684,0.0022951081845538,0.00590901249444297,0.0149058365778939,5.81284614514016e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.0609919754486967,0.0134505622789002,-0.0873550775153412,-0.0346288733820523,5.81528515397342e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40012,0.0199048309130957,0.00439207714647172,0.0112963597060112,0.0285133021201803,5.88509743351689e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0165030578551548,0.00364121037764568,-0.0236398301953403,-0.00936628551496927,5.88581714453901e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0344092926987522,0.00759263296980314,-0.0492908533195664,-0.0195277320779381,5.88661380178766e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0205660628962062,0.00453944966985809,-0.029463384249128,-0.0116687415432843,5.92646074878903e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.0149640760902998,0.00330517608441894,-0.0214422212157609,-0.00848593096483865,6.01361355116361e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0415176171868616,0.00917336231769009,-0.0594974073295341,-0.023537827044189,6.0654090733498e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.0105625907079371,0.00233427206507965,0.00598741746038104,0.0151377639554933,6.0906672787348e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.011459996154673,0.00253927068206907,0.00648302561781764,0.0164369666915284,6.44391079576753e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0312560745283149,0.00692672993718002,-0.0448324652051878,-0.0176796838514421,6.46428684295834e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37445,-0.0319564414884437,0.00708561046032504,-0.0458442379906808,-0.0180686449862066,6.53559177585977e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.0145822671345363,0.00323360437049993,0.0082444025683564,0.0209201317007161,6.54131173027744e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0279831859828791,0.006210463771833,-0.0401556949756718,-0.0158106769900864,6.66846461972671e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37388,0.0133157751898382,0.00295831658337755,0.00751747468641821,0.0191140756932582,6.81565735655494e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,39866,-0.0356867099809145,0.00793094628420388,-0.0512313646979541,-0.0201420552638749,6.85355892513811e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0230440500651605,0.00512226851972762,-0.0330836963638266,-0.0130044037664943,6.88318141843458e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0129726551830078,0.00288534977203412,-0.0186279407361946,-0.00731736962982088,6.98055790511003e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,39868,0.0114992255971254,0.00255983464771738,0.00648194968759933,0.0165165015066515,7.0992718320217e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0161594777800725,0.00359961971101509,-0.023214732413662,-0.00910422314648289,7.19929836204057e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37445,-0.0272773516706153,0.00608232265685569,-0.0391987040780525,-0.0153559992631782,7.36174053586364e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39238,0.0134597271326144,0.00300672606135985,0.00756654405234907,0.0193529102128797,7.64080457416549e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.024048135331936,0.00537528500661064,-0.0345836939448929,-0.0135125767189791,7.73717500717261e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.0122747980670028,0.00274492916154308,0.00689473691037836,0.0176548592236272,7.80894800982132e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0335705139014092,0.00751046046484107,-0.0482910164124977,-0.0188500113903207,7.89167003416662e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0336535092052102,0.00752976146442743,-0.048411841675488,-0.0188951767349325,7.90936375691485e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.0422419873208669,0.00945750329265346,-0.0607786937744677,-0.0237052808672661,8.00618178435886e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.0433386119970735,0.00972552374290819,-0.0624006385331736,-0.0242765854609735,8.39953195624971e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.0121968266262995,0.00273940721885043,0.00682758847735266,0.0175660647752463,8.55060424717532e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0195283276983358,0.00439242118893332,-0.0281374732286451,-0.0109191821680265,8.81231593354811e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.028626226466662,0.00643970909447514,0.0160043966414907,0.0412480562918332,8.84812762136605e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37388,-0.0266214680618946,0.00599855872567482,-0.0383786431642172,-0.0148642929595719,9.15262012144396e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0202655341390574,0.00457007001919823,-0.029222871376686,-0.0113081969014289,9.29424480742739e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0568583663269185,0.0128314111298861,-0.0820079321414952,-0.0317088005123418,9.43417312736458e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0337699467331415,0.0076229284911469,-0.0487108865757894,-0.0188290068904936,9.4966324367451e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0257153032777244,0.00582338776144924,-0.0371291432901649,-0.0143014632652839,1.01387445635759e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,39866,-0.0171866692496106,0.00389429285931526,-0.0248194832538685,-0.00955385524535268,1.02474098789174e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0214445856463978,0.00486658859274829,-0.0309830992881845,-0.0119060720046112,1.05732789599705e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00869333818818351,0.00197315750933428,0.00482594946988831,0.0125607269064787,1.06075111147893e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.0130925648728907,0.00297229543647636,0.00726686581739704,0.0189182639283843,1.06553236534068e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0179537677953986,0.00408972731580548,-0.0259696333343773,-0.00993790225641984,1.14087839247394e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0256883028413855,0.00585496159940586,0.01421257810655,0.037164027576221,1.15559674707874e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0107242209189273,0.00245818558626725,0.00590617716984347,0.0155422646680111,1.2928793737657e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37445,0.00966342989930552,0.0022157314223152,0.00532059631156772,0.0140062634870433,1.30254862974366e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0250423979981884,0.00574377950844814,-0.0363002058347467,-0.01378459016163,1.30944531347293e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPS,Colipase,39836,0.0293825810071834,0.00674679816306424,0.0161588566075775,0.0426063054067893,1.33870519266428e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0358606930320763,0.00824014478125975,-0.0520113768033454,-0.0197100092608071,1.35772479073099e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.0330858371908814,0.0076029400955176,-0.0479875997780959,-0.0181840746036669,1.35912956380727e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0291383862600606,0.00669933072915505,-0.0422690744892045,-0.0160076980309167,1.37326122152314e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0209095797341567,0.00480979835285496,-0.0303367845057524,-0.0114823749625609,1.38864797503634e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.0428461282637929,0.00985963366078654,-0.0621710102389345,-0.0235212462886513,1.39741328339392e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.0180133378587362,0.00414761128864551,0.00988401973299103,0.0261426559844814,1.41383452696767e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.026007620492709,0.00599432462797537,-0.0377564967635407,-0.0142587442218773,1.4420550180484e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37021,0.0176078498393117,0.00405936467199129,0.00965149508220877,0.0255642045964146,1.45127836842982e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40058,-0.0174118151121279,0.00402028258305865,-0.0252915689749229,-0.00953206124933299,1.49330932892789e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,39788,-0.0298462840687112,0.00692052077621197,-0.0434105047900866,-0.0162820633473357,1.62226794109553e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.0477345385966384,0.0110720603557348,-0.0694357768938785,-0.0260333002993982,1.63298176167271e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0379351394843404,0.00880063628921868,0.0206858923574717,0.055184386611209,1.64073029171422e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0306144866780783,0.00711701054051127,-0.0445638273374804,-0.0166651460186762,1.70795231992906e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0233224020269946,0.00543016323366212,-0.0339655219649724,-0.0126792820890168,1.75931617024356e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0138268240808608,0.00321960796893511,-0.0201372556999736,-0.00751639246174794,1.76305742956507e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0463317230813681,0.0107905213639779,0.0251823012079713,0.0674811449547649,1.76727878959583e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0494350514582971,0.0115280119413859,-0.0720299548634135,-0.0268401480531807,1.81150444394577e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.0138443343802714,0.00323228863019683,0.00750904866508563,0.0201796200954572,1.85370506785736e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0202592782056767,0.00473855393413043,-0.0295468439165723,-0.010971712494781,1.91874917725984e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.031179183592754,0.00729722801653327,-0.0454817505051592,-0.0168766166803488,1.94437585718191e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.0124297780905674,0.00291169915233569,0.00672284775198943,0.0181367084291453,1.97804064794092e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.0331114579709104,0.00777129780701449,-0.0483432016726588,-0.017879714269162,2.04946461893966e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,36763,-0.00982070497282938,0.00230726722111997,-0.0143429487262245,-0.00529846121943423,2.09191575169467e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0227415506452612,0.00534738984959287,-0.0332224347504633,-0.0122606665400592,2.12281956117975e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0203790840371157,0.00479843908742199,0.0109741434257686,0.0297840246484628,2.18109190782058e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0242699433050458,0.00571683986208785,-0.035474949434738,-0.0130649371753536,2.19512076213178e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.0450340356813061,0.0106175824362499,-0.0658444972563558,-0.0242235741062564,2.23548567178445e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,0.0165031416766701,0.0038912513459685,0.00887628903857182,0.0241299943147683,2.23709730949707e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0314414075877418,0.00742696666484321,-0.0459982622508345,-0.0168845529246491,2.31734517145188e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37306,-0.0388312013823672,0.00919378165802777,-0.0568510134321017,-0.0208113893326328,2.41973144745685e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,0.0113896385998001,0.00269742670402639,0.00610268225990838,0.0166765949396918,2.43279185224628e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0332283537573402,0.00787072345483654,-0.0486549717288199,-0.0178017357858606,2.43976259704417e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,39699,0.0278345730670976,0.00659516560493524,0.0149080484814245,0.0407610976527707,2.45172298655711e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39477,0.0232178604898158,0.00550614464998364,0.0124258169758479,0.0340099040037838,2.49279235071074e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37424,0.00929918739136602,0.00220759688485226,0.00497229749705558,0.0136260772856765,2.5435161126794e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.016560519942607,0.00393497668756525,-0.0242730742502349,-0.00884796563497915,2.58448974171844e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.00843061107434089,0.00200389317409016,0.00450298045312417,0.0123582416955576,2.60065980966538e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0080306614216946,0.00191084303332154,-0.0117759137670048,-0.00428540907638438,2.65207649341616e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0243243915415038,0.0057913248858414,-0.0356753883177529,-0.0129733947652547,2.68179738049956e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0162262739480219,0.00387209978402947,-0.0238155895247197,-0.00863695837132414,2.80034095994433e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.019309565658802,0.00461364483827423,-0.0283523095418195,-0.0102668217757845,2.86615475996452e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37382,-0.0426354719300121,0.0101940689643658,-0.0626158471001692,-0.0226550967598551,2.90292129717377e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.0431641618497126,0.0103216624075938,-0.0633946201685965,-0.0229337035308287,2.90901100028113e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0309949894292721,0.00741744871282779,-0.0455331889064146,-0.0164567899521297,2.95074853022973e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0122998693716315,0.00294599919542151,-0.0180740277946576,-0.00652571094860532,2.99698660347364e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0109542878995009,0.0026239848314851,-0.0160972981692117,-0.0058112776297901,2.99973559475311e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.038677213291136,0.00926892492361195,-0.0568443061414154,-0.0205101204408566,3.0249759333612e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.0342654464327176,0.00821401026537685,-0.0503649065528563,-0.018165986312579,3.04082527673729e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.029068738875186,0.00696811716988198,-0.0427262485281547,-0.0154112292222173,3.04253285113391e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0163169782178987,0.00392116781224465,-0.0240024671298982,-0.00863148930589919,3.18453500484007e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.012699455603318,0.00305213351729908,-0.0186816372972242,-0.00671727390941178,3.18708308354748e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0113831675731019,0.00274132811825314,-0.0167561706848781,-0.00601016446132575,3.30670642674997e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0293220486700759,0.00706657453423599,-0.0431725347571784,-0.0154715625829733,3.35378288276776e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00819794534514392,0.0019761896035674,0.00432461372215182,0.012071276968136,3.36969136437996e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.00945407100938812,0.00227952801581985,0.00498619609838122,0.013921945920395,3.38043290575601e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0113380963039454,0.00273753222128378,-0.0167036594576616,-0.00597253315022919,3.46464197337232e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0234344723024919,0.00566728695959351,-0.0345423547432952,-0.0123265898616886,3.56712079716158e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.0399327658294949,0.0096597866647663,0.020999583966553,0.0588659476924368,3.58442196736289e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.0122973469223727,0.00297528732345449,-0.0181289100763435,-0.00646578376840192,3.59974080933682e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.00943950293909911,0.00228649569867749,0.00495797136969123,0.013921034508507,3.67172353286556e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0275607955802971,0.00667627689951669,-0.0406462983033498,-0.0144752928572444,3.67849360819601e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0414965538959215,0.0100598569156696,-0.0612138734506339,-0.0217792343412092,3.72652182145899e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0310337722455774,0.00752612285115215,0.0162825714573191,0.0457849730338356,3.7507853271348e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.0135693525304202,0.00329106706781415,0.00711886107750448,0.020019843983336,3.76053541651615e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0283404757399505,0.00687420216297453,-0.0418139119793805,-0.0148670395005204,3.76330642689856e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0270336053114657,0.00656145160211831,-0.0398940504516175,-0.0141731601713138,3.80718534840243e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0203267102309435,0.00495004991324945,-0.0300288080609124,-0.0106246124009746,4.04344347117989e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.0157540448753036,0.00384454929836519,-0.0232893615000993,-0.0082187282505078,4.19665879643442e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0185436969371035,0.00453433352449908,-0.0274309906451217,-0.00965640322908534,4.34203152771672e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0258199268120263,0.00631372423189398,-0.0381948263065385,-0.0134450273175141,4.34437317555908e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37368,-0.0261448923990853,0.00639589752233311,-0.0386808515428582,-0.0136089332553124,4.38078941165191e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.0343967178834233,0.00841653059448144,-0.0508931178486069,-0.0179003179182397,4.39880304577158e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40052,0.00773272696900646,0.00189483049930991,0.00401885919035905,0.0114465947476539,4.50651650490113e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,39859,-0.0125127849152118,0.00306950816138932,-0.0185290209115349,-0.00649654891888877,4.59437730026367e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.0407622043880841,0.0100242123118536,-0.0604096605193171,-0.021114748256851,4.80206555168932e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0444029106251971,0.010933689354437,-0.0658329417598935,-0.0229728794905006,4.90748349043085e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.00951107969562288,0.00234642531235882,-0.0141100733078462,-0.00491208608339959,5.07526502910315e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0389599833165947,0.00961700545946735,-0.0578093140171507,-0.0201106526160387,5.12117652476779e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0126082684643569,0.00311320684493847,-0.0187101538804363,-0.00650638304827748,5.14724141000564e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0169805822211795,0.00419295108618395,-0.0251987663501,-0.00876239809225895,5.15021068790372e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0188461410817119,0.00466110861641075,0.00971036819354679,0.0279819139698769,5.3001492460692e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,39868,-0.0210310708194263,0.00521251147082432,-0.031247593302242,-0.0108145483366107,5.4919261607654e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0232776285586682,0.00578259481993743,-0.0346115144057456,-0.0119437427115909,5.71313963423291e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0136832275764592,0.0034040584541261,0.00701127300637199,0.0203551821465463,5.85409234279255e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,39858,0.0186794484580051,0.00464810126633261,0.00956916997599321,0.027789726940017,5.87813693475956e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.00830386125628233,0.00206683709816428,-0.0123548619686843,-0.00425286054388035,5.90438147007296e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0158550618037993,0.00395356452785322,-0.0236040482783916,-0.00810607532920697,6.09164979932401e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0356701887060291,0.00891355800817295,-0.0531407624020481,-0.0181996150100101,6.32085054607412e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,39985,0.0117277517006415,0.00293410915803783,0.00597689775088737,0.0174786056503957,6.44248488142972e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0330527123849229,0.0082738316342981,-0.0492694223881471,-0.0168360023816986,6.50263538438743e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.025306757337552,0.00634048546953622,-0.037734108857843,-0.0128794058172611,6.60034320345275e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.0132078449388928,0.0033103823064357,0.0067194956182788,0.0196961942595067,6.64791215127659e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0128692816272755,0.00322613279304537,-0.0191925019016444,-0.00654606135290656,6.66793786564474e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,39720,-0.020044079669606,0.00502524212959958,-0.0298935542436211,-0.0101946050955908,6.6740352695639e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0141337560466768,0.00354427002865663,-0.0210805253028438,-0.00718698679050979,6.70550808522726e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0243566047622002,0.00610883721794134,-0.0363299257093652,-0.0123832838150351,6.72339768160274e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0279199694345394,0.00701330957964673,-0.041666056210647,-0.0141738826584318,6.89260928221864e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0256435523672127,0.00644141219336429,-0.0382687202662067,-0.0130183844682187,6.89708364868603e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0226504513737864,0.00569350854354661,-0.0338097281191378,-0.0114911746284351,6.97171338900404e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0139189308215517,0.00350029875434804,-0.0207795163800738,-0.00705834526302951,7.02622879964115e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.00772004798275704,0.00194188130353899,-0.0115261353376935,-0.00391396062782061,7.0581470860215e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFP,Properdin,37453,0.00899737886584074,0.00226340973622097,0.00456109578284764,0.0134336619488338,7.07004948815861e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37249,0.012167847871667,0.0030615365294566,0.00616723627393205,0.0181684594694019,7.0919559661733e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0186482401897886,0.00469454477099098,-0.0278495479409309,-0.00944693243864624,7.1544616274196e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.015204309886183,0.00384707872709003,-0.0227445841912795,-0.00766403558108654,7.77865422709845e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,39858,-0.0248446326540409,0.00628652749458008,-0.0371662265434178,-0.012523038764664,7.78194408003661e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.0109032309928665,0.00275921844188591,0.0054951628467701,0.0163112991389629,7.79840870123224e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0198725707692113,0.00503225041889661,-0.0297357815902487,-0.010009359948174,7.88005753990949e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.0400682819512521,0.0101505413458214,-0.0599633429890622,-0.0201732209134421,7.93397548222369e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0144644941094068,0.00366732381154618,-0.0216524487800373,-0.00727653943877628,8.04232780957103e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37371,-0.0327671270334924,0.00830895825111157,-0.049052685205671,-0.0164815688613137,8.06759322324392e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00676518769927455,0.0017162712781791,0.00340129599404351,0.0101290794045056,8.1218310404844e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0255713553450259,0.00649001773242346,-0.0382917901005759,-0.012850920589476,8.17923176334453e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.0330773384691116,0.00839911780865245,-0.0495396093740704,-0.0166150675641528,8.24457954604489e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDK,Midkine,39843,-0.019427131929276,0.00493795271600617,-0.0291055192526481,-0.00974874460590385,8.38103158308845e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0349227801996786,0.00887695240162526,-0.0523216069068641,-0.017523953492493,8.39276879906986e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0185236806572302,0.0047124367029677,-0.0277600565950469,-0.00928730471941356,8.50259324930967e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0228599708223201,0.00581702950596972,-0.0342613486540207,-0.0114585929906194,8.5367567938956e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37445,0.0235402939944113,0.00600218118210222,0.0117760188774909,0.0353045691113316,8.82646654387891e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,39587,-0.0437362175372081,0.0111638543830589,-0.0656173721280034,-0.0218550629464127,8.97897155046794e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0159722183693157,0.00408352103807369,-0.0239759196039401,-0.00796851713469125,9.2216507056612e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0296614980534649,0.00758808017470419,-0.0445341351958851,-0.0147888609110447,9.31456911716972e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37437,-0.0174675549688915,0.00447148405499431,-0.0262316637166803,-0.00870344622110262,9.41223611622192e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0126064953271069,0.00322775003009429,-0.0189328853860917,-0.00628010526812208,9.43504009053892e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0222859879551324,0.00570733968063817,-0.0334723737291832,-0.0110996021810816,9.47726227405541e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0157380635746147,0.00403204736405741,-0.0236408764081672,-0.00783525074106213,9.53722547789659e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBN,Nibrin,39587,-0.0196250442689026,0.0050305874166565,-0.0294849956055493,-0.00976509293225582,9.61377168075603e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0214025519488488,0.00549910094346644,-0.032180789798043,-0.0106243140996546,9.98202952109259e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37056,0.0204350172983697,0.00525023988406767,0.010144547125597,0.0307254874711423,9.98252235060488e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0313583176118297,0.00805905523982091,-0.0471540658818787,-0.0155625693417807,0.000100282940042558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0197343722631864,0.00508006119480709,-0.0296912922050083,-0.0097774523213645,0.000102968827865012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2,Prothrombin,37453,0.00557483070351898,0.00143583740801441,0.00276058938381075,0.00838907202322722,0.000103819922034106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00922632640768195,0.00238556313134618,-0.0139020301451205,-0.00455062267024343,0.000110439947773853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00462332792341595,0.00120023644047665,0.00227086450008173,0.00697579134675018,0.000117610150169605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0119761408669371,0.00311030521348867,0.00587994264849934,0.0180723390853749,0.000118357760726988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37368,-0.0241017312493649,0.0062659936032962,-0.0363830787118254,-0.0118203837869043,0.000120399981238121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0117508502843226,0.00305741352449486,-0.0177433807923325,-0.00575831977631263,0.000121807101946651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0253617871347689,0.00661877219705283,-0.0383345806409924,-0.0123889936285453,0.000127698454607607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0254261815235792,0.00663944831562621,-0.0384395002222065,-0.0124128628249518,0.000128949556327287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0280090004545665,0.00734153209962576,-0.042398403369833,-0.0136195975393001,0.000136706890575532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37056,0.0127804330797436,0.00335023022598049,0.00621398183682183,0.0193468843226653,0.000136918754005309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0187728406871016,0.00492518313184321,-0.0284261996255143,-0.00911948174868887,0.000138681016031059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.0094599266427144,0.00248489930495926,0.00458952400499426,0.0143303292804346,0.000141299955162415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELP,P-selectin,39931,-0.0212803422315712,0.00560350933697773,-0.0322632205320475,-0.0102974639310948,0.000146593352452967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0182176465814231,0.00479695909510152,-0.0276196864078221,-0.00881560675502413,0.000146652166427812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0115734676295328,0.00304784128664168,-0.0175472365513504,-0.00559969870771507,0.000146939425347985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0167932702238181,0.00442315786326431,-0.0254626596358161,-0.00812388081182007,0.000147207589619176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.018040975736283,0.00475731357279474,-0.0273653103389607,-0.00871664113360533,0.000149931861926673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0249115524455179,0.00657228905178552,-0.0377932389870175,-0.0120298659040183,0.000150974615899152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0306414400722007,0.00810651687304428,-0.0465302131433675,-0.0147526670010339,0.000157596104850234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0120093359066461,0.00317722826720098,0.00578196850293215,0.01823670331036,0.000157636471476084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,37453,0.00820973017809337,0.00217255483610778,0.00395152269932211,0.0124679376568646,0.000158235439522938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0130871865668054,0.00346675232369018,-0.0198820211212382,-0.00629235201237266,0.000160550197351245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,39749,0.0206014337864432,0.00546015490444625,0.00989953017372854,0.0313033373991578,0.000161849977700919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0189864378320148,0.00504457780971954,-0.0288738103390651,-0.00909906532496454,0.000167999749578585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0227627644128856,0.00605600514445934,-0.0346325344960259,-0.0108929943297453,0.000171403312851093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.0135353144946984,0.00360497276796502,0.00646956786948695,0.0206010611199098,0.000174341437776112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0187037642003704,0.00498265347801409,-0.028469765017278,-0.00893776338346274,0.00017482191869308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39419,-0.0251112784225211,0.00670202190169837,-0.03824724134985,-0.0119753154951923,0.000179736477722339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,39889,0.0108074384588843,0.00288479029773746,0.00515324947531891,0.0164616274424497,0.000180053932580906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0105230517348955,0.00280928521308211,-0.0160292507525365,-0.00501685271725458,0.000180457932174039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.00737160648259255,0.00196883177106597,0.00351269621130326,0.0112305167538818,0.000181634936969627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40058,-0.0139541400450186,0.0037271166915293,-0.021259288760416,-0.00664899132962114,0.000181776118035097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.0395525760869155,0.0105672366369723,-0.0602643598953811,-0.0188407922784499,0.000182629502784688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0234144395216416,0.00625713844353103,-0.0356784308709624,-0.0111504481723208,0.000183287215241943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0160839399235203,0.00430265188124045,-0.0245171376107515,-0.00765074223628896,0.000186143318392095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0229127350488434,0.00613048428875808,-0.0349284842548092,-0.0108969858428775,0.000186618128210938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,39885,0.011576102883354,0.00310683738500429,0.00548670160874561,0.0176655041579624,0.000195203844033206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,39880,-0.0212529877275138,0.00570545429111788,-0.0324356781381048,-0.0100702973169227,0.000195962322342016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,36991,-0.023423413239243,0.00628785923543635,-0.0357476173406982,-0.0110992091377877,0.00019599273114311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.0165635359766997,0.00444902515885029,-0.0252836252880462,-0.0078434466653531,0.000197574111922513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0198959025226074,0.00534761073278659,-0.0303772195588692,-0.00941458548634573,0.000199494688718226
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.022161406124779,0.0059632604329559,-0.0338493965733726,-0.0104734156761854,0.000202978682527512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37385,-0.035046424748959,0.0094397230847547,-0.0535482819950782,-0.0165445675028398,0.000205920803689182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,39587,-0.0240656957800481,0.00648504452099889,-0.0367763830412059,-0.0113550085188902,0.000207192041992017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,39868,0.016438806109616,0.00443009466717436,0.00775582056195423,0.0251217916572777,0.000207376641684765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0118882432199456,0.00320491834279118,-0.0181698831718163,-0.00560660326807488,0.000208474172791889
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0146928916073904,0.00396101682705244,-0.0224564845884131,-0.00692929862636758,0.000208625689931728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,0.0100220130003562,0.00270223760816973,0.00472562728834354,0.0153183987123689,0.000208961828289931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.00754444852772707,0.00203473893288984,0.00355636021926299,0.0115325368361911,0.000209759163678562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,39931,0.0232734625785075,0.00627707068580222,0.0109704040343351,0.0355765211226799,0.000209857571512573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.00948863985069324,0.00255976785585777,0.00447149485321201,0.0145057848481745,0.000210723317665587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39405,-0.0427802002104393,0.0115497496467012,-0.0654177095179737,-0.020142690902905,0.000212966346791328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39455,-0.0314388127924869,0.00848999809921381,-0.048079209066946,-0.0147984165180278,0.000213764789132253
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.0456049892237071,0.0123186096738575,-0.0697494641844677,-0.0214605142629464,0.000214518881086222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0235435840803548,0.00637242054156055,-0.0360335283418135,-0.0110536398188961,0.000221096314027369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37124,-0.010521774044915,0.00285002689292331,-0.0161078267550447,-0.00493572133478534,0.000223551366035992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0120804111768659,0.00327646698271559,-0.0185022864629884,-0.00565853589074329,0.000227647719105457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0115285696071702,0.00313174910136178,-0.0176667978458393,-0.00539034136850111,0.000233071477689648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0166954853658823,0.00454102031271709,-0.0255958851788078,-0.00779508555295684,0.000237147086853059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0275181332220139,0.00748862602290226,-0.0421958402269023,-0.0128404262171255,0.000238944262778849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0223198235522803,0.00607467638822676,-0.0342261892732048,-0.0104134578313559,0.00023933516865161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37415,-0.0160277849001497,0.00436836816857655,-0.0245897865105598,-0.0074657832897397,0.000244381313278508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0282759576395024,0.00770709763090316,-0.0433818689960725,-0.0131700462829322,0.000244631174453664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0126449514437541,0.00344914423183947,-0.0194052741381594,-0.00588462874934872,0.00024706802916718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37169,0.0117942366113198,0.00322554823704238,0.00547216206671676,0.0181163111559229,0.000256661637495498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39421,-0.0164717634707611,0.00451197417823081,-0.0253152328600935,-0.00762829408142871,0.000262406004312898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0102889429609756,0.0028222744957501,0.00475728494930536,0.0158206009726458,0.000267777207905596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,39749,-0.0231038281529628,0.00634436775022403,-0.0355387889434019,-0.0106688673625237,0.000271780225734052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37021,0.025327769697727,0.00696089943358699,0.0116844068078965,0.0389711325875575,0.000275197289118425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0277639413378675,0.00763676752849123,-0.0427320056937103,-0.0127958769820247,0.000278266648306548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0161441057481221,0.00444075654152676,-0.0248479885695145,-0.00744022292672964,0.000278562911082979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0246054934133987,0.00679113747391242,-0.0379161228622671,-0.0112948639645304,0.000292100372849074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.023855497426833,0.00658481002503673,-0.0367617250759049,-0.010949269777761,0.000292519861609782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.0133317044288441,0.00368359211778453,-0.0205515449797018,-0.00611186387798645,0.000296579935873529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37388,-0.0195822807824725,0.00541933252776848,-0.0302041725368987,-0.00896038902804629,0.000303289826365247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0344825451934743,0.00955418339291438,-0.0532087446435865,-0.0157563457433622,0.000308330937735001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0076959337674201,0.00213885839480126,-0.0118880962212306,-0.00350377131360963,0.00032162755668463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0177711879806201,0.00494074843572491,-0.0274550549146409,-0.00808732104659927,0.000323257880527778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0126583557506621,0.00352607080543957,-0.0195694545293237,-0.00574725697200058,0.00033193593567009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.0163503250993976,0.00455521695183504,-0.0252785503249943,-0.00742209987380096,0.000332655637630291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.0126724495949484,0.00354301339720644,0.00572814333642374,0.019616755853473,0.000349141562191429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0186818943430443,0.00523567900173919,-0.0289438251864531,-0.00841996349963551,0.000360749162888281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,39967,0.0142543711043568,0.00399529669086199,0.00642358959026733,0.0220851526184463,0.000361053014977592
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,37453,-0.0144481195403528,0.00405425860391655,-0.0223944664040293,-0.00650177267667638,0.000366931138258995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,39908,0.0286434051678263,0.00804293849412159,0.012879245719348,0.0444075646163046,0.000370075760128111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37357,-0.0110942445195614,0.00311870971538345,-0.017206915561713,-0.00498157347740982,0.000375943637941394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0186587234683189,0.00525523776765868,-0.0289589894929299,-0.00835845744370788,0.000385826638167446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37169,-0.0187331163303879,0.00528812767481236,-0.0290978465730201,-0.00836838608775566,0.000397731475206637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0164210074676961,0.00464214773728972,-0.025519617032784,-0.00732239790260829,0.000405482548114053
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0154358742099729,0.00437071495397341,-0.0240024755197607,-0.00686927290018499,0.000414152199289043
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0190800156430977,0.00540246205460006,-0.0296688412701138,-0.0084911900160816,0.000414243797119354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,39866,0.0133040009740922,0.00377580823580978,0.00590341683190505,0.0207045851162794,0.000427099970919782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37056,-0.014450406803607,0.00410146004745682,-0.0224892684966223,-0.00641154511059159,0.000427755246191547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37411,0.0100713274758946,0.00286429227860478,0.00445731460982926,0.01568534034196,0.000439258029919814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0197977262890533,0.00564767978654642,-0.0308671786706843,-0.00872827390742233,0.00045709371428558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0143865420923643,0.00410833493578347,0.00633420561822874,0.0224388785664999,0.00046362936349765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0192931371182758,0.00551365477030407,-0.0300999004680718,-0.00848637376847981,0.000468033573445063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0268697295121103,0.00767943807017433,-0.041921428129652,-0.0118180308945686,0.000468427344739742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,39868,0.0262051645472879,0.00749220788684924,0.0115204370890634,0.0408898920055124,0.000470639581379343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0124735700845878,0.00356883020336579,-0.0194684772831848,-0.00547866288599089,0.000475363912337459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0220348137743631,0.00631580700539068,-0.0344137955049288,-0.00965583204379735,0.000486666208280444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0149823156802132,0.00429594671798871,-0.0234023712474711,-0.00656226011295537,0.000489026106264939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0298746666724719,0.00857695472376242,-0.0466854979310462,-0.0130638354138975,0.000496914140876984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,39788,0.00997277858548281,0.00286559839899281,0.0043562057234569,0.0155893514475087,0.000502430565731061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,39931,-0.0164088073571117,0.00473404064695536,-0.0256875270251442,-0.00713008768907922,0.000529384201146165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,39831,-0.00894413748173566,0.00258077131739925,-0.0140024492638382,-0.00388582569963314,0.000530274281274089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39477,0.0283718370093362,0.00819267302565491,0.0123141978790526,0.0444294761396198,0.000535471365778987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00952195505449299,0.00274983138554525,0.00413228553882429,0.0149116245701617,0.00053609907606915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.0390829756079156,0.0112872971337574,-0.06120607799008,-0.0169598732257511,0.000536442501179071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0114925046666203,0.00331947570573504,-0.017998677049861,-0.00498633228337965,0.000537284665094091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0184628462694441,0.00533532998176595,-0.0289200930337054,-0.00800559950518283,0.00054060942553921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.0138501620855693,0.0040026897458081,0.00600489018378546,0.0216954339873532,0.000541153383264696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.023006465254245,0.00664927010217229,-0.0360390346545027,-0.0099738958539873,0.000541844409846214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.00650676541898192,0.00188069394363219,-0.010192925548501,-0.00282060528946284,0.000542301314554975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0132488568013524,0.00383015455989625,-0.0207559597387491,-0.00574175386395578,0.000543422550892441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0172274077626952,0.00499179814671772,-0.0270113321302619,-0.00744348339512841,0.000559967717082311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0147367780449317,0.00427743831406836,-0.0231205571405057,-0.00635299894935773,0.00057232456843637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0194085354438065,0.00563499284087843,-0.0304531214119282,-0.0083639494756848,0.000574020045369723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.0356083914806807,0.0103600256848364,-0.0559140418229601,-0.0153027411384013,0.000589478040724097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37437,-0.0099056558153739,0.00288445496630713,-0.0155591875493359,-0.00425212408141193,0.00059618727010056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00993690267387561,0.00289371064109191,0.00426522981733547,0.0156085755304158,0.000596326939321504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.00974632160458017,0.00284644343497994,-0.0153253507371408,-0.00416729247201949,0.000618571740076737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.0411480777341749,0.0120368583092311,-0.0647403200202677,-0.017555835448082,0.000631620890337485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0220001790238261,0.00644370056796998,-0.0346298321370472,-0.00937052591060491,0.000641246769284842
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.0122690439799096,0.00359439247192613,0.00522403473493437,0.0193140532248848,0.000643546459426679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0179478719017899,0.00525863910726132,-0.0282548045520221,-0.00764093925155767,0.000644044339410807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.015678636499012,0.00461450009998892,-0.0247230566949903,-0.0066342163030337,0.000681588961473254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0297114371543392,0.00874861414395842,-0.0468587208764977,-0.0125641534321807,0.000685119369661192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0184875170914224,0.00544499137856432,-0.0291597001934085,-0.00781533398943633,0.000687116681082037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0167458400665851,0.0049368605677875,-0.0264220867794486,-0.00706959335372163,0.000695559336913997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0254451205361781,0.00750600114263597,-0.0401568827757446,-0.0107333582966116,0.000700995895249505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0134152196139311,0.00395921007825795,-0.0211752713673167,-0.00565516786054555,0.0007051306633047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0196613096720506,0.00581088855832145,-0.0310506512463606,-0.00827196809774055,0.000717633397497317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0181149982153885,0.00536030823935847,-0.0286212023645311,-0.00760879406624594,0.000728361573131434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.00879621519407844,0.0026033468916476,0.00369365528644914,0.0138987751017077,0.000729736645559402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.0223147259496132,0.00660624232584122,-0.035262960908262,-0.00936649099096445,0.000732400168183391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.0143129940988186,0.00424343965820579,0.00599585236873523,0.0226301358289019,0.000745702698482504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0320923447588434,0.00953160246434237,-0.0507742855889544,-0.0134104039287323,0.000761902918388568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.0276921791044482,0.00823119717672481,-0.0438253255708289,-0.0115590326380676,0.000769525949013608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0221556595938997,0.00658944999749202,-0.0350709815889841,-0.00924033759881539,0.000775120073129343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37095,-0.0466121391224558,0.0138894725026481,-0.0738355052276461,-0.0193887730172655,0.000793202330211472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0251601337447377,0.00751466449608358,-0.0398888761570616,-0.0104313913324139,0.000815785610877713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.021841515466347,0.00654166038882311,-0.0346631698284403,-0.00901986110425375,0.000843644707620125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39489,-0.0255261088274379,0.0076490881092078,-0.0405183215214852,-0.0105338961333907,0.000848415180258056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40009,0.00829372961507442,0.00248713712195955,0.00341894085603371,0.0131685183741151,0.000855993701627467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00844659200819182,0.0025337482361884,0.00348044546526257,0.0134127385511211,0.000859144015769893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,39587,0.011021981674204,0.00330770782761889,0.00453887433207101,0.0175050890163371,0.000863574244906983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.00704653277491167,0.00211472229282594,-0.0111913884688505,-0.00290167708097282,0.000864191213851402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.00909138036246873,0.00272987348119465,0.00374082833932721,0.0144419323856102,0.000869815290100518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0156205253756998,0.00469174710648814,-0.0248163497044165,-0.00642470104698304,0.000872835780404568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0076195781929625,0.00229003134541227,-0.0121080396299705,-0.00313111675595445,0.000878955056559126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0237843534806147,0.00714907811727988,-0.0377965465904832,-0.00977216037074609,0.000880154016762471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0125165875342671,0.0037632294352774,-0.0198925172274108,-0.0051406578411234,0.000882943171166636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.045885504848773,0.0137954601540469,-0.072924606750705,-0.0188464029468411,0.000882951572494588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.0159559734630645,0.00480790717110589,0.00653247540769693,0.025379471518432,0.000906410397878949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,39587,-0.0256212351566616,0.00772811709210084,-0.0407683446571792,-0.0104741256561439,0.000917430811814171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.00805817415115378,0.00243537318366635,-0.0128315055911398,-0.00328484271116773,0.000939011158180145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.00871551075991313,0.00263522858683212,-0.0138805587901041,-0.00355046272972218,0.000944031853941547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.0153259278025472,0.00463438722629442,0.00624252883901013,0.0244093267660843,0.000945534156916656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,0.0129670373145258,0.00392444165990458,0.00527513166111278,0.0206589429679387,0.00095464278445936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0113509746620475,0.00343999642244607,-0.0180933676500418,-0.00460858167405324,0.000970435470702653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.00948286692790442,0.00287447620569715,-0.0151168402910708,-0.00384889356473802,0.000972538338516278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0192912135096232,0.00585526991994927,-0.0307675425527238,-0.00781488446652266,0.00098750525915184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0348866139867742,0.0105983351994499,-0.0556593509776961,-0.0141138769958524,0.000998365243791212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0233752696854983,0.00710523174858695,-0.0373015239127287,-0.0094490154582679,0.0010049044794641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.0139453873885711,0.0042433864026664,-0.0222624247377973,-0.00562835003934498,0.00101702825074097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0157813483665605,0.00480989502796006,0.00635395411175876,0.0252087426213622,0.00103660190672793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0153264216908233,0.0046734667522707,-0.0244864165252739,-0.00616642685637275,0.00104270315468322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0215637469370515,0.00658011891168277,-0.0344607800039497,-0.00866671387015324,0.00105145638549783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,39868,-0.0392587719361574,0.0119807296217089,-0.0627410019947069,-0.0157765418776079,0.00105204334938992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,39587,0.00899797261317243,0.00274596431675118,0.00361588255234011,0.0143800626740048,0.00105218628088834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0292562652484888,0.00893954066358615,-0.0467777649491176,-0.0117347655478599,0.00106764298343881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0308502653104803,0.00943024164071185,-0.0493335389262756,-0.0123669916946851,0.00107238104608198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0136111847257552,0.00417017891966933,-0.0217847354083071,-0.00543763404320333,0.00110107808393749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.00730740018752818,0.00223930069954437,-0.0116964295586351,-0.00291837081642121,0.00110371336361623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,37453,-0.0231346301479984,0.00709038461991117,-0.0370317840030243,-0.00923747629297252,0.00110582790099232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40052,0.0101905257879318,0.00312459230434765,0.00406632487141039,0.0163147267044532,0.00111095246947703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39489,-0.0232609049549663,0.00714202966708157,-0.0372592831024462,-0.00926252680748646,0.00112874620111021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0149460790015742,0.00459692417623265,-0.0239560503869902,-0.00593610761615825,0.00115105305314236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0114798568110902,0.00353381680101591,0.00455357588109903,0.0184061377410814,0.00116276412539752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0297991204071719,0.00918297303148753,-0.0477977475488875,-0.0118004932654564,0.00117679342095771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0166663339411049,0.00513841992195356,-0.0267376369881339,-0.00659503089407596,0.00118373532941186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37056,-0.0156525098515923,0.0048301192859424,-0.0251195436520394,-0.00618547605114518,0.00119571873105024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0131789072520023,0.00406706812957834,0.00520745371802878,0.0211503607859759,0.00119612374968338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0203603560021454,0.00628769259008152,-0.0326842334787052,-0.0080364785255856,0.00120564146145305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0380283367918385,0.0117447313838327,-0.0610480103041505,-0.0150086632795264,0.0012070877743453
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGN,Mimecan,39858,-0.0124493181986018,0.00385012275673875,-0.0199955588018098,-0.00490307759539388,0.0012253727380698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0106227979027942,0.00329080673234205,-0.0170727790981847,-0.00417281670740381,0.00124953751314961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0206269800022041,0.00639985530502593,-0.0331706964000549,-0.00808326360435327,0.00127090261569697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.0306530149139044,0.00952099627450327,-0.0493141676119308,-0.011991862215878,0.00128717477110945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.00716318959534673,0.00222741845797191,-0.0115289297729717,-0.00279744941772179,0.00130289314526611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.0103920187089872,0.00323258935720013,0.00405614356887496,0.0167278938490995,0.00130856181100719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0155684639920249,0.00485006210565477,0.00606234226494151,0.0250745857191082,0.00133066165755246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.00941438783730411,0.00293427953885148,0.00366319994115521,0.015165575733453,0.00133789672618802
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0328467097560308,0.0102388773809666,-0.0529149094227253,-0.0127785100893363,0.0013396123136596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0282461104192981,0.00882207267823,-0.0455373728686289,-0.0109548479699672,0.00136917196012566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0217315765209466,0.00678911898730245,-0.0350382497360594,-0.00842490330583379,0.00137301833951481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.010476381130547,0.00328149849503577,-0.0169081181808171,-0.0040446440802769,0.00141339088652842
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0212408190210293,0.00665471310392785,-0.0342840567047279,-0.00819758133733076,0.0014163803607455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0235405805374512,0.0073825729065138,-0.0380104234342183,-0.00907073764068417,0.00143255316761181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0265922882669972,0.00835692441776904,-0.0429718601258245,-0.0102127164081699,0.00146506505897022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37043,-0.0226619621184451,0.00712914128933935,-0.0366350790455503,-0.00868884519133999,0.00148238748828478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0172944905757695,0.00544162161133718,0.00662891221754858,0.0279600689339903,0.00148478085285298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,39885,0.00922582528747968,0.00290295929707337,0.00353602506521588,0.0149156255097435,0.00148537452311504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0301361518999078,0.00949121241494179,-0.0487389282331937,-0.0115333755666219,0.00150037942171495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0220890303776569,0.00696726077100348,-0.0357448614888237,-0.00843319926649007,0.00152513415000713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0135052479473941,0.00426003996666768,-0.0218549262820628,-0.0051555696127255,0.00152674039946943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0194173912768568,0.00612747172933157,-0.0314272358663467,-0.00740754668736697,0.00153363212470942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0239028274332155,0.00754418454621317,-0.0386894291437933,-0.00911622572263771,0.00153642113582585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARC,SPARC,39913,-0.0218063509052412,0.0068839508436431,-0.0352988945587816,-0.00831380725170067,0.00153933205789929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0219727431021514,0.00694147536674143,-0.0355780348209646,-0.00836745138333822,0.00155144942139349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0154869688431664,0.00489945756146767,-0.025089905663643,-0.00588403202268979,0.00157599358248108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.0145658338734905,0.00461346220866567,0.0055234479445058,0.0236082198024752,0.00159563482453277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.00864162858421211,0.00273816195314206,-0.0140084260123705,-0.00327483115605368,0.00160248859883398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39489,-0.0106435603712717,0.00338008596276208,-0.0172685288582854,-0.004018591884258,0.00164193483375279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,39587,0.01458280304206,0.00463310495756554,0.00550191732523157,0.0236636887588885,0.00164967841629084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0205321495667036,0.0065378079742052,-0.0333462531961458,-0.00771804593726137,0.00169007890212575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.01852877802561,0.00590397486174204,0.00695698729659556,0.0301005687546244,0.00170274109066389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0141593268054454,0.00451981811631608,-0.0230181703134249,-0.00530048329746586,0.00173508179586553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0077781527213755,0.00249159546855272,-0.0126616798397388,-0.00289462560301217,0.00180095104169322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0238001331337053,0.00762463752805509,-0.0387444226886933,-0.00885584357871733,0.00180266603111115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0196117773655467,0.0062876276725972,-0.0319355276038372,-0.0072880271272562,0.001817304075009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39477,-0.0124013124842232,0.00397669779832849,-0.0201956401689471,-0.00460698479949939,0.00182107617815238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0155198984261333,0.00498413628027089,-0.0252888055354643,-0.00575099131680239,0.00185043605692614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39489,0.013521471390498,0.00434599915337131,0.00500331304989021,0.0220396297311057,0.00186635343995992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0292739035687681,0.00942273403371191,-0.0477424622748435,-0.0108053448626928,0.0018949908637107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39489,0.0113723183057881,0.00366532479425985,0.00418828170903881,0.0185563549025374,0.00192120843226066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,36962,0.00941823081085139,0.00303804551955258,0.00346366159252835,0.0153728000291744,0.0019386855238119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.00954266414798886,0.00307868983170731,0.00350843207784254,0.0155768962181352,0.00194200076098908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.021207816969687,0.00684517233293878,0.00779127919712701,0.034624354742247,0.00195029611080909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.021255807425216,0.00686474519240839,-0.0347107080023364,-0.00780090684809553,0.00196251563908704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.0169421530750332,0.00548045777994949,-0.0276838503237342,-0.00620045582633225,0.00199575742721729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.0148893577932906,0.00482435287507354,-0.0243450894284348,-0.0054336261581465,0.00203090521581559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0202982827971051,0.00658283410059281,-0.033200637634267,-0.00739592795994323,0.00204992624155182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37411,0.0106334981876709,0.00345000799551347,0.0038714825164645,0.0173955138588773,0.00205912454027874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,0.00762974794452243,0.00247579139774438,0.00277719680494345,0.0124822990841014,0.00206139099408786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0251649104856937,0.00816906813805389,-0.0411762840362793,-0.00915353693510809,0.00207059983106077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00992970303754797,0.00322427594004007,0.00361012219506942,0.0162492838800265,0.00207584942782522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,39858,-0.0218206556938819,0.00708787466955513,-0.03571289004621,-0.00792842134155386,0.00208335156201629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37437,0.00787135159873642,0.00256254832337091,0.00284875688492945,0.0128939463125434,0.00213272402849003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,39858,-0.0135680933921621,0.00441998780169586,-0.022231269483486,-0.00490491730083821,0.00214623501841224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0191094637963075,0.00623624302697051,-0.0313325001291697,-0.00688642746344528,0.00218572463487824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37388,-0.00639105177646904,0.00208735627280011,-0.0104822700711572,-0.00229983348178083,0.00220447595381804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0203255616292955,0.00665989060978893,-0.0333789472244818,-0.00727217603410923,0.00227820030934367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0392513826496481,0.0129164250259127,-0.0645675757004371,-0.0139351895988591,0.00237929769339448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0163111413991487,0.00537449868241378,-0.0268451588166797,-0.00577712398161772,0.00241073316513175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0096554400473064,0.00318276654803743,0.00341721761315304,0.0158936624814598,0.00241992918097235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.0101167866912035,0.00333773454965472,0.00357482697388027,0.0166587464085268,0.0024417702309681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.010639656279314,0.00351071410790014,-0.0175206559307983,-0.00375865662782976,0.00244434128123446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,39715,-0.0215296177869622,0.00710459201033221,-0.0354546181272134,-0.00760461744671111,0.0024463944950855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0124371298101769,0.0041051048940813,0.00439112421777758,0.0204831354025763,0.00245291575989321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00806446595356453,0.00266279374086722,0.00284539022146477,0.0132835416856643,0.00246101379100964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.030634092533929,0.0101195815729366,-0.0504684724168848,-0.0107997126509732,0.00247216936032275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0160744293427116,0.00531077714690668,0.00566530613477447,0.0264835525506487,0.00247670952927377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.0183584728907315,0.0060675020280512,-0.0302507768657118,-0.00646616891575111,0.00248532988467872
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00806796878383006,0.00267454552625477,0.00282585955237072,0.0133100780152894,0.00256044286675998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0186519926807107,0.0061882237531398,-0.0307809112368647,-0.00652307412455672,0.00258137690603425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0127349605409798,0.00422529318805562,0.00445338589239081,0.0210165351895689,0.00258332124693341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0172141452809115,0.00571381740067084,-0.0284132273862263,-0.00601506317559665,0.00259393730427809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0105641448541073,0.00350830934979874,-0.0174404311797128,-0.00368785852850176,0.00260729812456971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0158583509309399,0.00526928735909924,-0.0261861541547744,-0.00553054770710536,0.00262024850649916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0188848949981396,0.00628483771889437,-0.0312031769271726,-0.00656661306910667,0.00266211627553001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00926940318220196,0.0030863555644472,0.00322014627588546,0.0153186600885185,0.00267433831381687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0164341798320799,0.00547202279252014,-0.0271593445054194,-0.00570901515874042,0.00267468169709025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.00763596525573276,0.00254495412214053,-0.0126240753351282,-0.00264785517633732,0.00270009184393473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0200598118233471,0.00668837232917591,-0.0331690215885319,-0.00695060205816228,0.00271095999335462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.0188126609462333,0.00627607511903462,0.00651155371292541,0.0311137681795411,0.0027260260524059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37411,-0.0160986654364927,0.00537792769104207,-0.0266394037109352,-0.00555792716205025,0.00276322049018818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00821098797829078,0.00274827130443268,0.00282437622160273,0.0135975997349788,0.00281522043330292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.00955251240489349,0.00320124291510079,-0.015826948518491,-0.00327807629129595,0.00285026615618358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0300808427526604,0.0100901120011481,-0.0498574622749107,-0.0103042232304101,0.00287626906266906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37056,0.00783944887444516,0.00263091518290204,0.00268285511595716,0.0129960426329332,0.00289016532801084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0130636435822191,0.00438579908318335,0.00446747737917976,0.0216598097852585,0.00290062056292501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37169,0.0122973899883282,0.00413023479822942,0.00420212978379857,0.0203926501928579,0.00291221273751357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0156926418543417,0.00527535613099778,-0.0260323398710973,-0.00535294383758601,0.00293701134645646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0135870360751241,0.0045684556131999,-0.0225412090769959,-0.00463286307325227,0.00294367499164332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0190489214078601,0.00640653132387047,-0.0316057228026462,-0.00649212001307394,0.00295008878247816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.00768122878831483,0.00258339207909976,-0.0127446772633503,-0.00261778031327931,0.0029504448304555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0124033410774331,0.00417781506688398,-0.0205918586085257,-0.00421482354634046,0.00299346115264715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0306022532423183,0.0103218535617271,-0.0508330862233033,-0.0103714202613332,0.00303326363313979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0184515406945962,0.00622447443606886,-0.0306515105892911,-0.00625157079990122,0.00303777957124836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39315,0.00736065733592027,0.00248458431548597,0.00249087207756778,0.0122304425942728,0.00305585909550031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0179464968861845,0.00606805684072126,-0.0298398882939982,-0.00605310547837087,0.00310659545657764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.00760890959376627,0.0025736605925434,0.00256453483238121,0.0126532843551513,0.00311657445320078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0085856782551256,0.0029056984075622,0.00289050937630369,0.0142808471339475,0.00313359920281115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00801407259542009,0.00271544165757963,0.00269180694656401,0.0133363382442762,0.00316999847841349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.010385471644149,0.00352127242811206,0.00348377768504941,0.0172871656032487,0.00318901932688104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00813248770767304,0.00275916052911863,0.00272453307060053,0.0135404423447456,0.00320970170403777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0155024357284672,0.00526130696951356,-0.0258145973887138,-0.00519027406822062,0.00321941560376953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0108472569438053,0.00368229139837925,-0.0180645480846286,-0.00362996580298193,0.00322605940178204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,39660,-0.010794451959705,0.00367078283982178,-0.0179891863257557,-0.00359971759365433,0.00328009404237212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.00953309247445014,0.00324364263568874,0.0031755529085002,0.0158906320404001,0.00329734724977103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00793425928064094,0.0026996984752891,0.00264285026907431,0.0132256682922076,0.00329808797309064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.00938048981813424,0.00319534137126959,-0.0156433589058226,-0.00311762073044584,0.0033329641628112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37437,0.0134545895703988,0.00458439731088157,0.00446917084107088,0.0224400082997267,0.00334251197190971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0180451584665319,0.00615119862232229,0.00598880916678024,0.0301015077662836,0.0033553552672655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40058,0.0114909238779424,0.00391748183843316,0.00381265947461337,0.0191691882812714,0.00335911827007365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0124923579034926,0.00427074846559151,-0.020863024896052,-0.00412169091093329,0.00344934761098405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,39587,-0.014135150220438,0.00483341730852303,-0.0236086481451431,-0.00466165229573282,0.00345543566684921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0193948301340747,0.00663517994389887,-0.0323997828241165,-0.00638987744403293,0.00347217563211331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.0257929321626132,0.00883691952064673,-0.0431132944230808,-0.0084725699021456,0.00352010034960271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0192980319190097,0.00662053777028365,-0.0322742859487656,-0.00632177788925371,0.00356319692169197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37437,0.0142103221247635,0.00487940518396242,0.00464668796419717,0.0237739562853299,0.00359355009585555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0192987048603286,0.00662798983635442,-0.0322895649395832,-0.00630784478107391,0.00359964709395883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0118252913383791,0.00406230150484371,-0.0197874022878728,-0.00386318038888545,0.0036089305173163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0169730841109916,0.00583482935412933,-0.0284093496450851,-0.00553681857689814,0.00363264398538144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.00965313121106173,0.00332139252723001,-0.0161630605644325,-0.00314320185769091,0.00366175295755237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.01616774408376,0.0055758563092092,-0.02709642244981,-0.00523906571770994,0.00374161693594868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0192364311691779,0.0066465126366345,-0.0322635959369815,-0.00620926640137427,0.00380733107964478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.019439588520024,0.00671813422956186,-0.0326071316099653,-0.00627204543008278,0.0038136274379169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0206912279680094,0.00715539786008045,-0.034715807773767,-0.00666664816225167,0.0038368558727249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,0.00948380216926699,0.00328043111854538,0.00305415717691805,0.0159134471616159,0.0038450428209732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0186668866565073,0.0064618966809093,-0.0313322041510895,-0.00600156916192508,0.00387279455517137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.0128895635365559,0.00447340778494486,-0.0216574427950478,-0.00412168427806398,0.00396582993934577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0161543824451821,0.00561646867666506,-0.0271626610514457,-0.00514610383891862,0.00403072075583263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.00939718707128792,0.00326720891246142,-0.0158009165397123,-0.00299345760286353,0.00403123865939702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0112338039684923,0.00390584044508083,0.00357835669613382,0.0188892512408507,0.00403198150596968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0285141427659314,0.00991455927947687,-0.0479466789537061,-0.00908160657815677,0.00403297997952476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.025967739706569,0.00903712306075078,-0.0436805009056405,-0.00825497850749746,0.00406560191860997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.00812441548852623,0.00282767879712413,0.00258216504616293,0.0136666659308895,0.00406897499408001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40030,0.0168575431933105,0.00587162333597481,0.00534916145479986,0.0283659249318211,0.00409681902571031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00866549337399545,0.00302154933485551,0.00274325667767865,0.0145877300703122,0.0041374460690141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40058,-0.0125596321644908,0.00437997086108902,-0.0211443750522252,-0.00397488927675627,0.00414243006539428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0169438985388309,0.00591396571469144,-0.0285352713396261,-0.00535252573803567,0.00417564230910006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0131037013639695,0.00457552454157785,-0.0220717294654621,-0.00413567326247692,0.00419058587316108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0116662605805638,0.0040748198425248,-0.0196529074719124,-0.0036796136892152,0.00420176512710967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37021,0.0133764612124924,0.00468348711654965,0.00419682646405512,0.0225560959609298,0.00429564782238825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0115453805255521,0.00404478192431708,0.00361760795389058,0.0194731530972135,0.00431853368130385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.00705434042041086,0.00247305240738483,0.0022071577019366,0.0119015231388851,0.0043434044622447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.00767204565846194,0.00269458456163747,-0.0129534313992714,-0.0023906599176525,0.0044160656404141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0297270866163841,0.0104517770417516,-0.0502125696182172,-0.00924160361455098,0.00445878607594418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.0129912488097312,0.00457367363672328,0.00402684848175363,0.0219556491377089,0.00451182213862429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0195831391271706,0.00689775799174241,-0.0331027447909858,-0.00606353346335551,0.00453034180064512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,39856,0.0109054725353393,0.00384483259984019,0.00336960063965248,0.018441344431026,0.00456829659284163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37208,-0.00765705534933984,0.00269954051220223,-0.0129481547532562,-0.00236595594542346,0.00456897768738565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.00993390949518531,0.0035035964311403,-0.0168009585002203,-0.00306686049015033,0.00458440205416682
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0115217613979642,0.00406948990922757,0.0035455611758782,0.0194979616200503,0.00464361420516036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.0120056209334453,0.00424148904919519,0.00369230239702273,0.0203189394698679,0.00465425901483054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.019149616667647,0.00677508408381868,0.00587045186336234,0.0324287814719316,0.0047123289532326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,39585,-0.0348849095850177,0.012346120006088,-0.0590833047969502,-0.0106865143730853,0.00472550530008236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0141443497447006,0.00500632734721465,-0.0239567513452413,-0.00433194814415984,0.00473062120213838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0127505232571411,0.00451572118271996,-0.0216013367752722,-0.00389970973900993,0.00475491834167311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0176443894821689,0.00625863512512592,0.00537746463692213,0.0299113143274157,0.0048214647553918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,39775,-0.00921902565856791,0.00327739005612755,-0.0156427101685779,-0.00279534114855792,0.0049154489312949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0270029463377709,0.009602364031867,-0.0458235798402302,-0.00818231283531157,0.00492783726830767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.0126332568367784,0.00449455054434155,0.00382393776986894,0.0214425759036878,0.00494794092468087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0123783488309671,0.00443054610929224,-0.0210622192051799,-0.00369447845675432,0.00521572636827951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0115651320676176,0.00415263768055998,-0.0197043019215152,-0.00342596221372006,0.00536025785444787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,39558,-0.0115071614101479,0.00413591223848464,-0.0196135493975778,-0.00340077342271804,0.00540470955642553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0124869342500317,0.00449130408301549,0.00368397824732135,0.0212898902527421,0.00543946024115625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0102343918521966,0.00368977320698135,0.00300243636651315,0.01746634733788,0.00554865244514485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0129808000257593,0.00468232413560424,0.00380344471997501,0.0221581553315436,0.00557402199423384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI3,Elafin,39594,-0.0143174972801988,0.00517126030672496,-0.0244531674813797,-0.00418182707901785,0.00563520160935016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,39881,-0.0289151822966266,0.0104441137393453,-0.0493856452257434,-0.00844471936750968,0.00563688749278928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0227913062485148,0.00823356835347635,-0.0389291002213284,-0.00665351227570116,0.00564496875777231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0116403518660314,0.00420567913457826,-0.0198834829698048,-0.00339722076225805,0.00565073024306232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0167983669511999,0.00607658341173667,-0.0287084704382038,-0.00488826346419605,0.00570869199126772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39489,-0.0180451239985906,0.00652801855406792,-0.0308400403645637,-0.00525020763261746,0.00571193328799825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.00520321202873054,0.00188369957166974,-0.00889526318920323,-0.00151116086825785,0.00574754959492215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.013011070614213,0.00471633587607018,-0.0222550889313106,-0.00376705229711549,0.00581057096062942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.00864689581263817,0.00314223804342072,0.00248810924753357,0.0148056823777428,0.00593448050166456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0217384404193539,0.00791166643150549,-0.0372453066251047,-0.00623157421360315,0.00601078311142639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0166672646901291,0.00607145840558098,-0.0285673231650678,-0.00476720621519033,0.00605590766302059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37347,-0.00750029875039866,0.00273337814635535,-0.0128577199172551,-0.00214287758354217,0.00607819300523929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0104098056254442,0.00379405246251924,0.00297346279890649,0.0178461484519819,0.00608158860829818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0177455414676069,0.00647755540173617,-0.0304415500550098,-0.00504953288020402,0.00616052852745644
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0120188682120098,0.0043906365247176,-0.0206245158004563,-0.00341322062356331,0.00620124802243165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.00851181963396104,0.00311584233334432,-0.0146188706073159,-0.00240476866060618,0.00630750532574655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00817079528335275,0.00299411684689076,-0.0140392643032586,-0.00230232626344687,0.00636069479230156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0159483770834431,0.00585259310754369,0.00447729459265742,0.0274194595742287,0.00643686103270512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0180977719435076,0.00665161674687384,-0.0311349407673803,-0.00506060311963487,0.00651931138641707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0214213331285038,0.00787642482583633,-0.036859125787143,-0.00598354046986461,0.00654158938192228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.012129473056924,0.00446188227206321,-0.0208747623101679,-0.00338418380368012,0.00656552977618837
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0226979373315353,0.00835269887150763,-0.0390692271196903,-0.00632664754338038,0.00658734307730855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.0301578259833043,0.0111233164850751,-0.0519595262940515,-0.00835612567255706,0.00671066872654369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37021,0.0138104578164,0.00509383521733242,0.00382654079042851,0.0237943748423716,0.00671251020594073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00991134403228478,0.00365757496579043,0.00274249709933553,0.017080190965234,0.00674083480246299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00903108983403007,0.00333415816791764,0.0024961398249115,0.0155660398431486,0.00676408838697962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37388,0.0192023842022751,0.00709345743271737,0.00529920763414907,0.0331055607704011,0.00679680891853101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,39908,0.00681388453514866,0.00251769601121992,0.00187920035315763,0.0117485687171397,0.00680896231523923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0181682825169711,0.00671818269244951,-0.0313359205941721,-0.00500064443977004,0.00685271044574338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0137386640031096,0.00508045697902213,0.00378096832422625,0.023696359681993,0.00685533374965675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37021,0.00938388286164623,0.00347106986955538,0.00258058591731767,0.0161871798059748,0.00687107670450985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.00893497844813299,0.00330587450072332,-0.0154144924695507,-0.00245546442671528,0.00688527754761685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0124492959854961,0.00460845822500424,-0.0214818741065044,-0.00341671786448784,0.00691199940153041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0140760203083053,0.00521558612058617,-0.0242985691046542,-0.00385347151195641,0.00696702304803393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,39788,0.0074693788772764,0.00276923958169654,0.00204166929715119,0.0128970884574016,0.00699847389941794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0200140698108053,0.00742207115036731,-0.0345613292655253,-0.00546681035608542,0.0070146087708546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.014615193973595,0.00542450406493166,-0.0252472219408611,-0.00398316600632894,0.00706118567676585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0130677281888848,0.00485241229856035,-0.0225784562940631,-0.00355700008370651,0.00708943917253575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00781296201857346,0.00290344380343469,-0.0135037118733054,-0.00212221216384147,0.00713268454639689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,0.00666842107666646,0.00247838100921208,0.00181079429861078,0.0115260478547221,0.00714031954220539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37437,-0.00801212237758635,0.00297907393689846,-0.0138511072939073,-0.00217313746126538,0.00716535754255712
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_DRA,,39799,0.00932448207855601,0.00346763759771177,0.00252791238704094,0.0161210517700711,0.00717406803440697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0308886671484962,0.0115131522171422,-0.0534544454940949,-0.00832288880289749,0.00730772717230694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.0103283914719167,0.00385128935385637,0.00277986433835822,0.0178769186054752,0.0073315903616962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.00887439183348727,0.00331026253283206,0.00238627726913644,0.0153625063978381,0.00735222028313175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0115140533430989,0.00429758741634507,-0.0199373246791352,-0.00309078200706255,0.00738759472261585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39344,-0.0156749362573598,0.00585269815516775,-0.0271462246414886,-0.00420364787323098,0.00740880571721276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0190376513388447,0.00710877353451236,-0.032970847466489,-0.0051044552112005,0.00741278891165434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,36962,0.0156144244629327,0.00583740230421965,0.0041731159466622,0.0270557329792032,0.00748460157633673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0189852331106125,0.00710238633819547,-0.0329059103334756,-0.00506455588774938,0.00752349611028476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37124,0.00879625856757205,0.00329102722492918,0.00234584520671087,0.0152466719284332,0.00753130269808484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0222349331459534,0.00832043520087977,-0.0385429861396778,-0.00592688015222909,0.00754055271805226
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40030,0.0075594868834899,0.00282962420145851,0.00201342344863123,0.0131055503183486,0.00755771056953582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0125581279551224,0.00470732854652927,-0.0217844919063198,-0.00333176400392503,0.00764445131069651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.00942084142629202,0.00353367263021287,-0.0163468397815092,-0.00249484307107479,0.00768463815909087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.0141618811567265,0.00532002159282111,0.00373463883479712,0.0245891234786559,0.00777563861912423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.00940651693305783,0.0035439219663815,0.0024604298789501,0.0163526039871656,0.00795767958248551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37220,-0.00856638697535729,0.00322852896036927,-0.0148943037376811,-0.00223847021303352,0.00797936970622634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39489,0.0122367309315369,0.00461676718724076,0.00318786724454506,0.0212855946185288,0.00804542402141743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,39615,-0.0193622627153949,0.00730840257423278,-0.0336867317608911,-0.00503779366989861,0.00807355239493969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERVV_1,,37021,0.0124843192077518,0.00471556288494939,0.00324181595325099,0.0217268224622526,0.00811927807817575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37169,0.00750287464452353,0.0028409167047479,0.00193467790321764,0.0130710713858294,0.00827571000214208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39489,-0.0174542211191676,0.00661472995230434,-0.0304190918256841,-0.00448935041265112,0.00833095927689577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40009,-0.0061833761030083,0.00234493268783598,-0.0107794441711668,-0.00158730803484978,0.00837451526574884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37021,-0.0101342451461498,0.00384980374901497,-0.0176798604942192,-0.00258862979808047,0.00848815516977692
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0157871234973801,0.00599737288882352,-0.0275419743594742,-0.00403227263528596,0.00848957640539822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0131965754527733,0.00501360812563702,-0.0230232473790219,-0.00336990352652478,0.00849294376615001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0119121637380732,0.00452665419825906,0.0030399215094854,0.0207844059666609,0.00850928859198319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37039,-0.0108224187921688,0.00411307819024813,-0.0188840520450552,-0.00276078553928251,0.00851776602504866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.00696565702291386,0.00264819140251009,0.00177520187399408,0.0121561121718336,0.00853974285903637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0218098949617599,0.00832757116576399,-0.0381319344466573,-0.00548785547686249,0.00882735789892454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,39555,-0.00969817586387129,0.00370521318280343,-0.016960393702166,-0.00243595802557656,0.00886768578525833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0183623484833364,0.00701795701254382,-0.0321175442279223,-0.00460715273875052,0.0088940156757531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.00812728546072174,0.00311282846852508,0.0020261416624126,0.0142284292590309,0.00903893264607205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37056,-0.0147126089338607,0.00565726993744007,-0.0258008580112433,-0.00362435985647819,0.00931496562996271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,0.00572074005785949,0.00220336746710087,0.00140213982234179,0.0100393402933772,0.00943184524243524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.0109216231941442,0.00420767615946592,0.002674577921591,0.0191686684666974,0.00945190758143741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.026570076865267,0.010240592568589,-0.0466416382997014,-0.00649851543083256,0.00947918315851966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.00990592900840944,0.00382429655987676,-0.0174015502657679,-0.00241030775105099,0.0096005981337828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0154054887542779,0.00595014588162157,-0.0270677746822562,-0.00374320282629965,0.00963158128313145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00803268433237415,0.00310277420807692,0.00195124688454339,0.0141141217802049,0.00963796231560731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37056,0.0103054924251262,0.00398406089857911,0.00249673306391116,0.0181142517863413,0.00970114246027409
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.0102554946997122,0.0039655953816439,0.00248292775169019,0.0180280616477343,0.00971710155146632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0101599572921178,0.00393178775029496,0.00245365330153968,0.0178662612826959,0.00977347843162555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0129900246630911,0.00503173702438692,-0.0228522292308894,-0.00312782009529274,0.00984285310198447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0135165952164186,0.00523595121774609,-0.023779059603201,-0.00325413082963632,0.00984796456341736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0107920662151525,0.00418474485516992,-0.0189941661312855,-0.00258996629901942,0.00992209999179317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0127592607554335,0.00495115932897048,-0.0224635330402156,-0.00305498847065134,0.00997432556625346
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37311,0.0181628724391653,0.00704857638896712,0.00434766271678979,0.0319780821615409,0.00998210755027667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,0.00878022758214412,0.00341409434802158,0.00208860266002184,0.0154718525042664,0.0101274876454129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0109944580187331,0.00427711138267975,-0.0193775963287854,-0.00261131970868077,0.0101648136800155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,39971,0.0286092226304688,0.0111419738591006,0.00677095386663152,0.050447491394306,0.0102465697043036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0099240576110581,0.00386801525845117,-0.0175053675176224,-0.00234274770449382,0.0103086190677715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,39868,0.00951328071463686,0.00371486635483078,0.00223214265916854,0.0167944187701052,0.0104502008956614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.010495929682114,0.00409923452812108,0.00246143000699667,0.0185304293572313,0.0104641010078432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0189589047135669,0.00740499261887231,-0.0334726902465566,-0.00444511918057718,0.010467839064138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00556222856937437,0.00217322788880823,0.00130270190731024,0.00982175523143851,0.0104934612702487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0167894873754801,0.00655987864347122,-0.0296468495166837,-0.00393212523427647,0.0104956749901917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.00826435256244118,0.00323020251032724,-0.0145955494826826,-0.0019331556421998,0.0105227191046598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.0217921649591639,0.00852397806040734,-0.0384991619575623,-0.00508516796076551,0.0105800356520604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0252899413605748,0.00990941998171269,-0.0447124045247316,-0.0058674781964179,0.010718088135342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,36962,0.00891142539960455,0.00349429156266652,0.00206261393677817,0.0157602368624309,0.0107748894635558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,39866,-0.0121242149881736,0.00476655324527931,-0.021466659348921,-0.00278177062742612,0.0109809198073313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.0168977301029772,0.00664554089320983,-0.0299229902536685,-0.00387246995228598,0.0110108297793239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.00583481710052247,0.00229938487171487,-0.0103416114490836,-0.00132802275196133,0.0111724572661266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.019083244849227,0.00752069255275619,-0.0338238022526292,-0.00434268744582493,0.0111783773302614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,39903,0.0135396501990691,0.00533662722780644,0.00307986083256849,0.0239994395655697,0.0111863334186439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37411,-0.0200420183478336,0.00790102614301128,-0.0355280295881357,-0.00455600710753146,0.0112034866004933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0243000693832835,0.00958534311882291,-0.0430873418961764,-0.00551279687039061,0.0112521552023709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.00894690687512716,0.00352964995406883,-0.0158650207851021,-0.00202879296515226,0.0112631441162925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37382,-0.011206711328359,0.00442656140933214,-0.01988277169065,-0.00253065096606799,0.0113624384877889
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0122234227532067,0.0048300789501886,0.00275646801083707,0.0216903774955764,0.01139347605883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0109702793932729,0.00433757463121999,-0.019471925670464,-0.00246863311608169,0.0114459292776467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0119658419963391,0.00473539841000436,-0.0212472228799477,-0.00268446111273058,0.0115174607407375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37039,-0.0108079187768783,0.0042788335601466,-0.0191944325547657,-0.00242140499899098,0.0115517498908441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0164418558393881,0.00651421179337204,-0.0292097109543973,-0.00367400072437891,0.0116124594213509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.0128114214206775,0.0050780339176876,-0.0227643678993452,-0.00285847494200983,0.0116486721507998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,39587,0.0120266987767097,0.00476755968527056,0.00268228179357943,0.02137111575984,0.0116584978017262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0071296954943929,0.00282986888719362,-0.0126762385132924,-0.00158315247549341,0.0117656931089672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0120284784616875,0.00477581812296713,-0.021389081982703,-0.0026678749406719,0.0117929634968593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0138466300379441,0.00549962781293197,0.00306735952459748,0.0246259005512908,0.0118228891451583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.0220334382862921,0.00877341599742386,-0.0392293336412429,-0.00483754293134137,0.0120356106750893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37445,-0.0169102861371199,0.00673423216790409,-0.0301093811862119,-0.00371119108802792,0.0120472965496416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,39846,-0.00914204879425113,0.00364308759333526,-0.0162825004771882,-0.00200159711131402,0.0121026549209462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,0.0084753984575361,0.00338091334230226,0.00184880830662367,0.0151019886084485,0.0121933010070983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.0226901710890155,0.00905457342172239,-0.0404371349955914,-0.0049432071824396,0.0122226538120669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.00916140959444075,0.00365827919959094,-0.016331636825639,-0.0019911823632425,0.012279341056295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0107846077608081,0.00431138716394587,-0.019234926602142,-0.00233428891947421,0.0123796480833909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAYN,Layilin,39713,-0.00787680315119969,0.00314944682455703,-0.0140497189273315,-0.00170388737506792,0.0123939184414534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0104765362317942,0.00419139530175107,-0.0186916710232263,-0.00226140144036206,0.0124454814684009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0130611890882015,0.00523760177656019,-0.0233268885702595,-0.0027954896061435,0.0126525054488916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37388,-0.0334270765116113,0.013434595090789,-0.0597588828895577,-0.00709527013366483,0.012853465331482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00672903863745975,0.00270998694932765,0.00141746421677755,0.0120406130581419,0.0130384294512515
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0121535478704145,0.00490079725876963,-0.021759110497603,-0.00254798524322603,0.0131515650329009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0157759869734755,0.0063615628022417,-0.0282446500658692,-0.00330732388108173,0.0131543124634431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.00803091769608182,0.00324577950666938,-0.0143926455291538,-0.00166918986300984,0.0133612701060885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,39585,0.00781442076582182,0.00316364629598553,0.00161367402569018,0.0140151675059535,0.0135192780168824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0142677667193841,0.00577628175333363,-0.025589278955918,-0.00294625448285017,0.0135214564917594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.020096790436759,0.00813872320868759,-0.0360486879257867,-0.00414489294773137,0.0135490476600378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0133210786864535,0.00540296054381149,-0.023910881352324,-0.002731276020583,0.0136921188669541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0213065236707826,0.00864337472264327,0.00436550921440181,0.0382475381271634,0.013709091431558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37388,-0.00912029831546395,0.0037037451770859,-0.0163796388625523,-0.00186095776837559,0.0138113978813469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,0.00873853434161223,0.00354980124952261,0.00178092389254791,0.0156961447906766,0.0138408593297754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.0108355685014193,0.00440340520564238,0.00220489429836024,0.0194662427044784,0.0138784701295154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0165931857709147,0.00675250604047276,-0.0298280976102413,-0.00335827393158811,0.0140095905975141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37411,-0.0149170982129337,0.00607299597547919,-0.0268201703248729,-0.0030140261009945,0.0140500565489347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0140796182218561,0.00573325425208579,-0.0253167965559443,-0.00284243988776797,0.0140706680186466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.0132430538156202,0.00540560778816123,0.00264806255082416,0.0238380450804162,0.0143012864263555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0133190816325161,0.00544356684373601,-0.0239884726462387,-0.00264969061879348,0.0144278731147263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0110182178699531,0.00450716051090554,-0.019852252471328,-0.00218418326857828,0.014513840832981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0131221715143458,0.00536841451959997,0.00260007905592985,0.0236442639727617,0.0145231648880796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.00685983296530988,0.00280902294397241,-0.0123655179354958,-0.00135414799512396,0.0146159963934412
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0216275281151412,0.0088573959165863,-0.0389880241116504,-0.00426703211863204,0.014629047018695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,39908,-0.00689462159503053,0.0028243131377362,-0.0124302753449935,-0.00135896784506758,0.0146505914054371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0157029488325493,0.00643706273738495,-0.0283195917978238,-0.00308630586727485,0.0147200651885035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0115302647052482,0.00473288776215797,-0.0208067247190778,-0.00225380469141858,0.0148555984476264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.0166714844361873,0.00685523736534457,0.00323521920011197,0.0301077496722627,0.0150320200867674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0192516346576613,0.00794117598446013,-0.0348163395872031,-0.00368692972811944,0.0153498532345666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.00622202693928196,0.00257070191207888,0.00118345119160735,0.0112606026869566,0.0155186098023806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,39892,0.010562123988995,0.00436772172107594,0.00200138941568619,0.0191228585623039,0.0156075967254069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.00728790353409706,0.00301455641218192,0.0013793729662205,0.0131964341019736,0.0156379914319678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0118060467281984,0.00488519601053338,-0.0213810309088439,-0.00223106254755301,0.015675452905981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0191112361862769,0.00793493922036864,-0.0346637170581994,-0.00355875531435439,0.0160322228394766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0102310995542252,0.00424879329122623,-0.0185587344050286,-0.00190346470342177,0.0160538220918914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00775237211356397,0.00322022313622937,0.00144073476655441,0.0140640094605735,0.0160802037030405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,36818,0.00919652671318779,0.0038216062713106,0.00170617842141901,0.0166868750049566,0.0161220579390879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.013525210575203,0.00562307180658744,-0.0245464313161144,-0.00250398983429163,0.0161701916283455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0149771474317382,0.00623052998785941,-0.0271889862079426,-0.0027653086555337,0.0162354226401591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0212834070822873,0.00886118695628097,0.00391548064797659,0.038651333516598,0.0163232028459675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40052,0.00397364052985417,0.00165461445447613,0.000730596199080962,0.00721668486062738,0.0163369443641946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LXN,Latexin,39682,0.0156689686289855,0.0065288431147262,0.00287243612412216,0.0284655011338489,0.0164083039389619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.00542424577173867,0.00226718473858922,0.0009805636841038,0.00986792785937354,0.0167454667189378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAT,Catalase,37252,-0.0123600412670312,0.00516948816110916,-0.0224922380628051,-0.00222784447125721,0.0168180904747988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00955964732512639,0.00400145072568486,-0.0174024907474687,-0.00171680390278406,0.0169062141381366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.0079207067221442,0.00331798059703852,0.0014174647519487,0.0144239486923397,0.0169909565908794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.0108434161160706,0.00455444226406667,0.0019167092784999,0.0197701229536412,0.0172867942093546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0278985611532005,0.0117322078322697,-0.0508936885044491,-0.00490343380195188,0.0174231421818466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0111231741569124,0.00467934672340018,0.00195165457904801,0.0202946937347767,0.0174646186166526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0140032779457982,0.00589382233657196,-0.0255551697254793,-0.00245138616611716,0.017517026812307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0216212727914018,0.00910242797046753,-0.0394620316135181,-0.00378051396928539,0.0175451710843589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37056,0.00386591521198114,0.00162811645932955,0.000674806951695224,0.00705702347226706,0.0175883367264891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.00989347019132514,0.00416915830139549,-0.0180650204620603,-0.00172191992058999,0.0176556298057655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.0108117928264949,0.00455655074182528,0.00188095337251734,0.0197426322804725,0.0176679697784559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.0114692656829021,0.00484002776708249,0.00198281125942043,0.0209557201063838,0.017818336677766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0075420636348346,0.00318595439690242,-0.0137865342527633,-0.00129759301690586,0.0179309869646372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0129114619177314,0.00545686810105994,-0.0236069233958089,-0.00221600043965395,0.017988940394357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0131677500041274,0.00556521438251862,-0.0240755701938639,-0.00225992981439091,0.0179895459595779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0147215070635697,0.00622413775725221,-0.0269208170677841,-0.00252219705935537,0.0180333749649799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.00838050943701879,0.00354432368350645,-0.0153273838566914,-0.00143363501734614,0.018069527246447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.0261432448293573,0.0110638376880298,-0.0478283666978958,-0.00445812296081882,0.0181422265651504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.00627080448260695,0.00265381654545828,-0.0114722849117052,-0.00106932405350872,0.0181447652307897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,39885,0.00543833680316105,0.00230297093473258,0.000924513771085194,0.00995215983523691,0.0182158187848951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40030,-0.0256497333030829,0.0108857704435825,-0.0469858433725047,-0.00431362323366113,0.0184717285042629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.00844169597716666,0.00358410950613802,0.00141684134513614,0.0154665506091972,0.0185190180827703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.00772744734986002,0.00328189690945317,-0.0141599652923882,-0.0012949294073318,0.0185587260318805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.0069255467914983,0.00294276236638436,0.00115773255338495,0.0126933610296116,0.0186140032648057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40058,-0.0114038311432683,0.0048469386389303,-0.0209038308755717,-0.00190383141096489,0.0186450221765964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39456,-0.0142604196067394,0.00606710047860853,-0.0261519365448121,-0.00236890266866667,0.0187630863146241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00910527824302844,0.00387453522584677,0.00151118920036876,0.0166993672856881,0.0187865049385966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.00996373784487753,0.00424429937455735,-0.0182825646190099,-0.00164491107074512,0.018909055696271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0116149953358422,0.00495240338741907,-0.0213217059751835,-0.00190828469650079,0.0190248772411056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37368,0.00634615848250687,0.00270908934318382,0.00103634336986659,0.0116559735951472,0.0191672610261112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0108570840989587,0.00464543215319365,-0.0199621311192182,-0.00175203707869911,0.0194456964381222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0096384235117824,0.00412870607562054,-0.0177306874199987,-0.00154615960356614,0.0195846500184354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0203668267210949,0.0087266539217583,-0.0374710684077412,-0.00326258503444863,0.0196173970574984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.00955269848872911,0.00410226318132462,-0.0175931343241254,-0.00151226265333285,0.0198927697255683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0126874740615696,0.00545430373031026,0.00199703875016144,0.0233779093729777,0.020025804112842
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,0.00717433561791662,0.00308591508527756,0.00112594205077261,0.0132227291850606,0.0200916887150135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,36991,0.0218904928130722,0.00942630539508087,0.00341493423871367,0.0403660513874307,0.0202332335827859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,39868,0.00840050783258517,0.00361957094256511,0.00130614878515754,0.0154948668800128,0.0203070422504795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00760228216001004,0.00327951733971031,0.00117442817417783,0.0140301361458423,0.0204585907452374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,39992,0.00956683231795167,0.00413124627503238,0.00146958961888821,0.0176640750170151,0.020585737771614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.00671634002650741,0.00290240491048886,-0.0124050536510656,-0.00102762640194925,0.0206768846318167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,39749,0.00795653749216141,0.00344588833007781,0.0012025963652089,0.0147104786191139,0.0209566473242542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00894974028153119,0.00388438069162413,-0.0165631264371145,-0.0013363541259479,0.021235907216472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0245528190636611,0.010658021178103,0.00366309755457923,0.0454425405727429,0.0212548669906437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0123809824708019,0.0053827424729979,-0.0229311577178777,-0.00183080722372598,0.0214561925543144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0129620188348599,0.0056487361818875,0.00189049591836044,0.0240335417513594,0.0217673690611163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0128858816399962,0.00562988478192635,0.00185130746742055,0.0239204558125718,0.0221019248689112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0241631162306642,0.0105621615633183,-0.0448649528947681,-0.00346127956656031,0.0221700529210836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.00638398572289219,0.00279339053876883,-0.0118590311788791,-0.000908940266905283,0.0223053358459392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.00485839532390386,0.00212998101401442,0.000683632536435598,0.00903315811137213,0.022566849609199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,39868,0.0166776261148139,0.0073136379250867,0.00234289578164396,0.0310123564479838,0.0226002525605355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.00806702364469428,0.00354471193050763,0.00111938826089932,0.0150146590284892,0.0228719063851066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37411,0.00481176213413181,0.00211654374810881,0.000663336387838546,0.00896018788042507,0.023017334456477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.013031933377981,0.00573991573605103,0.00178169853532095,0.024282168220641,0.0231990866568861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0150519202833751,0.0066424660070355,-0.0280711536571646,-0.00203268690958547,0.0234662361264075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,39858,0.00745055680916103,0.00329028951863421,0.00100158935263798,0.0138995242656841,0.0235623776660558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37021,0.00775593566286268,0.00342565813552905,0.00104164571722575,0.0144702256084996,0.0235859080295583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0177361086793114,0.00783594308833929,-0.0330945571324564,-0.00237766022616642,0.0236227637808328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00860846471330428,0.00380917556766627,0.00114248060067839,0.0160744488259302,0.0238419587501108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00920166759970307,0.00407461935358782,0.00121541366667094,0.0171879215327352,0.0239439161378419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0190685819026231,0.00845434579237762,-0.0356390996556833,-0.00249806414956301,0.0241196797284528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0204206750417819,0.0090620292502284,-0.0381822523722295,-0.00265909771133422,0.0242482330476619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37235,0.00753250305423833,0.00334510634149248,0.000976094624913075,0.0140889114835636,0.0243512092266924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.012449962794161,0.00553207982632675,-0.0232928392537614,-0.00160708633456052,0.0244335419655734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0163072909435756,0.00724686317887863,-0.0305111427741777,-0.0021034391129735,0.0244492746965661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,39780,0.0147406460446305,0.00655169387449165,0.0018993260506269,0.0275819660386342,0.0244689910690477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.00805952868645695,0.0035825694302593,0.00103769260314872,0.0150813647697652,0.0244876034040395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0114959086380914,0.00511798545827169,-0.021527160136304,-0.00146465713987892,0.0247061674055312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,0.00560173258547522,0.00249622325430986,0.000709135007027903,0.0104943301639225,0.0248431548118181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00897893986562359,0.00401139464052683,0.001116606370191,0.0168412733610562,0.0252112121287564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0122984333386506,0.00551209728258199,-0.0231021440125113,-0.00149472266478992,0.0256861351955981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00805349280572079,0.00361109365971817,0.00097574923267317,0.0151312363787684,0.0257503800657613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.00175797254836507,0.000790275204876316,0.000209033146807494,0.00330691194992265,0.0261309756753703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37342,-0.0209804984943879,0.00943195985061547,-0.0394671398015942,-0.00249385718718157,0.0261377021334963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0110606689543341,0.00497676029843237,0.0013062187694067,0.0208151191392616,0.0262689158779059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0194053506154099,0.00873182975254101,-0.0365197369303903,-0.0022909643004295,0.0262723256968365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.0058358254019534,0.0026292246049114,0.000682545176327044,0.0109891056275798,0.0264625673273533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,39585,0.00824993302428373,0.00371868180341937,0.000961316689581769,0.0155385493589857,0.0265342998022899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.00497703839541726,0.00224472073670492,-0.0093766910393589,-0.00057738575147561,0.0266250932188875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0174603049640335,0.00787928949012842,-0.0329037123646852,-0.00201689756338182,0.026710258450668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.0122398085493185,0.00553019346057589,0.00140062936658979,0.0230789877320473,0.0268961979911937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.0319354155450818,0.0144450199700517,-0.060247654686383,-0.00362317640378049,0.0270646105656451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00486827595795318,0.00220371671760406,0.000548991191449233,0.00918756072445713,0.0271833692758375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37043,0.00634309215869056,0.00287303865230261,0.000711936400177454,0.0119742479172037,0.0272754346607786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,39858,0.0109681037552768,0.00496959242352335,0.001227702605171,0.0207085049053825,0.0273252073230154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0155551211866258,0.00706175877144525,-0.0293961683786584,-0.00171407399459307,0.027631187140076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0198561928686195,0.00904908773408468,-0.0375924048274255,-0.00211998090981352,0.0282301723337665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0118977198200298,0.00542278418660865,0.00126906281427685,0.0225263768257827,0.0282506230055844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.0181653035021737,0.00828416292132828,-0.0344022628279771,-0.00192834417637025,0.0283410906695178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40030,0.00530707590301528,0.00242972647104637,0.000544812019764406,0.0100693397862662,0.0289598330834989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37382,-0.0122299598541994,0.0056056756556846,-0.0232170841393412,-0.00124283556905754,0.0291480852762249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,0.00286613828950031,0.00131933471074951,0.000280242256431276,0.00545203432256934,0.0298421332894603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0161190475072057,0.007452976830399,-0.0307268820947877,-0.00151121291962364,0.0305769056292007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0145945851370292,0.00674912761567144,-0.0278228752637452,-0.00136629501031321,0.0306016978413964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37039,0.00733531078018071,0.00339289259535045,0.000685241293293838,0.0139853802670676,0.030638910257008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,0.0067459176480871,0.00312395758482969,0.000622960781820903,0.0128688745143533,0.0308331356923951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.00849834696449716,0.00393919421317283,-0.0162191676223159,-0.000777526306678405,0.030993446938451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.00817050159991814,0.00378793671168627,-0.0155948575548232,-0.00074614564501306,0.0310221043568083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.00583078613768913,0.00270434595916092,-0.0111313042176445,-0.000530268057733725,0.0310922136884404
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,0.00506622089115231,0.00235011294161479,0.000459999525587325,0.00967244225671731,0.0311192221466059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00690201843968761,0.00320919341998094,0.000611999336524967,0.0131920375428503,0.0315178878379763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.00644440512291005,0.0029990530146114,-0.0123225490315484,-0.000566261214271712,0.0316668906150645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37437,-0.0117680604884494,0.00547878808936801,-0.0225064851436107,-0.0010296358332881,0.0317368539679909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,39931,-0.0194970224367331,0.00907847519153948,-0.0372908338121504,-0.00170321106131566,0.031759672962544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.00562271093604485,0.00261960561082154,0.000488283938834628,0.0107571379332551,0.0318591004672107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0127831716829785,0.0059733977479173,-0.0244910312688964,-0.00107531209706061,0.0323717073003448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.0117565883670945,0.00549788975820091,0.000980724441020752,0.0225324522931683,0.0325041539871946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.0165881672636563,0.00776203939454161,-0.0318017644769578,-0.00137457005035471,0.0326062486526737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.00636887898901098,0.00298431915578639,-0.0122181445343523,-0.000519613443669653,0.0328488271805836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.012262013066775,0.00575620757826167,0.000979846213382124,0.0235441799201679,0.0331715463013809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00745468292638507,0.00350035192991428,0.000593993143753069,0.0143153727090171,0.0332122629511583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0141467672744901,0.0066510107544324,0.00111078619580264,0.0271827483531777,0.0334377377298242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0145206225925412,0.00683974755537648,-0.0279265278010792,-0.00111471738400334,0.0337712086464423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.00914664130904659,0.00432196280056303,-0.0176176883981501,-0.000675594219943046,0.0343366167717942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0073799085571094,0.00349053460742845,-0.0142213563876691,-0.000538460726549642,0.0345082546659829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.0103901240399854,0.00491644608218017,0.000753889718912227,0.0200263583610585,0.0345904140547076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.00869995383571709,0.00411954601673189,-0.0167742640285116,-0.000625643642922582,0.0347131573635998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.0127970241936657,0.00606062019676833,-0.0246758397793317,-0.000918208607999809,0.0347472210876161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37056,0.00569429797603929,0.00269691649499574,0.000408341645847637,0.0109802543062309,0.0347557886891422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.00829890079113545,0.00393100839175719,-0.0160036772389795,-0.000594124343291346,0.0347787638651473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0166480817069683,0.00788705031037162,-0.0321067003152967,-0.00118946309863997,0.0348039252766545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0126507904821295,0.00600468275451112,-0.0244199686809713,-0.000881612283287684,0.0351485909225173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.00776528502841228,0.00368807079266725,-0.0149939037820401,-0.000536666274784471,0.0352649085348257
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37348,0.0119400275718858,0.00567427826921693,0.000818442164220631,0.023061612979551,0.0353762168575354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0181251907854443,0.00863590818262811,-0.0350515708233954,-0.00119881074749325,0.0358515843584112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.007055994782954,0.00336502735208614,0.000460541172865158,0.0136514483930428,0.0360248624959298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.010132072216584,0.00483211087620645,-0.0196030095339487,-0.000661134899219396,0.0360279001100229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37043,-0.0106246621323313,0.0050730693742056,-0.0205678781057742,-0.000681446158888306,0.0362499757676553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,0.00443316972340017,0.00212252900733576,0.000273012869022076,0.00859332657777826,0.0367572208972448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37382,0.0125501443423156,0.00601016358454111,0.000770223716615073,0.0243300649680162,0.0368026497771782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C3,Complement C3,36816,-0.00943669529394571,0.00452068625257419,-0.0182972403489911,-0.000576150238900286,0.0368671899667046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0180983238484761,0.00867529711717525,-0.0351019061981396,-0.00109474149881263,0.0369772249185112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.00935914548475771,0.00448769806823824,0.00056325727101076,0.0181550336985047,0.0370388506462221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0188921164100765,0.00905936504868743,-0.0366484719055039,-0.00113576091464915,0.0370550316094912
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.00820149180598053,0.00394016182807348,0.000478774622956517,0.0159242089890045,0.0374032549101869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.0112649737333423,0.00542304854457361,-0.0218941488807066,-0.000635798585978018,0.0377987034602844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,36962,0.00950486118712345,0.0045826750393259,0.000522818110044683,0.0184869042642022,0.0380908282576135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0137777089555426,0.0066506624111981,-0.0268130072814909,-0.000742410629594358,0.0383159782685159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.0072008524544377,0.00347832279801902,0.000383339770320416,0.014018365138555,0.0384517112253567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.00840006227664268,0.00405826422829872,-0.0163542601641082,-0.000445864389177181,0.0384843453491951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.00609232190898334,0.00294507300882683,-0.0118646650062839,-0.000319978811682752,0.0385949379092579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40058,-0.0111252707994445,0.00537849792465537,-0.021667126731769,-0.000583414867120005,0.0386115196320461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,36962,0.00832725647586758,0.00403749640968803,0.000413763512879049,0.0162407494388561,0.0391817052983797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37340,-0.00950138745330199,0.00462279275536628,-0.0185620612538199,-0.000440713652784089,0.0398658877110901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00710717186457726,0.00346439863322687,0.000316950543452596,0.0138973931857019,0.0402391523780828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.022020127347708,0.0107391715927155,-0.0430689036694304,-0.00097135102598556,0.0403367869844026
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.00880238910726267,0.00429415945072528,-0.0172189416306842,-0.00038583658384111,0.0403955763841764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37021,0.0166297603174723,0.00812451386571135,0.000705713140678067,0.0325538074942665,0.0406914348515228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.0050585948181089,0.00247692490584718,0.000203822002648433,0.00991336763356937,0.0411429474607105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00856519747976766,0.00420355456791486,0.000326230526654529,0.0168041644328808,0.0416090317411083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0196666776535823,0.00966127219614227,-0.0386027711580211,-0.000730584149143454,0.0418079170813904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,0.00507889555347625,0.00249716019883117,0.000184461563767149,0.00997332954318534,0.0419843328177488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0117902196191458,0.00579973459706516,-0.0231576994293935,-0.000422739808898041,0.042080508547215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.00757286536367682,0.00372740651541126,-0.0148785821338829,-0.00026714859347075,0.0422067539671102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0119184088837274,0.00587807056469436,-0.0234394271905283,-0.000397390576926409,0.0426171662297985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,39750,-0.0130653745663763,0.00645229906914294,-0.0257118807418965,-0.00041886839085617,0.042892504246014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,39866,0.00665319368546527,0.00328967721660336,0.000205426340922687,0.0131009610300079,0.0431469206264971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40052,-0.0102340547508982,0.00506395562267906,-0.0201594077713492,-0.000308701730447296,0.0433002691710582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0157588071951115,0.00779872491632162,-0.0310443080311019,-0.000473306359121134,0.0433285372352367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0165406471896086,0.00819379453472329,-0.0326004844776663,-0.000480809901550965,0.0435402357760388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00785555743252128,0.00389250835660808,0.000226241053569447,0.0154848738114731,0.0435985625422063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00683219766420561,0.00338668513188739,0.00019429480570634,0.0134701005227049,0.0436772010027461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00726076194980458,0.00359933265308077,0.000206069949766278,0.0143154539498429,0.0436894284006196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37437,-0.0166167336678315,0.00826239596788662,-0.0328110297648893,-0.000422437570773721,0.0443316944728403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0137076769911068,0.0068195227675385,-0.0270739416154822,-0.000341412366731332,0.0444442334806261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0156377892288658,0.0077802245024167,-0.0308870292536026,-0.000388549204129106,0.0444543458670169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37056,0.00683265440536114,0.00340113535300047,0.000166429113480224,0.0134988796972421,0.0445645266794015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37162,-0.00444579259142902,0.00221397123075109,-0.00878517620370115,-0.000106408979156895,0.0446568310441914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.00598267336832336,0.00298215952413529,0.000137640701018193,0.0118277060356285,0.0448602601973866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0185984457794399,0.00927123271094909,-0.0367700618929001,-0.000426829665979664,0.0448691047742557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.0058003515637211,0.00289229680358612,0.000131449828692315,0.0114692532987499,0.0449349556963318
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.00648286408706931,0.00323552760209501,-0.0128244981871755,-0.000141229986963089,0.0451275057696725
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.0150945598883215,0.00753775920443228,-0.0298685679290088,-0.000320551847634239,0.045245018887219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.0122550789768665,0.00612458317308667,0.000250895957616678,0.0242592619961164,0.0454163901060467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.0118973404824993,0.00595127600093829,-0.0235618414443384,-0.000232839520660234,0.0456150817790563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0119958899124365,0.00600365291129099,0.000228730206306198,0.0237630496185669,0.0457265683498971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.00733945644917389,0.00368497852837526,-0.0145620143647894,-0.000116898533558388,0.0464188459416181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0175185894038281,0.00880342579975773,-0.0347733039713532,-0.000263874836302917,0.0466108547863172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0112186763790891,0.00564353584209668,0.000157346128579643,0.0222800066295986,0.0468423097456428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.00544459253791855,0.00274022569641806,-0.010815434902898,-7.37501729391422e-05,0.0469526024846766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,39788,0.00365512032716555,0.0018434357749922,4.19862081808406e-05,0.00726825444615026,0.0474095996929274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.00628747401588699,0.00317574800536943,-0.0125119401064111,-6.3007925362916e-05,0.047741735065002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.006395654009569,0.00323245926200412,-0.0127312741630971,-6.0033856040918e-05,0.0478813169217652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,0.0163868611277077,0.00828366663493254,0.000150874523239961,0.0326228477321755,0.0479221593220103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.00520963715594934,0.00263763399456735,3.98745265973279e-05,0.0103793997853014,0.0482719157350911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.0073249380612525,0.00371317024123598,4.71243884299886e-05,0.014602751734075,0.0485516578693941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0154785012477408,0.00786159497103208,-0.0308872273909637,-6.97751045179405e-05,0.0489882900868425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,0.0100160309603728,0.00509168732269802,3.63238078846858e-05,0.0199957381128609,0.0491853218084438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00722137731824492,0.00367168907540014,2.48667304606539e-05,0.0144178879060292,0.0492302523418267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,39862,-0.00476175838237001,0.00242261892049269,-0.00951009146653569,-1.34252982043276e-05,0.0493688474295329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0162739907525547,0.00828313790208291,-0.0325089410406372,-3.90404644721731e-05,0.0494678372132521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0142739649818213,0.00726719734419078,-0.0285176717764352,-3.02581872073607e-05,0.0495319648961228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0110531532880221,0.00563766096512658,-0.0221029687796702,-3.33779637399882e-06,0.049944075536258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0054209710296265,0.00276567985567793,-0.0108417035467552,-2.38512497766942e-07,0.0500066586969931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0173629905737501,0.00886609083578614,-0.034740528611891,1.45474643907031e-05,0.0502083239019146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSPN,Persephin,39866,-0.0180244322704858,0.00920859229960146,-0.0360732731777046,2.44086367330934e-05,0.0503237613631693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.00611201644731608,0.00312420521146281,-1.14257671510222e-05,0.0122354586617832,0.0504458453502117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0151259399749323,0.0077418590085124,-4.81036817520323e-05,0.0302999836316166,0.0507477645623789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,-0.0114474181594245,0.00586307130014121,-0.0229390379077013,4.42015888522766e-05,0.0509046300102253
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0150322743025838,0.00769947282477083,-0.0301232410391346,5.86924339670662e-05,0.0509112606803943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.00555868934798688,0.00284950078648169,-0.011143710889491,2.63321935172426e-05,0.0511032738274629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00759069706078112,0.00389314051174614,-0.0152212524638036,3.98583422413223e-05,0.051225710448159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37388,0.0165561967259262,0.00851457954120556,-0.00013237917483673,0.0332447726266891,0.0518615896316136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTN,Titin,37021,-0.0130151806250648,0.00670526097940726,-0.026157492144703,0.000127130894573484,0.0522747313632089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00645372806914437,0.00332696099655319,-6.7115484099876e-05,0.0129745716223886,0.0524221293150881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0158505964612907,0.0081740904169988,-0.0318718136786083,0.000170620756026921,0.0525034202432796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.0118413333857541,0.00610735725707558,-0.000129086838114049,0.0238117536096222,0.0525392845078185
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,0.00600231682329712,0.00309633930048446,-6.65082056524264e-05,0.0120711418522467,0.0525773233975111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0131601391434779,0.00679724539736847,-0.000162461835364325,0.0264827401223201,0.0528770267368995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0189616599027384,0.00979876060722622,-0.0381672306929018,0.000243910887424956,0.0529978631769116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0139352481739424,0.00720254931104813,-0.0280522448235967,0.000181748475711957,0.0530403726035275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0124994113636701,0.00646116968590634,-0.0251633039480465,0.000164481220706376,0.0530644523798714
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40030,0.00584927690154796,0.00302641335299757,-8.24932703272843e-05,0.0117810470734232,0.053285400557395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.00925694866003531,0.00479004557158277,-0.00013154066026691,0.0186454379803375,0.0533145720822928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.0142071993893748,0.00736782099943332,-0.000233729769514529,0.0286481285482641,0.0538422220572635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0128541413587352,0.00667217614136551,-0.0259316065958116,0.000223323878341175,0.0540598227346472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00819625276400525,0.00425726572491546,-0.0165404935848396,0.00014798805682906,0.0542210747366459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.00672501258430442,0.00349491571942123,-0.000125022225761187,0.01357504739437,0.054347003110085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00798023859095836,0.00415795429858968,-0.000169351834277407,0.0161298290161941,0.0549717216028302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40052,-0.0166704679177999,0.00868992498324282,-0.0337027208849558,0.000361785049356009,0.0550820194168196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40012,0.0054762478898493,0.00285595083766061,-0.000121415751965494,0.0110739115316641,0.0551937400801883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0162031364047841,0.00845224016240224,-0.0327695271230924,0.000363254313524321,0.0552566152886645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37445,-0.0172019335199315,0.00897409313846505,-0.034791156071323,0.000387289031460028,0.0552787508038254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.00831586434335274,0.00434625473724319,-0.0168345236283494,0.000202794941643904,0.055725586392642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.0103485680722633,0.00541036347948656,-0.0209528804920569,0.000255744347530378,0.0558040546729683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.0212893428854502,0.0111424689819296,-0.0431285820900322,0.000549896319131753,0.0560708791649219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.00986158926268734,0.0051623374780404,-0.0199797707196465,0.000256592194271842,0.056116738091945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40042,-0.00601707501895318,0.00316138173636772,-0.0122133832222339,0.00017923318432755,0.0570184291935574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37382,-0.0192767538732885,0.0101375721950465,-0.0391463953755797,0.000592887629002642,0.0572557170835846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.00923612235430002,0.00485800842133621,-0.018757818860119,0.000285574151518945,0.0572960077132148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,0.00632368134249591,0.00332794931894167,-0.000199099322629763,0.0128464620076216,0.0574283853828302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39477,-0.0107829432131581,0.00568892783751724,-0.0219332417746919,0.000367355348375675,0.0580543995109914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00598599355117219,0.00315841443874122,-0.0002044987487606,0.012176485851105,0.058080870505445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0154457691809466,0.00815075870015511,-0.0314212562332506,0.000529717871357395,0.0581090784127113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.014713363390815,0.00776444951644808,-0.0299316844430532,0.000504957661423278,0.0581182926561942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39477,0.0073370534361897,0.0038816914952778,-0.000271061894554785,0.0149451687669342,0.0587538432156812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0143105326874318,0.00757614670928422,-0.0291597802376288,0.000538714862765325,0.0589241997296578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37072,-0.00807951830413448,0.00427876533394024,-0.0164658983586574,0.000306861750388401,0.0590099053249647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0182542115062477,0.00966898717413719,-0.0372054263675566,0.000697003355061242,0.0590595406146342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.0049193583361102,0.00260667901505098,-0.0100284492056101,0.000189732533389716,0.0591497229799999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.019879949188411,0.0105349252150038,-0.0405284026098184,0.000768504232996414,0.0591746781922034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37382,0.0129656217353021,0.00687114076483899,-0.000501814163782331,0.0264330576343865,0.0591860515757732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.01079827112822,0.00572985909845588,-0.0220287949611935,0.000432252704753562,0.0595073504697772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.00897197665134982,0.00476450208491877,-0.0183104007377906,0.000366447435090962,0.0597065451105417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.00698917847117806,0.00371173079911774,-0.0142641708374488,0.000285813895092715,0.0597221566499087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37382,-0.0145658266645342,0.0077355338470303,-0.0297274730047136,0.000595819675645164,0.0597250309546897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.00786073368289227,0.00417717636713865,-0.016047999362484,0.000326531996699478,0.0598811817178002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0167879340981405,0.00892182285313437,-0.0342747068902839,0.000698838694002848,0.0599027100995393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,39720,0.0230895335694923,0.0122748238705772,-0.000969121216839067,0.0471481883558236,0.0599836858434657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.0138215015288734,0.00736402883412808,-0.000611994986017677,0.0282549980437644,0.0605547788455858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00873474396455505,0.00465701405515938,-0.000393003583557339,0.0178624915126674,0.0607308589193576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.00706207056945097,0.00376760215867277,-0.0144465708004496,0.00032242966154766,0.0608905099358313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.011891187856656,0.00636825332964536,-0.0243729643827609,0.000590588669448923,0.0618874324588041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40009,-0.00403077123850218,0.00216081199765894,-0.0082659627539137,0.00020442027690935,0.062143960805307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00991213072085142,0.0053154951579515,-0.000506239788733515,0.0203305012304364,0.0622370827350573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.00692797835901079,0.00371592161936722,-0.000355228014948954,0.0142111847329705,0.0622873161137824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0087604509827,0.00471291117710912,-0.0179977568898339,0.000476854924433875,0.0630743672352396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0111631535275186,0.00601410348164227,-0.0229507963515375,0.000624489296500214,0.0634528301670218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37124,-0.00978895756486946,0.00527434799453358,-0.0201266796341553,0.000548764504416347,0.0634819994969895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00503028358181726,0.002717492925424,-0.00029600255201379,0.0103565697156483,0.0641810741090891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,39826,-0.0047456382994042,0.00256989698833391,-0.00978263639653867,0.000291359797730272,0.0648198740254572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0111994748627254,0.00606481954336026,-0.000687571442260674,0.0230865211677115,0.0648232869631833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0148390820948072,0.00806387453146495,-0.0306442761764785,0.000966111986864145,0.0657617817027586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.00872316628566619,0.00474383563051807,-0.0180210841214816,0.00057475155014922,0.065957208982428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.00807113216916985,0.00439297464809576,-0.0166813624794375,0.000539098141097828,0.0661869299839627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.00857415617143687,0.0046859757491932,-0.000610356296981801,0.0177586686398555,0.0673101329596813
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00605612654963553,0.00331675427190739,-0.00044471182330296,0.012556964922574,0.0678808619747403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00389796573053364,0.00213569381213676,-0.000287994141254399,0.00808392560232169,0.0680006960297391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.0143728766774086,0.0078776544433522,-0.0298130793863789,0.00106732603156169,0.0680967510494932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,39868,0.00707904676826921,0.00388052163394249,-0.000526775634258065,0.0146848691707965,0.068132716289785
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0163639745201212,0.00897203955120018,-0.0339491720404736,0.00122122300023111,0.0681919845447192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0100875280904718,0.00553224499555683,-0.0209307282817631,0.000755672100819635,0.0682605994491228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0130960918033943,0.00719807328684764,-0.0272043154456156,0.00101213183882711,0.0688713029711442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00792738155001417,0.00436099080926445,-0.000620160436144152,0.0164749235361725,0.0691184497728111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00609771593751454,0.00335923337430549,-0.000486381476124218,0.0126818133511533,0.0695140527862992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0179418368925505,0.00989991631045456,-0.0373456728610414,0.00146199907594044,0.0699553121208387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37411,-0.0135573525704577,0.00750668317226579,-0.0282704515880987,0.00115574644718323,0.0709346350959576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00646864427331067,0.00358274800919642,-0.000553541824714323,0.0134908303713357,0.0710196335416876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0095662033454335,0.00530379472459888,-0.0199616410056473,0.000829234314780304,0.0713045739976892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.00704862747935034,0.00390930821568233,-0.0147108715820877,0.000613616623387025,0.0714045625263252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,39559,-0.00954806363578111,0.00530122279705045,-0.019938460318,0.000842333046437774,0.0717053729623705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37382,-0.00590938810491193,0.00328929034922832,-0.0123563971893994,0.000537620979575572,0.0724287453473713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,39866,-0.01010606063263,0.00563945809974641,-0.021159398508133,0.000947277242872937,0.073147537803731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.0071406262481938,0.00399170037534508,-0.00068310648748256,0.0149643589838702,0.0736590715743415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,0.00509503458372903,0.00284894618977612,-0.000488899948232161,0.0106789691156902,0.0737314121953711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0206911055376844,0.0116116243085562,-0.0434498891824545,0.00206767810708575,0.0747830281721404
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.00567733128533319,0.00318838080205062,-0.0119265576573524,0.000571895086686019,0.0749920897046906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,37453,0.00364565836645369,0.00204786239546725,-0.000368151928662122,0.0076594686615695,0.0750612743361032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.00771242842161965,0.00433544778249588,-0.0162099060753116,0.000785049232072273,0.0752754373932373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00893988765515613,0.00503293438449945,-0.00092466373846279,0.0188044390487751,0.0757097083778236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37388,-0.014659400357337,0.00825944179357141,-0.0308479062727369,0.001529105558063,0.0759425384605304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0151700940133975,0.00855723010162293,-0.0319422650125784,0.00160207698578345,0.0762881080676075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40058,-0.0134260126630938,0.00759957855551812,-0.0283211866319093,0.00146916130572176,0.0773009021783031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,36962,0.00518823126830858,0.00293725152017337,-0.000568781711231227,0.0109452442478484,0.0773594568919669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0182195929444812,0.0103186499488579,-0.00200496095528037,0.0384441468442427,0.0774694342096467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,36962,0.00757768204671887,0.00430804324136949,-0.00086608270636533,0.0160214467998031,0.0786073941479008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,0.0117405657118484,0.00668792245187537,-0.00136776229382733,0.0248488937175241,0.0791991201080123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.011038568317171,0.00628827983410353,-0.00128646015767191,0.0233635967920139,0.0792106804499245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.0101022954864974,0.00575805806566307,-0.00118349832220224,0.021388089295197,0.0793746563438035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,39866,-0.0111021080685785,0.00632829292728566,-0.0235055622060584,0.00130134606890141,0.0793878642714608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.00459268109152595,0.00262631437091693,-0.00974025725852314,0.000554895075471238,0.0803625148665267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.00473290598421923,0.00271002368148288,-0.0100445523999257,0.00057874043148722,0.0807570700647632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37424,0.00248478815189069,0.00142443089607645,-0.000307096404419152,0.00527667270820053,0.0811106821132986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.00685071240147188,0.00393293764748789,-0.0145592701905481,0.000857845387604381,0.0815525330635062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.00985850828946521,0.00565980794721884,-0.00123471528708372,0.0209517318660141,0.0815546983116343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,39985,-0.0118578022522031,0.00681807838418965,-0.0252212358852148,0.00150563138080858,0.0820238222601585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.00680041202204127,0.00391125738307344,-0.0144664764928652,0.000865652448782665,0.082111356064981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,39913,-0.00481984920659249,0.00277404640112064,-0.0102569801527889,0.000617281739603964,0.0823217190224909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40011,0.00904277973914208,0.00520782656861216,-0.00116456033533776,0.0192501198136219,0.0825152647868047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0082058333596081,0.00472684247846318,-0.0174704446173959,0.00105877789817972,0.0825822545851938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37368,0.00764890388368038,0.00441196855577517,-0.000998554485638959,0.0162963622529997,0.0829992138527967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.00900178494933685,0.00519233537492585,-0.0191787622841915,0.0011751923855178,0.0830001910834067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00585132974389167,0.0033770841737983,-0.000767755236753003,0.0124704147245363,0.083180095775216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.00441733996523465,0.0025569731575573,-0.00942900735404697,0.000594327423577662,0.0840853571976363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0175319093140672,0.01015637172567,-0.0374383978963805,0.00237457926824595,0.0843351343731209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.021652560871206,0.0125473177603974,-0.0462453036815849,0.00294018193917294,0.0844256507141207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.00682882325853055,0.00396125440189238,-0.0145928818862396,0.000935235369178515,0.0847449072397565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0147813652077176,0.00859871869146706,-0.031634853842993,0.00207212342755786,0.0856344960355181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.00692489603967458,0.00403610128856465,-0.0148356545652613,0.000985862485912129,0.0862333353029547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.0129259998786211,0.00753666703490151,-0.00184586750978588,0.027697867267028,0.0863537522502248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.0105227207370426,0.00613596802486638,-0.00150377659169552,0.0225492180657807,0.0863826990618857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37039,0.00713615529662369,0.00416584436152815,-0.00102889965197148,0.0153012102452189,0.086733237462381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGMN,Legumain,39931,-0.00599934056702934,0.00350374782961614,-0.012866686313077,0.000868005179018288,0.0868673562472713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0104647921728487,0.00611786486735292,-0.0224558073128604,0.00152622296716301,0.0871872629794252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00697087135797819,0.00408056594274178,-0.00102703788979569,0.0149687806057521,0.0876025346221262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.00618509247523459,0.00362090662330416,-0.000911884506441565,0.0132820694569107,0.0876298199224138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0087927193952455,0.00515062648225443,-0.0188879473004642,0.00130250850997319,0.0878202809441947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.0100231886904737,0.00588451503808353,-0.00151046078416998,0.0215568381651175,0.0885324924684895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.012523426793875,0.00735316090914545,-0.0269356221758,0.00188876858805012,0.0885662068385604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0103497802141413,0.00609764250931235,-0.0223011595323935,0.00160159910411093,0.0896550797944066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,39585,-0.00743888440200875,0.00438351057627713,-0.0160305651315119,0.00115279632749443,0.0897135624369898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,39866,-0.00543712710557575,0.00320650064689363,-0.0117218683734873,0.000847614162335762,0.089970195960425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.00637907794437737,0.00376432959754184,-0.0137571639555594,0.000999008066804625,0.0901720736286444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0104096172364205,0.00615004945594878,-0.00164447969723908,0.0224637141700802,0.0905539195161216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0146103817667511,0.00864720527493843,-0.0315589041056305,0.00233814057212817,0.0911261473247989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPART,Spartin,37124,-0.0128967409468433,0.00763956725067166,-0.0278702927581598,0.00207681086447311,0.0914058087842923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00481865495726216,0.00285844582333586,-0.000783898856476117,0.0104212087710004,0.0918655873566257
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0108721652789035,0.00645680607423528,-0.0235275051844047,0.0017831746265976,0.0922343276561272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00789432759427727,0.00469318125132794,-0.01709296284688,0.0013043076583255,0.0925755627688248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39477,0.0145257117578596,0.00863708167375244,-0.00240296832269517,0.0314543918384144,0.0926305913522758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,39868,-0.0113777554997307,0.00677357165031625,-0.0246539559343506,0.00189844493488913,0.0930298335861032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.00811108159292497,0.00483280734788749,-0.0013612208089345,0.0175833839947844,0.0933012474218591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.00553233685594385,0.00330122063126754,-0.000938055581340524,0.0120027292932282,0.0937918820495456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0107529417705795,0.00642648842742419,-0.0233488590883309,0.00184297554717191,0.0943072744510123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.00460427147777532,0.00275466358328833,-0.0100034121010205,0.000794869145469813,0.0946572018927714
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.00855837048850155,0.00512340619230217,-0.0186002466254138,0.00148350564841071,0.0948550050973907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0102865322527184,0.00616518081703661,-0.0223702866541102,0.00179722214867332,0.0952383281701783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37437,0.00474100981202085,0.0028419795711,-0.000829270147335137,0.0103112897713768,0.095297729301162
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,39788,-0.00964090789026465,0.00579533944800077,-0.0209997732083462,0.00171795742781686,0.0962196150790718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.00572715871350999,0.00344375125613978,-0.00102259374852399,0.012476911175544,0.0963246540813347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,0.00858154715935628,0.005164001870501,-0.00153989650682569,0.0187029908255382,0.0965763219176549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.015013263510632,0.00905165939673467,-0.00272798890696792,0.032754515928232,0.0972119781791164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.00885102636467022,0.005341561036864,-0.0193204859969237,0.00161843326758323,0.0975372862350711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.00432730686745742,0.00261596868647666,-0.000799991758036833,0.00945460549295167,0.0981087815883677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.00889239822183596,0.00538869520572991,-0.0194542408250666,0.00166944438139466,0.0989269630830703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.00965899167213995,0.0058676218585029,-0.0211595305148056,0.00184154717052573,0.0997527938217896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37411,-0.00589687214249135,0.00358359911299624,-0.012920726403964,0.00112698211898129,0.0998864962981083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.00989187982375763,0.00602086125347079,-0.0216927678805604,0.00190900823304512,0.100420371053613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,39810,-0.00650750012334047,0.00396151196467794,-0.0142720635741092,0.00125706332742829,0.100468680368177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.00839611784877757,0.00512076577975859,-0.0184328187771044,0.00164058307954927,0.101103323055466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,39844,-0.019937847640641,0.0121702089032838,-0.0437914570910773,0.00391576180979526,0.10138918605158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.00648489254357234,0.00396575181011701,-0.001287981004257,0.0142577660914017,0.102026012702959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.00486417575664983,0.00297807736217148,-0.0107012073865059,0.000972855873206275,0.102424009002945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.00604645085016136,0.00370301690226366,-0.0133043639785981,0.00121146227827542,0.102521291587218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.00626444707660103,0.00383901219571881,-0.0137889109802099,0.00126001682700784,0.102744194911994
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,39788,-0.00463288136511295,0.00284026934072607,-0.010199809272936,0.000934046542710144,0.102880223313493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0117667327329934,0.0072517431163517,-0.0259801492410427,0.00244668377505596,0.104697022370891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,39691,0.00752267793743161,0.00465063038737685,-0.00159255762182701,0.0166379134966902,0.105777181173088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37382,-0.00526423002561323,0.00325544837132395,-0.0116449088334082,0.00111644878218171,0.105890334716807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.00554663623784817,0.00343403901170317,-0.0122773527007864,0.00118408022509003,0.106292580590625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00773625894474269,0.00479412908058775,-0.00166023405320929,0.0171327519426947,0.106617771854359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.00417926749599569,0.00259426485641129,-0.00926402661456182,0.000905491622570437,0.107207065015019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00527279671633839,0.00328937219322523,-0.00117437278238305,0.0117199662150598,0.108963250171627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,36991,0.00832508733950234,0.0051945870053638,-0.00185630319101071,0.0185064778700154,0.109036745997172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.0166721264399966,0.010417316697904,-0.0370900671678884,0.00374581428789515,0.109528230250545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0108099718763909,0.00676050705519519,-0.00244062195179165,0.0240605657045735,0.109842699869757
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.00678080584048945,0.00424786771432268,-0.001545014879583,0.0151066265605619,0.110449241850536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.00632927358545382,0.00397423935137138,-0.0141187827141417,0.00146023554323407,0.111279010943739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.00713825105326602,0.00448314433856342,-0.0159252139568503,0.00164871185031828,0.111354337856811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.00501125432633198,0.00315478279489461,-0.00117211995166147,0.0111946286043254,0.112202026263993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.00698207428762128,0.00440296624417556,-0.0016477395509628,0.0156118881262054,0.112815728250378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,0.00682883774670251,0.00430989698809211,-0.00161856034995802,0.015276235843363,0.113109972159189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37437,0.0139574352558295,0.00881225841089873,-0.00331459122953204,0.031229461741191,0.113247538522611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0121339800465918,0.00766219248188335,-0.0271518773110831,0.0028839172178996,0.113300548953283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0113334123997554,0.00717191149775991,-0.0253903589353648,0.00272353413585402,0.11407378844804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00401285699631199,0.00253946241211108,-0.000964489331425719,0.0089902033240497,0.114085347031371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0452077938283665,0.0286795119544988,-0.101419637259184,0.011004049602451,0.114974207477559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00489125117609124,0.00310479887422335,-0.00119415461738654,0.010976656969569,0.115191818535778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0109896261891181,0.00697682230978805,-0.0246641979163027,0.00268494553806646,0.115242797957811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.00562617825383034,0.00358748356293116,-0.0126576460371754,0.00140528952951473,0.116839872602069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0062151572669401,0.00396764121351649,-0.00156141951155222,0.0139917340454324,0.117264653228732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,39796,-0.00491276365871499,0.00314449931129283,-0.0110759823088489,0.00125045499141895,0.118228773404312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00712079685773557,0.00457800667985835,-0.0160936899502579,0.0018520962347868,0.119866286887969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00889926990106962,0.00572234674417242,-0.00231652971750833,0.0201150695196476,0.11992737102032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.00450454844249717,0.00290012133896266,-0.010188786266864,0.00117968938186965,0.120392178156803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.012770879752207,0.00822894940864932,-0.0288996205931596,0.0033578610887457,0.120695168932396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,39866,0.0129655206075851,0.00836246213233397,-0.00342490517178947,0.0293559463869597,0.121055003167287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00731920907053147,0.00472459877541646,-0.00194100452928479,0.0165794226703477,0.121364837256454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.00806652790123204,0.00521091311300013,-0.0182799176027123,0.00214686180024822,0.121644687546696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.01080563366826,0.0070213822577436,-0.00295627555691741,0.0245675428934375,0.123837850994429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.00619654233485929,0.00403307303603408,-0.0141013654854861,0.00170828081576751,0.124456446954146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0142008722642022,0.00925272499538641,-0.0323362132551596,0.00393446872675515,0.124858339732918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.00720616290420805,0.00470042459329866,-0.0164189951070734,0.00200666929865733,0.125274183063949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0074816432107763,0.00488227025140633,-0.0170508929035327,0.00208760648198011,0.125444885367158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.00573243886861196,0.00374278047693606,-0.0130682886034066,0.00160341086618271,0.125641657034803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37021,-0.00772689180771878,0.00505074932719455,-0.0176263604890201,0.00217257687358254,0.126077750972173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.00337415231902895,0.00220825011921565,-0.00095401791463373,0.00770232255269162,0.126538692098924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0181680653984243,0.0118920108399672,-0.0414764066447599,0.00514027584791142,0.126597694794793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00380698652388227,0.00249317224054675,-0.00107963106758935,0.0086936041153539,0.12679303171055
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.00795105562584845,0.00522574363303205,-0.0181935131465913,0.00229140189489436,0.128153658674424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.00881976799898872,0.00579727817525512,-0.0201824332224888,0.00254289722451131,0.12819190577037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37056,0.00440000601759418,0.00289511942285596,-0.00127442805120351,0.0100744400863919,0.128584901752426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.00702355300677889,0.00462156113383821,-0.0160818128291018,0.002034706815544,0.128601312047498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37437,0.0128240187806887,0.00844893894031105,-0.00373590154232099,0.0293839391036983,0.129081564395467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.00911815842166952,0.00601328885161898,-0.00266788772750368,0.0209042045708427,0.129455289406671
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0108729145005242,0.00717743912044367,-0.0249406951765938,0.00319486617554537,0.129827644491204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.00891027418238396,0.0058824762155616,-0.0204399275648847,0.00261937920011678,0.129868642078985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.00990932091775267,0.00656164328708382,-0.022770141760437,0.00295149992493161,0.13101896789771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0220238777975365,0.0145885193648264,-0.0506173757525964,0.00656962015752329,0.1311469031159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.00367878889778189,0.0024423417824119,-0.00110820099574543,0.0084657787913092,0.132025149866218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.012601680297862,0.00837752272665693,-0.0290216248421095,0.00381826424638562,0.132546711911597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.00469377326654135,0.00312262164231307,-0.010814111685475,0.00142656515239227,0.132823295631121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.0057098999962628,0.00380645874514629,-0.00175075914422394,0.0131705591367495,0.133623785452578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,37453,0.003905544709172,0.00260539154176424,-0.00120102271268591,0.00901211213102991,0.133890602975056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.00520270259352898,0.00347539352089018,-0.0120144738944737,0.00160906870741577,0.134410585393146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.00438410059476659,0.00292859432546373,-0.0101241454726755,0.00135594428314232,0.134416957827463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37388,-0.00400521443405189,0.00267707886843148,-0.00925228901617759,0.00124186014807382,0.13464735019286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,36868,0.00636064218558947,0.00426047355415198,-0.00198988598054841,0.0147111703517273,0.135476482772145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.00951418404720017,0.0063733478924733,-0.0220059459164478,0.0029775778220475,0.135510800562397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37021,0.00942547853669969,0.00631400365217727,-0.00294996862156775,0.0218009256949671,0.135516259667777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37169,0.0061025040280156,0.00409121388497697,-0.00191627518653926,0.0141212832425705,0.13582457222438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0101597939971238,0.00681465380153991,-0.00319692745389443,0.023516515448142,0.136013910967991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.0038174058927543,0.00256410697780471,-0.00884305556925152,0.00120824378374293,0.136563421697794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37056,0.0152854258551741,0.0102751374469085,-0.00485384354076661,0.0354246952511149,0.136876933061865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,0.00570741072969505,0.00386193153230657,-0.00186197507362582,0.0132767965330159,0.139463961670733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0112450698532376,0.00761590499424726,-0.0261722436419623,0.00368210393548702,0.139822832230436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.00719325310668245,0.00487676558566075,-0.0167517136545775,0.00236520744121262,0.1402351157032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.00342845151000598,0.00232678767478933,-0.00113205233258111,0.00798895535259307,0.14064764691304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.0066052622009054,0.00448956709499197,-0.00219428930527886,0.0154048137070897,0.141248171091735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37382,0.0165156276745976,0.0112265758106667,-0.00548846091430921,0.0385197162635044,0.141282238897565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00712109759020526,0.0048454991398629,-0.00237608072392602,0.0166182759043365,0.141684787332139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0054272141667161,0.00369772538753652,-0.0126747559262877,0.00182032759285547,0.142204377489802
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00771318665736242,0.00525539175918292,-0.0025873811906361,0.0180137545053609,0.142216840383153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,0.00568175469675117,0.00388142046565502,-0.00192582941593267,0.013289338809435,0.143259335118436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0111892045074686,0.00765000426781322,-0.0261832128723825,0.0038048038574453,0.143589022322182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.00473587776810785,0.00324035729818886,-0.00161522253634231,0.011086978072558,0.143890168883481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0160202539878692,0.0109633405991943,-0.03750840156229,0.00546789358655157,0.143964580487097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.00383842402439762,0.00262877793027577,-0.00899082876773813,0.00131398071894289,0.144266858974184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.0102200497948881,0.00700053394478616,-0.00350099673689276,0.023941096326669,0.144342648864222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,39866,-0.00974943837422253,0.00667887509786517,-0.0228400335660383,0.0033411568175932,0.14438046000326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.00833356086392929,0.00571279063653801,-0.0195306305115438,0.00286350878368521,0.14465582944359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0122720620615928,0.00842592901962407,-0.028786882940056,0.00424275881687036,0.145288071884023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.00726665933342949,0.00498984040058429,-0.0170467465185747,0.00251342785171572,0.145335452792388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00360805041209857,0.00247941550557758,-0.00846770480303062,0.00125160397883348,0.145636510303752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37043,-0.00433727261014512,0.00298336139086214,-0.0101846609362349,0.00151011571594467,0.146019822030597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSG,Basigin,40040,-0.0027503000534193,0.00189966153669713,-0.00647363666534567,0.000973036558507077,0.147696774410459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00459949690360566,0.00317815759656436,-0.00162969198566048,0.0108286857928718,0.147858865752636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,39913,0.00535451647202752,0.00370465987825817,-0.00190661688935848,0.0126156498334135,0.14838015730343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.00874025450987277,0.00605788244540522,-0.020613704102867,0.00313319508312146,0.14910268288288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00376737781826094,0.00262378588472641,-0.00137524251580283,0.0089099981523247,0.151066538997362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0137674004367079,0.00959566541561458,-0.0325749046513124,0.0050401037778967,0.151380888514539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00391844352154609,0.00273684693649407,-0.00928266351707446,0.00144577647398228,0.152238707117339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.00843246187415156,0.00589121871126745,-0.0199792505482358,0.00311432679993265,0.152346081601108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,0.00650740837701301,0.00454816025421783,-0.00240698572125393,0.0154218024752799,0.152517545299427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.00709230069793401,0.00495712809920176,-0.00262367037650143,0.0168082717723695,0.152532000644523
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.0056462512378149,0.00394697309074137,-0.0020898160200382,0.013382318495668,0.152589587562227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.0180845385380925,0.0126430683699303,-0.0428649525431558,0.00669587546697083,0.152624105151611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.00833507803953226,0.00583148438597155,-0.0197647874360365,0.00309463135697199,0.15293435781444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.00793669547933973,0.00555588897916366,-0.00295284691982105,0.0188262378785005,0.153162261376618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00444518637864349,0.003112834806514,-0.00165596984212395,0.0105463425994109,0.153310166087129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.00500834821576949,0.0035128293105236,-0.0118934936643957,0.00187679723285676,0.153969776023199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,39776,0.00541570190775709,0.00380027374597832,-0.00203283463436041,0.0128642384498746,0.154153092910985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.00778110637056032,0.00547604533885658,-0.0185141552347192,0.00295194249359858,0.155358984862554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.00732761277164767,0.00515841271460663,-0.00278287614898132,0.0174381016922767,0.155481085870833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.00544906702176514,0.0038392616663286,-0.00207588584423892,0.0129740198877692,0.15583499970244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.00966400755849742,0.00681042943871043,-0.0230124492583699,0.00368443414137502,0.155922347045485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.00767943493645488,0.0054123120816971,-0.0182875666165812,0.00292869674367143,0.155956311274237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00757460734784439,0.00534144141891473,-0.00289461783322847,0.0180438325289172,0.156186343158377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00480528035005513,0.00340500201145287,-0.0018685235923925,0.0114790842925028,0.15819332056657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.00889687329901011,0.00632776594699217,-0.0212992945551148,0.00350554795709455,0.159746056943105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,39892,-0.00514951746472156,0.00367162890256257,-0.0123459101137442,0.00204687518430108,0.160780645731428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00593128741536084,0.00423350844371905,-0.00236638913432849,0.0142289639650502,0.161226985799603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,39868,0.00458633296239858,0.00327460563502064,-0.00183189408224188,0.011004560007039,0.161360385051197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.00438308300429817,0.00313129770149642,-0.0105204264992312,0.00175426049063482,0.161606351506388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,39587,-0.00850419387241904,0.00607682865341091,-0.0204147780331044,0.00340639028826634,0.161698988161982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0163899791007606,0.0117151290701967,-0.0393516320783462,0.006571673876825,0.161819190426139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37388,-0.00519977616888371,0.00372039740405462,-0.0124917550808308,0.00209220274306333,0.162244123213029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00717516269091349,0.00513651505856442,-0.00289240682387277,0.0172427322056998,0.162469034640301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00472826241510529,0.00338816755988712,-0.00191254600227346,0.011369070832484,0.16288202528587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.00658843505461775,0.00473287378764724,-0.0158648676784063,0.00268799756917083,0.163927797388771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37056,0.0138834747085647,0.00998253329589202,-0.00568229055138368,0.0334492399685131,0.164316602155056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0116339471101794,0.0083786680624185,-0.0280561365125196,0.00478824229216087,0.16500231090955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00521644328411139,0.00376286755845059,-0.0125916636986745,0.00215877713045177,0.165680424303962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37124,-0.00504001756487888,0.00363582892842294,-0.0121662422645879,0.00208620713483009,0.16570649760816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37388,0.00305450083813524,0.00220583696849238,-0.00126893962010982,0.00737794129638031,0.166156185527116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00404026792253574,0.00291916559916136,-0.00976183249689201,0.00168129665182053,0.166366233546649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,39777,-0.00382957816502194,0.00276748457773181,-0.00925384793737629,0.00159469160733241,0.166446521499673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.0074542605352179,0.00539368923318685,-0.00311737036182832,0.0180258914322641,0.166984732916054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0114323266953496,0.00827671883550496,-0.0276546956129393,0.00479004222224012,0.167217692009406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.032306938477128,0.0233963388093706,-0.0781637625434944,0.0135498855892384,0.167346529945694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0109972464275784,0.00797299425561782,-0.0266243151685893,0.00462982231343256,0.167822129110723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.0098977726470508,0.00718730972121252,-0.00418935440652575,0.0239848997006273,0.168499283755908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00452647201483395,0.00329516816330844,-0.0019320575852506,0.0109850016149185,0.169567673564623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,39858,-0.00514913103925202,0.00375369844839443,-0.0125063799981051,0.00220811791960107,0.170160912608034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.00649039219760556,0.00473390134122638,-0.0157688388264093,0.00278805443119815,0.170383643729046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0118656886441112,0.00865925413256547,-0.0288378267439395,0.00510644945571711,0.170619729113599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0104386014751765,0.00762190594907604,-0.00450033418501249,0.0253775371353656,0.1708499176305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.0146268539066948,0.0107215519410391,-0.00638738789774188,0.0356410957111314,0.172513475230942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00580980275059609,0.00426057997955909,-0.00254093400933972,0.0141605395105319,0.17271125930519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0132869270521156,0.00976058198394584,-0.0324176677406495,0.00584381363641824,0.173447219768422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.0044089889726902,0.003241509229988,-0.00194436911808627,0.0107623470634667,0.173800858919636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.00595402772226275,0.00438352717125323,-0.0145457409779191,0.00263768553339358,0.174396598872759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.00898214590584031,0.00661327673376549,-0.0219441683040207,0.00397987649234005,0.174419811129925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0152471920823445,0.0112286965616716,-0.037255437343221,0.00676105317853189,0.174525232953223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,0.00811591940647712,0.00599173199129008,-0.00362787529645145,0.0198597141094057,0.175589872605262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0153418647739112,0.0113314143038611,-0.0375514368094789,0.00686770726165655,0.17578345827305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,39749,0.00556057152321506,0.00410719354105322,-0.00248952781724924,0.0136106708636794,0.175799800151723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.011240491138429,0.00833726038750069,-0.0275815214979303,0.00510053922107235,0.17760964270534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.00764397145542443,0.00567307661768146,-0.0187632016260801,0.00347525871523124,0.177866806437129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,-0.00404418615493963,0.00301684761059529,-0.0099572074717064,0.00186883516182713,0.18009474846192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0126722503141517,0.00946062022790783,-0.0312150659608511,0.00587056533254761,0.180439659112826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.00754864861545541,0.00563743022176949,-0.0185980118501236,0.00350071461921278,0.180586309027027
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.00250613824971342,0.00187402243525488,-0.00116694572338615,0.006179222222813,0.181145706676279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.00844484244871017,0.00631779056561197,-0.0208277119573096,0.0039380270598893,0.181347699359668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.00242374917874218,0.00181420617706353,-0.00597959328578669,0.00113209492830233,0.181577093398914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37368,0.00445931587780703,0.00334029721130421,-0.00208766665634922,0.0110062984119633,0.18189697322966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00377477599300596,0.00283146086390469,-0.00177488730024725,0.00932443928625916,0.18250094304424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37437,0.0128695869211612,0.00966175431319565,-0.00606745153270229,0.0318066253750247,0.182878119954456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,36962,0.00775944630561696,0.00585599674876587,-0.00371830732196416,0.0192371999331981,0.18518006463458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00533495033453269,0.00403594012964113,-0.00257549231956393,0.0132453929886293,0.186237541566459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.00441602355683315,0.00335678896807479,-0.0109953299342597,0.00216328282059344,0.188344321921204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.00490989357907025,0.00373557185812409,-0.00241182726285297,0.0122316144209935,0.188747267346256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.00891996219955353,0.00679436460097771,-0.0222369168174698,0.00439699241836278,0.18925717196467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.00476304190770593,0.00362933137102162,-0.0118765313949083,0.00235044757949644,0.189413082370174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.00492472717928289,0.0037537400693503,-0.0122820577152095,0.00243260335664369,0.189554965382173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39489,-0.00499841702459723,0.00381450564227234,-0.012474848083451,0.00247801403425656,0.19008966439771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.00783943179721395,0.00598597300788059,-0.0195719388926599,0.00389307529823201,0.190338925628643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,39564,0.00690628689502819,0.00527554993389409,-0.00343379097540422,0.0172463647654606,0.190515494423938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSND,Barttin,36962,0.0043210730752204,0.0033018614030813,-0.00215057527481894,0.0107927214252597,0.190666432261799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.0055753201282414,0.00426102317382639,-0.00277628529245832,0.0139269255489411,0.190744919610076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37382,0.0325017601091629,0.0248431713547463,-0.0161908557461399,0.0811943759644656,0.190801468741665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.00503807584303987,0.00385896417374827,-0.0126016456235865,0.00252549393750673,0.191723942550044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,39913,0.00704464928195851,0.00539878707445591,-0.00353697338397507,0.0176262719478921,0.19195998654013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.00769824378548442,0.00590177272783674,-0.0192657183320444,0.00386923076107559,0.19212108531584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.00587633605893455,0.00451714178714643,-0.0147299339617416,0.00297726184387246,0.193316246067637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00743954723011174,0.0057230384286656,-0.00377760809007284,0.0186567025502963,0.193643871346419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00520718348683508,0.00400931832092536,-0.00265108042217862,0.0130654473958488,0.194045470251449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESPL1,Separin,36962,0.0068418685477214,0.00526861586497329,-0.00348461854762625,0.017168355643069,0.194101226694765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00325360994005911,0.00250962206218373,-0.00166524930182101,0.00817246918193923,0.194841899836594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,0.00672499439417154,0.00518855087079912,-0.00344456531259474,0.0168945541009378,0.194955510871198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.0048662037199978,0.00376114445491774,-0.0122380468516366,0.00250563941164097,0.195753968881519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37169,-0.00546066815773172,0.00422227110602541,-0.0137363195255415,0.00281498321007808,0.195929363440156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0119699474850639,0.00926041477242737,-0.0301203604390216,0.0061804654688937,0.196173964710098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2,Brorin,39684,-0.00486011225501352,0.0037610668335894,-0.0122318032488488,0.00251157873882171,0.196301082949668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37437,-0.00988415627776491,0.00765648165206541,-0.0248908603158131,0.00512254776028329,0.196742032340532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00759093829499284,0.00588094327766993,-0.00393571052924022,0.0191175871192259,0.196806461374488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.00412685388077284,0.00319932267888257,-0.0103975263313827,0.00214381856983699,0.197102707814836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00735544127259328,0.00572590131462303,-0.00386732530406786,0.0185782078492544,0.198957907908557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37039,-0.00606958937042818,0.00472517149010684,-0.0153309254910376,0.00319174675018123,0.198981753642287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.00943088985057956,0.00734338170176684,-0.0238239179860426,0.00496213828488345,0.199065848239496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39477,-0.00854722193945639,0.00665872947652131,-0.0215983317134382,0.00450388783452538,0.199296958209956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00494372032334501,0.00386566206564868,-0.0026329773253264,0.0125204179720164,0.200960996139953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,36991,0.00590622420746389,0.00462161288463391,-0.00315213704641856,0.0149645854613464,0.201287051585081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0110208419447017,0.00865197796237256,-0.0279787187509519,0.00593703486154855,0.202754785657132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,0.00973122381112169,0.00766331721389758,-0.00528887792811757,0.024751325550361,0.204161710296106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,35640,-0.0125828207393294,0.00991006011505221,-0.0320065385648317,0.00684089708617295,0.204215968112881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.00413134948936874,0.00325421187315621,-0.0105096047607549,0.00224690578201744,0.204267063107057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37388,0.00333600468273663,0.00262837133174016,-0.00181560312747409,0.00848761249294734,0.204381295173651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00381706264588953,0.0030112220564149,-0.00208493258468367,0.00971905787646274,0.204958741539547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00493690838806992,0.0038952407624708,-0.00269776350637285,0.0125715802825127,0.205027361854211
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,0.00904389544392851,0.00714200506328824,-0.00495443448011644,0.0230422253679735,0.205428690609701
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.00635133302308147,0.00503921844031207,-0.0162282011660931,0.0035255351199302,0.20755092350862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.0116434526430944,0.00923868308344026,-0.00646436620044852,0.0297512714866373,0.207585883765529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.0054081605985391,0.00429131407407153,-0.0138191361837193,0.0030028149866411,0.207598594294183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.00448412633917826,0.00355877126114075,-0.00249106533265761,0.0114593180110141,0.207683572972207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37178,0.00444274482405441,0.00353337932023056,-0.00248267864359749,0.0113681682917063,0.208643818082366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.00786591952457861,0.0062635230987131,-0.00441058574889906,0.0201424247980563,0.209196425375065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.00756541164885244,0.00603962665446066,-0.00427225659389046,0.0194030798915953,0.210363054208112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.00357744467593429,0.00285875354580634,-0.00918060162571472,0.00202571227384615,0.210807092967156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39477,0.0200591962633975,0.0160428164676656,-0.0113847240132272,0.0515031165400222,0.211189073837268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.00509323407656267,0.00407672303218865,-0.0130836112196524,0.00289714306652709,0.211557483052137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00693923106165056,0.00555915364979656,-0.00395671009195069,0.0178351722152518,0.211960670510589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37124,0.00533532489320901,0.00428729718816096,-0.00306777759558648,0.0137384273820045,0.213356158779256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00698318871941991,0.00562404034875868,-0.0180063078029869,0.0040399303641471,0.214380753762501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.0057191476848079,0.00460921431464678,-0.0147532077415156,0.00331491237189978,0.21469835119662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37043,-0.00340978649592033,0.00275043717959063,-0.00880064336791796,0.0019810703760773,0.215099091702324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00421863184668643,0.00340566926219094,-0.00245647990720782,0.0108937436005807,0.215474830560282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,39766,0.00634039610848799,0.00513322623571477,-0.00372072731351295,0.0164015195304889,0.216786278951152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0047678480505346,0.0038628207662125,-0.0028032806512419,0.0123389767523111,0.217115535797228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0206621403888002,0.0167530485545055,-0.0121738347780306,0.053498115555631,0.217468748553107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.0096275758558759,0.00780981173266927,-0.0249348068519077,0.00567965514015588,0.217689715053643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.00449761491450064,0.00365541749417266,-0.0116622332030791,0.00266700337407777,0.218566538105374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,0.0103858212879942,0.00844247157458721,-0.00616142299819668,0.0269330655741852,0.218645143941147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40018,0.00249752239348725,0.00203136363327776,-0.00148395032773717,0.00647899511471167,0.218909530132977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.00602521308963275,0.00490419914556484,-0.0156374434149398,0.00358701723567433,0.21924641730734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00532772569692958,0.00433966422501418,-0.00317801618409822,0.0138334675779574,0.219588248345846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.00455623079851683,0.00371127387779026,-0.0118303275989857,0.00271786600195207,0.21959169643023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,39749,-0.00400954860839941,0.0032663051927545,-0.0104115067861982,0.00239240956939942,0.219634625128767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,39970,-0.00716262274318296,0.00587410897497732,-0.0186758763341385,0.00435063084777258,0.222727424823371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00616681125869855,0.00506044287427675,-0.016085279292281,0.00375165677488388,0.223006188480668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.00498978920138536,0.00410108263808424,-0.00304833276925974,0.0130279111720305,0.223740114314494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.00580742235884573,0.00477327009820206,-0.0151630317513218,0.00354818703363031,0.223753925468444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.00337256863828993,0.00277585211584522,-0.00881323878534655,0.0020681015087667,0.224396660306195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0104110795695648,0.00859637725197211,-0.0272599789834301,0.00643781984430052,0.225877845866544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0061723990152638,0.00510655422856181,-0.0161812453032449,0.00383644727271734,0.226787740752425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.0058803646334636,0.0048699571013434,-0.00366475128516946,0.0154254805520967,0.227269924524162
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.00560743223802585,0.00464885216451164,-0.00350431800441697,0.0147191824804687,0.227763295334852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.00725323074781021,0.00601571477348775,-0.0190440317038462,0.00453757020822578,0.227945657937883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39477,0.0162086712086962,0.0134448981497777,-0.0101433291648681,0.0425606715822604,0.228004313830718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37021,-0.00703995889012447,0.00584455601327054,-0.0184952886761347,0.00441537089588579,0.22840540787532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.00905321085349681,0.00751682770858488,-0.0237861931623232,0.00567977145532956,0.228459513865406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.00495544837986814,0.0041180919653026,-0.0130269086318612,0.00311601187212495,0.228867298526743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.0055009733687289,0.00457224891051837,-0.0034606344958871,0.0144625812333449,0.228946748587117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0101797411633072,0.00846221553782438,-0.026765683617443,0.00640620129082861,0.229011700273019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.00986016367102403,0.00820543907328853,-0.0259428242546696,0.00622249691262149,0.229512637493951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.00754177654515599,0.0062879181678735,-0.019866096154188,0.00478254306387606,0.230387056130736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00414551163085016,0.00346485626431158,-0.0109366299089009,0.00264560664720054,0.231540910100199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0104616447817773,0.00874923995245383,-0.00668686552503217,0.0276101550885868,0.231823351494844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37169,0.00601309372718439,0.00503093248003335,-0.00384753393368098,0.0158737213880498,0.23202062801419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.00531029235545536,0.00445123117515528,-0.00341412074784899,0.0140347054587597,0.2328896964245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.0072479140637706,0.00607538497596375,-0.0191556686166596,0.00465984048911836,0.232892231430281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.00323437943196116,0.00271285828479264,-0.00208282280623242,0.00855158167015474,0.233184546169687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00454706799839969,0.00381876283538596,-0.0029377071589568,0.0120318431557562,0.233782079633356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0082949231770527,0.00697790971773188,-0.0219716262238072,0.00538177986970179,0.234563048091634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37056,0.00373083440533257,0.00313907359372359,-0.00242174983836568,0.00988341864903082,0.234652168675947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.00285085815823329,0.00240681838977704,-0.0018665058857297,0.00756822220219628,0.236235784352644
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0142115943388465,0.0120063481027496,-0.0377440366202358,0.00932084794254281,0.236560526569877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,0.00483057827077909,0.00408125365823289,-0.00316867889935737,0.0128298354409155,0.236591643891153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.0072287035852735,0.00612105133413922,-0.00476855702963938,0.0192259642001864,0.237640811531261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.00687154626683543,0.00582241661097499,-0.0182834828243464,0.00454039029067556,0.237943042151109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.00614825394652216,0.00521133594028477,-0.0163624723894803,0.004065964496436,0.238106562781424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.00360753715788704,0.00306406939748583,-0.00239803886118518,0.00961311317695926,0.23906992477978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.0068409616348146,0.00581390375742872,-0.0182362129993749,0.00455428972974569,0.239354379106573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.00456177126731512,0.00387937375003314,-0.00304180128274984,0.0121653438173801,0.239654494325354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.00783388168071658,0.00666208114328898,-0.020891560721563,0.00522379736012982,0.239656335474707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37368,0.012456520191046,0.0106228101718318,-0.00836418774574438,0.0332772281278363,0.240968884198921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.00805942988937112,0.00687373381629979,-0.00541308839057648,0.0215319481693187,0.241018902029581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.00507922045091437,0.00433246228240727,-0.0135708465244326,0.00341240562260388,0.241068699093625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.00948214588355409,0.00809083265814475,-0.0253401778935178,0.00637588612640963,0.241233554064379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0128259518908752,0.0109616012707971,-0.0343106903816374,0.00865878659988708,0.241986455120758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.0080685729273015,0.00689928511409587,-0.0215911717509294,0.0054540258963264,0.242231650529643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.00970728917121456,0.00831203950897462,-0.0065843082663757,0.0259988866088048,0.242881666101273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.00945262779934831,0.00810347512605739,-0.0253354390464208,0.00643018344772418,0.243437107407545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.00363311741061369,0.00311532972767302,-0.00973916367685281,0.00247292885562542,0.243548474187969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.00758129431389249,0.00650758547311584,-0.0203361618411995,0.00517357321341456,0.244039012471155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.00737824109888887,0.00633455828344163,-0.0197939753344345,0.00503749313665672,0.244136967729965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAX,Protein max,39489,-0.0119878952372678,0.0102981758694208,-0.0321723199413326,0.00819652946679704,0.244409572186693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0127962523891679,0.0110110791801611,-0.0343779675822837,0.00878546280394796,0.245202365975061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,0.00474682855613463,0.00408719343361898,-0.00326407057375858,0.0127577276860278,0.245504195750178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.00843222669965282,0.00726816145169409,-0.0226778231449732,0.0058133697456676,0.246001586579268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00677636629605225,0.00585612181548987,-0.0182543650544124,0.0047016324623079,0.24723180174704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.00288406565180904,0.00249258229264766,-0.00776952694539847,0.00200139564178038,0.24726532906418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.00869295484538762,0.007521267466342,-0.00604872938864271,0.0234346390794179,0.247790579818717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.00743609369867163,0.00645232021353285,-0.00521045391985275,0.020082641317196,0.249149766878062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0027484653234298,0.00239536758612859,-0.00194645514538223,0.00744338579224183,0.251233491585026
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.00430751272917645,0.00375599783409107,-0.011669268483995,0.00305424302564205,0.2514670524006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.00670474985729005,0.00585945432106627,-0.00477978061199984,0.0181892803265799,0.252535827696608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37056,0.00540145720952663,0.00472532019114632,-0.00386017036512014,0.0146630847841734,0.253022758094686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37056,0.00983542995155393,0.00860537244948302,-0.00703110004943278,0.0267019599525406,0.253083970134438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37124,-0.0129714261138396,0.0113599047690552,-0.0352368394611878,0.00929398723350865,0.253532638068427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.00791255434576551,0.0069669952306394,-0.0215678649978187,0.00574275630628771,0.25609400611684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37380,0.00283232784126033,0.00249595878836554,-0.00205975138393612,0.00772440706645679,0.256493716435405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.00528630124800296,0.0046743672604788,-0.0144480610785414,0.00387545858253548,0.258112449509679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.00576653817345035,0.00510254353774853,-0.0157675235074375,0.00423444716053677,0.258438753581294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.0102835330583464,0.00910886482429299,-0.00756984199726787,0.0281369081139606,0.258935739032343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.00983295008172126,0.00871803311490989,-0.0269202949869447,0.00725439482350213,0.259387872838942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00532707916386709,0.00473302157403265,-0.0146038014489711,0.00394964312123691,0.260392041848597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,36991,0.00522957702550263,0.00464709378777732,-0.00387872679854092,0.0143378808495462,0.260464049863317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.00517415088580769,0.00459856892283996,-0.00383904420295864,0.014187345974574,0.26053622140319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00488744527962935,0.00434599921782398,-0.0134056037465643,0.00363071318730564,0.260781672324298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.00358459648478671,0.00319922785843111,-0.00985508308731168,0.00268589011773826,0.262539059077276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00533341106627644,0.00476668451919761,-0.00400929059135088,0.0146761127239038,0.263206081902872
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,39857,0.00639747020410051,0.00572983985113092,-0.00483301590411609,0.0176279563123171,0.264217174379048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00511322602382536,0.00459018622444434,-0.0141099910237363,0.00388353897608555,0.265322060562196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.009419187543895,0.00846645119452989,-0.0260134318851736,0.00717505679738358,0.265930415870726
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00591588749264539,0.00532302674239545,-0.00451724492244969,0.0163490199077405,0.26642666324982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.00924137238265047,0.00833601406673815,-0.0070972151881563,0.0255799599534572,0.267619557556113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.00837804116614355,0.00755803795147503,-0.0231917955510346,0.00643571321874751,0.267668668780754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.01080475928862,0.00975648086496625,-0.0299274617839539,0.00831794320671383,0.268121531227048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00319543940925358,0.00288714489748438,-0.00885424340832296,0.0024633645898158,0.268408482612529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,37453,-0.00278727235505865,0.00252894815632551,-0.00774401074145665,0.00216946603133936,0.270417329071522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37056,0.00529678862981164,0.00481185409455216,-0.00413444539551059,0.0147280226551339,0.271012869864002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00396283299384028,0.00360350003560606,-0.00310002707594759,0.0110256930636282,0.271474649515141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0125079229627896,0.0114397041946781,-0.0349297431843587,0.0099138972587794,0.274244324854378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.00645814801747812,0.00591375823748404,-0.0180491141629468,0.0051328181279906,0.274825747546151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37169,-0.00776381351919654,0.00711961584907192,-0.0217182605833775,0.00619063354498441,0.275520584061262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.0076732307737626,0.00704905078195844,-0.0214893703064011,0.00614290875887595,0.276372540069904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00603590040454112,0.00555730780927488,-0.0169282237107199,0.00485642290163766,0.277445476968765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.00900033716601826,0.0082993403758078,-0.0252670443026015,0.00726636997056503,0.278178888743881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,39868,0.00287739885015619,0.00265640596651375,-0.00232915684421076,0.00808395454452313,0.278739331195074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.00596405153200238,0.005532534243787,-0.0168078186498249,0.00487971558582014,0.281051725461681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.00566557886914095,0.00526275230258116,-0.0159805733822,0.00464941564391812,0.281700809853314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00491993871338855,0.00457444711369297,-0.0138858550562268,0.00404597762944967,0.282158827540999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,0.00429549181533236,0.00400766999008109,-0.00355954136522658,0.0121505249958913,0.283818371800918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0147986252041875,0.0138121467951715,-0.0418704329227237,0.0122731825143487,0.283996684133918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0073775297278339,0.00689172785399806,-0.0208853163216701,0.00613025686600229,0.284414843711927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.00681380466184705,0.00637709609720874,-0.00568530368868209,0.0193129130123762,0.285319661330686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.00646466453069164,0.00605048224175287,-0.0183236097245273,0.00539428066314398,0.285331978990245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.00315851257974838,0.00295853623939834,-0.00264021844947237,0.00895724360896914,0.285720632386882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.00764814585540422,0.0071675356884679,-0.0216965158048013,0.00640022409399287,0.285963812962736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,0.00655132814627989,0.00614016407413483,-0.00548339343902439,0.0185860497315842,0.286008063340678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37411,-0.00367920834097503,0.00344930357662875,-0.0104398433511674,0.00308142666921733,0.2861477792793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0075269600756184,0.00706683634326857,-0.0213779593084248,0.006324039157188,0.286842377058591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37056,0.00795714834490472,0.0074762272197496,-0.0066962570058045,0.0226105536956139,0.287200195274045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,39964,0.00346228901296277,0.00325413014605808,-0.00291580607331106,0.00984038409923661,0.287359334386505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00215336649803868,0.00202501978171701,-0.00612240527020401,0.00181567227412666,0.287625564448982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00487499949920657,0.00459226618413074,-0.0138758412201028,0.00412584222168969,0.288448579976996
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.00624438909457726,0.00588384972841621,-0.017776734562273,0.00528795637311853,0.288580574630969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.00397178666028275,0.00374440351982408,-0.011310817559138,0.00336724423857245,0.288830464271648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.00377354051856813,0.00357408998994221,-0.0107787568988549,0.0032316758617186,0.291076867129027
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00298156825556493,0.00282578331412436,-0.00255696704011882,0.00852010355124868,0.291385295115128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.00749288947300268,0.00710464154395269,-0.02141798689915,0.0064322079531446,0.291603077925747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00585008898260445,0.00555638882066457,-0.016740611071107,0.00504043310589811,0.292425245579817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.00955610696099305,0.00907790304750515,-0.0273487969341031,0.00823658301211705,0.29250810233072
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.0044097967252651,0.00419899284133497,-0.00382022924375144,0.0126398226942816,0.293643915849362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.00798884255276709,0.00761118254063866,-0.0229067603324189,0.00692907522688468,0.293909515188416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,39563,-0.00505768530179249,0.00482420530329119,-0.0145131276962432,0.00439775709265826,0.294471590540894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,0.00369696995070022,0.00353016313836265,-0.00322214980049058,0.010616089701891,0.294999194853958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.00759421945505103,0.00725811870348502,-0.0218201321138817,0.00663169320377961,0.295438376903846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.00743326456357029,0.00710839665634203,-0.0213657220100007,0.00649919288286008,0.295714386698883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,39830,0.0080644465331685,0.00771243192364025,-0.0070519200371664,0.0231808131035034,0.295741949459125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37043,0.00725699944677491,0.00695227195071579,-0.00636945357662805,0.0208834524701779,0.296582562565472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.00857552483858476,0.00821747274058797,-0.00753072173296765,0.0246817714101372,0.296702386424975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.00428648087911902,0.00411121334591521,-0.0123444590371128,0.00377149727887479,0.297137869971261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00284363870607978,0.00273866211705216,-0.00821141645550202,0.00252413904334246,0.29913438089002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,0.0111232179028545,0.010722170755422,-0.00989223677777254,0.0321386725834816,0.2995668377223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.011211766321992,0.010819221586955,-0.0324174406324238,0.0099939079884399,0.300089565666228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00443986880631785,0.00428776212521173,-0.00396414495909714,0.0128438825717328,0.300465855180619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37039,-0.00392931573625589,0.00380997812828556,-0.0113968728676956,0.00353824139518381,0.302408589306855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,36991,-0.00746021045574855,0.00724862030190923,-0.0216675062474906,0.00674708533599355,0.3034091675866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.00347668975918488,0.00338252440804006,-0.0101064375989434,0.00315305808057363,0.304041258770187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.00706794925876541,0.00688909114114129,-0.0205705678954023,0.00643466937787151,0.304927567717267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37437,0.00445778216304668,0.00434665108717577,-0.00406165396781783,0.0129772182939112,0.30511397360179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.00447874624394936,0.00438219203815847,-0.01306784263874,0.00411035015084124,0.306780656288147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.00707374057756774,0.00693542092780939,-0.0206671655960742,0.00651968444093867,0.307770834148745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37437,0.00366898755847542,0.0035984898114485,-0.00338405247196364,0.0107220275889145,0.30794067773916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,39866,-0.00310293020757659,0.00304466425790609,-0.00907047215307253,0.00286461173791935,0.30815330165709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,0.00335046624125551,0.00328756738148457,-0.00309316582645425,0.00979409830896526,0.308155604827241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,39868,-0.00237335589913297,0.00233331326531626,-0.00694664989915285,0.00219993810088691,0.309092086571411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,39783,0.00719090445928236,0.00708048316941607,-0.00668684255277315,0.0210686514713379,0.309837640300862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00724169165649258,0.00713825519528563,-0.0212326718392524,0.00674928852626726,0.310367388729449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.00585365189246786,0.00578367501159433,-0.0171896549151927,0.00548235113025702,0.311508805613501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,0.00327958935633376,0.00324375717217856,-0.00307817470113621,0.00963735341380373,0.312009454851866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0117957689695789,0.0116909131107318,-0.0347099586666133,0.0111184207274555,0.313007904354027
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.00278943197984091,0.00276913360587591,-0.0082169338473577,0.00263806988767589,0.313791382852798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.00426781857912371,0.00424528903117008,-0.00405294792196966,0.0125885850802171,0.314764644084256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.00225417108086683,0.00224362364006463,-0.0066516734153935,0.00214333125365985,0.315056110848237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.00409966199117177,0.00408477913944938,-0.0121058291044925,0.00390650512214901,0.315566058310776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37368,0.00489210846934517,0.00487878948635281,-0.00467031892390634,0.0144545358625967,0.316009123842512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.00262306381677238,0.00261712946833227,-0.00250650994115887,0.00775263757470364,0.316232275514075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.00248423917186214,0.00249158523547198,-0.00239926788966294,0.00736774623338722,0.318754436429334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0104019740067741,0.0104412788205223,-0.0308668804949979,0.0100629324814497,0.319153489171296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,0.00269295613552496,0.00270416143691895,-0.00260720028083619,0.00799311255188611,0.319335035501741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00760035061455387,0.00763891213595465,-0.00737191717191724,0.022572618401025,0.319777895958732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40058,-0.00337486646420922,0.00339648485201162,-0.010031976774152,0.00328224384573356,0.320415406666425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.00298309933307036,0.00300811974454903,-0.00887901403238645,0.00291281536624573,0.321367555734528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00333070533653387,0.00335926661446966,-0.00325345722782668,0.00991486790089441,0.321457482540174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,0.00935680231753385,0.00944199825244074,-0.00914951425725,0.0278631188923177,0.32171458388894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0123183354239607,0.0124582610368347,-0.0367365270561567,0.0120998562082352,0.322794099392074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.0026504500566499,0.00268502651427901,-0.00791310202463676,0.00261220191133695,0.323600218583793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00314686891648562,0.00318808373204488,-0.00939551303129358,0.00310177519832234,0.323622511236629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.00406635704231127,0.00412574810094172,-0.012152823320157,0.00402010923553451,0.324345070205374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.00581501574552433,0.00590181200562604,-0.0173825672765514,0.00575253578550271,0.32449812035107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.00659279677004529,0.00669126006190194,-0.00652207295128251,0.0197076664913731,0.324502265912956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37169,0.0159085947009476,0.0161620024516937,-0.0157689301043721,0.0475861195062673,0.324975713674743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.00338330522915335,0.00343785161158429,-0.0101214943878586,0.00335488392955186,0.32506508199894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37056,0.00309010946641469,0.0031408918600993,-0.00306603857937994,0.00924625751220932,0.325216231231418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00325889056866818,0.00331940911828586,-0.00324715130317211,0.00976493244050847,0.326232108325082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00635084413156921,0.00647112559651829,-0.00633256203760664,0.019034250300745,0.326407401567405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37124,0.00347299061270643,0.00354133054911192,-0.00346801726355293,0.0104139984889658,0.326757512301803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00525415940033218,0.00535915307927316,-0.00524978063504322,0.0157580994357076,0.326902602755658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0093450847760692,0.00954064206471571,-0.028044743222912,0.00935457367077359,0.327349191284349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.00836172250228912,0.00854248711474435,-0.0251049972471881,0.00838155224260981,0.327677357281413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00690722385722924,0.00709331818997279,-0.00699567979511744,0.0208101275095759,0.330191011788148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.00604462548891617,0.00621360134717059,-0.0182232841293705,0.00613403315153819,0.330664536447784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00723712835881311,0.00744829507876694,-0.0073615299955701,0.0218357867131963,0.331243101359187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.00345196670720179,0.00355672121289159,-0.00351920687006572,0.0104231402844693,0.331791496296482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0161712904724099,0.0166705096900477,-0.0488454894649033,0.0165029085200835,0.332037050564566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00226854717521651,0.00234008564517819,-0.00685511503976576,0.00231802068933274,0.332348429584847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.00949220794405786,0.00984451796503339,-0.0287874631555233,0.00980304726740759,0.334953931838229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.00798070090933744,0.00830336228625191,-0.0242552909903912,0.00829388917171631,0.3364988593258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.00623512563076939,0.00648786612826008,-0.0189513432421592,0.00648109198062037,0.336547129214091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-0.00212058412365219,0.00221645970777302,-0.00646484515088731,0.00222367690358293,0.338710859596156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.00261890907913013,0.00273928984837112,-0.00798791718193752,0.00275009902367727,0.339062488850484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.00454684410591782,0.00475859949680255,-0.0138736991196508,0.00478001090781517,0.339341761486373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.00347721673681286,0.00363990156610867,-0.00365699033276014,0.0106114238063859,0.339437835009866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.00607427801571262,0.00637181900965281,-0.00641448724320689,0.0185630432746321,0.340450918086256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.00479212277027008,0.00503771494393852,-0.0146660440603896,0.00508179851984942,0.341492208874115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.00646894743973883,0.00680326735576527,-0.0198033514570388,0.0068654565775611,0.341690582886963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.0145971356356925,0.0153941920858795,-0.0447697521240163,0.0155754808526314,0.343032564338623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,39812,-0.00441065431322154,0.00465510796584743,-0.0135346659262825,0.00471335729983942,0.343405026471896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37382,0.00283684236297213,0.00300067946794268,-0.00304448939419552,0.00871817412013979,0.344471595763013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.00604807192278795,0.00641303766602658,-0.0186176257482001,0.00652148190262415,0.345651693559258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.00319427206071781,0.00339079991785931,-0.00345169577828644,0.00984023989972207,0.34618856925891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.00802122059644428,0.00852225649249064,-0.0247248433217259,0.00868240212883736,0.346612203505401
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.00565306632677176,0.00600853982176897,-0.0174298043774389,0.00612367172389542,0.3468048094485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00408313560450497,0.00434081166925514,-0.0044248552672351,0.012591126476245,0.346906844268141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.00381784833905535,0.00406873103575149,-0.00415686449101758,0.0117925611691283,0.348087336203492
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.00606495649390374,0.00646926692007428,-0.00661480666944185,0.0187447196572493,0.348517112791655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.00351859966506901,0.00375468766916293,-0.0108777874966284,0.00384058816649033,0.348712663271871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0080405960609155,0.00860740321578141,-0.0249111063638471,0.00882991424201606,0.350241136576679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.00333265180913107,0.00356850677950447,-0.0103269250969598,0.00366162147869769,0.350369232041166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,0.00304867580365057,0.0032677145220822,-0.00335604465963053,0.00945339626693167,0.350853130453757
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37056,0.00542466487775293,0.00581555471683709,-0.00597382236724776,0.0168231521227536,0.35094781646113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00359138318960822,0.00385645046269084,-0.0111500260964823,0.00396725971726583,0.351732609639125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.00360785168252429,0.00387860236436655,-0.00399420895163415,0.0112099123166827,0.352287315089551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.00372531886862192,0.00400663264367087,-0.0115783188502168,0.00412768111297298,0.352497486643418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.00459621618836084,0.00495141465115238,-0.0143009889046195,0.00510855652789781,0.353287625479037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.00331696847833865,0.00357779715509385,-0.0103294509023226,0.00369551394564531,0.353892234228392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.00526899324982319,0.00570167626302894,-0.0164442787253599,0.00590629222571353,0.355441371539625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00830566041582491,0.00898873806244938,-0.00931226618657587,0.0259235870182257,0.355499446102513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,39841,0.00601121524543844,0.00650903641015642,-0.00674649611846815,0.018768926609345,0.355751030929898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.00309758537682713,0.00335442893030383,-0.00347709532656837,0.00967226608022264,0.355796131543036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.00931878774506282,0.0101201947291734,-0.0105167939241171,0.0291543694142427,0.357165480477565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.00456364934027304,0.00495937127662392,-0.0142840170424559,0.00515671836190985,0.357481338968675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.00659011686632257,0.00719887000320348,-0.0206999020726014,0.00751966833995624,0.359978489672981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00294191355532512,0.00321440707442061,-0.00335832431053927,0.00924215142118951,0.36008898258968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.0057716504771492,0.0063158039480338,-0.0181506262152954,0.00660732526099705,0.360816317759609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0105042029498714,0.01149872074629,-0.0330416956125998,0.012033289712857,0.360990766543767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.00602222323104674,0.00660403236411577,-0.0189661266647137,0.00692168020262017,0.36183714727533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00268545657278016,0.00294753542359536,-0.00846262600302706,0.00309171285746675,0.362264091147473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.00592020059814169,0.00651440863691947,-0.0186884415265038,0.00684804033022048,0.363479940699072
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.00307439166476845,0.00338409307739683,-0.00970721409646624,0.00355843076692934,0.363636771587158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.0048111095360513,0.00529602846924218,-0.00556910626366337,0.015191325335766,0.363663702126003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00453151335601192,0.00500497851196537,-0.0143412712394641,0.0052782445274402,0.365269452314283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.00724819042316264,0.00801293447929144,-0.0229535420025739,0.00845716115624858,0.365711460299954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,-0.0113893505381412,0.0125934846521991,-0.0360725804564514,0.0132938793801689,0.365805120302489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,39587,0.00464265718157322,0.0051477988627187,-0.00544702858935543,0.0147323429525019,0.367138520811113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00229547346935801,0.00255180313983026,-0.0027060606847093,0.00729700762342531,0.368376408385958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00347318312460136,0.00386590681809031,-0.00410399423885565,0.0110503604880584,0.368981617025277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37031,0.00611429769500685,0.00683028975990294,-0.00727307023440292,0.0195016656244166,0.370710448406291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,39585,0.00525538154348081,0.00587758278892417,-0.00626468072281057,0.0167754438097722,0.371260704639728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00521718644025829,0.00584967927532367,-0.0166825578198927,0.0062481849393761,0.372475972380486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,39901,-0.00255186074662345,0.00287781487587744,-0.00819237790334323,0.00308865641009633,0.375234589543112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,36991,0.00369013975391151,0.00417382500734066,-0.00449055726047618,0.0118708367682992,0.376650523392292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39489,0.00276435891027761,0.00313329623061723,-0.00337690170173217,0.00890561952228738,0.377653763221279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.00470678479778381,0.00533796361257239,-0.00575562388285808,0.0151691934784257,0.377922001170129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39489,0.00453268162876608,0.00514137422969454,-0.00554441186143522,0.0146097751189674,0.378001861563228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00160315230283035,0.00182211965638251,-0.00196820222367937,0.00517450682934007,0.37896792587383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.00478260506876211,0.00545600451462332,-0.00591116377989959,0.0154763739174238,0.380732496035948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.0104901634653004,0.0119783697349587,-0.0129874412152187,0.0339677681458194,0.381174279524013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,39858,-0.0104310240066168,0.0119130422484608,-0.0337805868136,0.0129185388003664,0.381262304849208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00463320635053992,0.00531821939474889,-0.0057905036631679,0.0150569163642477,0.383663517287841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39438,0.00367276027011656,0.00424701050086415,-0.00465138031157718,0.0119969008518103,0.387168920511262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,39585,-0.00632168282893642,0.00734533085606524,-0.0207185313068243,0.00807516564895144,0.389449673804783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.00187352310849884,0.00217843205678069,-0.00239620372279132,0.00614324993978899,0.389786125809747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.00444197212815473,0.00516867923935254,-0.0145725834372857,0.00568863918097625,0.390131989792684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00220481266015553,0.00256988197489861,-0.00283215601064574,0.00724178133095679,0.390939544519003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.00309232418389339,0.00360580143726312,-0.0101596950009291,0.00397504663314232,0.391128149956379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCT,Secretin,37039,-0.00370800502037993,0.00433077461959896,-0.0121963232747939,0.00478031323403403,0.391903266797864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.00451346698799239,0.00527724806406379,-0.00582993921757264,0.0148568731935574,0.392415076794417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39405,0.00562436781505098,0.00657751556331355,-0.00726756268904357,0.0185162983191455,0.392514500944926
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.0036327102412294,0.00425744123863977,-0.00471187458650455,0.0119772950689633,0.393529893067742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.00208690299468825,0.00244757626766609,-0.00688415247931379,0.00271034648993728,0.393871263517345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.00323536522504979,0.00379582976863027,-0.00420446112146554,0.0106751915715651,0.394034425696634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.0046958506344531,0.00552199432136732,-0.015518959504333,0.00612725823542683,0.39512364425775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37388,-0.00422473754637823,0.00497123604003585,-0.0139683601848485,0.00551888509209203,0.395431065687047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,39862,0.00290564154730828,0.00343237175559341,-0.00382180709365481,0.00963309018827137,0.397263974986721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37056,0.003537646475455,0.00418385770297443,-0.00466271462237488,0.0117380075732849,0.397821080987877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37380,0.00261494488554674,0.00309755103559194,-0.00345625514421346,0.00868614491530695,0.39857398005403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,0.00297222681599402,0.00352457011257284,-0.00393593060464875,0.00988038423663679,0.399080214636324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00333224991904625,0.00395425332574747,-0.0110825864375113,0.0044180865994188,0.399411299989581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.00485685444040719,0.00577747442983341,-0.00646699544206629,0.0161807043228807,0.40055460240296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.00606903189432208,0.00725038671378722,-0.020279789853345,0.00814172606470088,0.402571778283137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,0.00723075111335034,0.0086505815420197,-0.00972438870900828,0.024185890935709,0.403243509762553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.00626882295159326,0.00750712608975329,-0.0209827900875097,0.00844514418432319,0.403702532782275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,36962,0.00583093625811016,0.00698950701505531,-0.00786849749139824,0.0195303700076186,0.404160164345893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.00432387897555774,0.00519596016280323,-0.0145079608946521,0.00586020294353658,0.405329991555381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.00299337545604181,0.00359896488017684,-0.0100473466211884,0.0040605957091048,0.405574746335803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,39587,0.00628921375886957,0.00756855769425134,-0.00854515932186304,0.0211235868396022,0.406005478306902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,0.00182314978608885,0.00219708497588246,-0.00248313676664077,0.00612943633881848,0.40666207473468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.00753653830586857,0.00909737072436112,-0.0253673849256164,0.0102943083138792,0.407441421329403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37043,-0.00697299554004034,0.00843057874061829,-0.0234969298716522,0.00955093879157152,0.408191061551024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.00598313912615206,0.00724624344791963,-0.0201857762840745,0.00821949803177042,0.40899303723299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.00511227403320388,0.00622184081909991,-0.0173070820386397,0.00708253397223195,0.411281601977159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.00521506155888549,0.00635149499216069,-0.0176639917435204,0.00723386862574946,0.411617681616597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.0062133619979299,0.00757125959446906,-0.00862630680722945,0.0210530308030892,0.411859506440661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0081858059160511,0.00999030906452504,-0.0277668116825202,0.011395199850418,0.412584987798439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39489,-0.00492645274518712,0.0060184047987953,-0.0167225261508259,0.00686962066045166,0.41304738658582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00576377469125982,0.00708181382558919,-0.0196441297894146,0.00811658040689498,0.415726220456888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00392105225315253,0.00481776434957334,-0.00552176587201121,0.0133638703783163,0.415732000584553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00236501801859082,0.00290588287396858,-0.00806054845156923,0.0033305124143876,0.415732709283045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,39585,0.00856621978220785,0.010550310913842,-0.0121123896089225,0.0292448291733382,0.416838332649617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.00286505757520998,0.00356214858450424,-0.00411675365041832,0.00984686880083829,0.421234765812889
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.00374536950293634,0.00466055880934296,-0.0128800647692485,0.00538932576337586,0.421622058549974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0113097230323639,0.0140996280335662,-0.0389449939781537,0.0163255479134259,0.422492787135041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.00494926009773868,0.00617032833054275,-0.0170431036256025,0.00714458343012511,0.422505602008996
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,39585,-0.0038048665490616,0.00474413766111617,-0.0131033763648493,0.0054936432667261,0.422556768951518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,39587,-0.00369559642247167,0.0046112033821339,-0.0127335550514541,0.00534236220651076,0.422889879542178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37161,0.00767796208971434,0.0095829286588699,-0.0111045780816707,0.0264605022610993,0.423022956223463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00339028470816738,0.00423569316596942,-0.0116922433134674,0.00491167389713268,0.423486262641356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.00712492826324343,0.00890366528067517,-0.0245761122133668,0.0103262556868799,0.423594979966033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,0.00748233659065159,0.00935884769084938,-0.0108610048834132,0.0258256780647164,0.4240187855484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,0.00197832712515182,0.00247954284833054,-0.00288157685757604,0.00683823110787968,0.424966239488425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.00229856599202542,0.00288153668638992,-0.00794637789734966,0.00334924591329882,0.425063652039815
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.00316458185119208,0.00397990420075364,-0.0109651940846692,0.00463603038228506,0.426546249506763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,39587,0.00372363835502475,0.00468764484258249,-0.00546414553643693,0.0129114222464864,0.427002736748051
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,0.00325146918711044,0.00410701909875939,-0.00479828824645796,0.0113012266206788,0.428558103042619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37021,-0.00585418662061184,0.00741802604890183,-0.0203935176764594,0.00868514443523575,0.43001875531419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00173243652537274,0.00221113207902545,-0.00260138234951715,0.00606625540026262,0.433341153323437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00471209518152035,0.00603430261074835,-0.0165393282985871,0.00711513793554642,0.434882006873534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.00365047947361636,0.00468992646271926,-0.0128427353405461,0.0055417763933134,0.436366874623926
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00443021131315604,0.00569646511137318,-0.0155952829314475,0.00673486030513539,0.436752616807794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.00658550178174477,0.00848294233984928,-0.0100410652043598,0.0232120687678494,0.437572193832785
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00452835645000408,0.00583816222056193,-0.0159711544023055,0.0069144415022973,0.437970875569291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,0.00298507150028159,0.0038633729067083,-0.00458713939686669,0.0105572823974299,0.439735407902955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00370988084578653,0.00480142923753471,-0.00570092045978149,0.0131206821513546,0.439736448739703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00758142721903073,0.00981893066379573,-0.0268265313200704,0.0116636768820089,0.440055142578573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37056,0.00196719024158284,0.00255292454917541,-0.00303654187480097,0.00697092235796665,0.440979552576436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00235987552507269,0.00306637450996138,-0.008369969564597,0.00365021851445162,0.441549982170339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,39587,0.00365301624037128,0.00476053059508633,-0.00567762372599793,0.0129836562067405,0.4428820847913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,0.00463175356266919,0.00605891202766427,-0.00724371401155278,0.0165072211368912,0.444611009245964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00427768390535753,0.00560326394007132,-0.00670471341718227,0.0152600812278973,0.445222017154697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.00249067084138803,0.00326685416373863,-0.00889370500231575,0.0039123633195397,0.445828864892511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,36991,-0.00478711516934011,0.00628887927754959,-0.0171133185533373,0.00753908821465709,0.446549363611906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00506548992782587,0.00666487806833874,-0.00799767108611806,0.0181286509417698,0.447251671496796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.00395818702956836,0.00521455372781383,-0.00626233827694676,0.0141787123360835,0.447824844067855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00615408061273089,0.00811029298206002,-0.00974209363210675,0.0220502548575685,0.447986541106274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.00367729816988431,0.00485806128891431,-0.00584450195638774,0.0131990982961564,0.449092356650732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,0.00413743054092255,0.00547020491079264,-0.00658417108423103,0.0148590321660761,0.449448477850654
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.00402804687824828,0.00533215969916333,-0.00642298613211184,0.0144790798886084,0.450007502548896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00341583965953473,0.00454563727400621,-0.0123252887165869,0.00549360939751745,0.452392631482442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,39913,0.00158470182157902,0.00211502137317077,-0.0025607400698357,0.00573014371299374,0.453711232134199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.00302560453616035,0.00404384219842296,-0.00490032617274865,0.0109515352450693,0.454352609190733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39477,0.00222569439725445,0.00298119625155113,-0.00361745025578577,0.00806883905029467,0.45532980140817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,0.00800175354002625,0.0107265925590382,-0.0130223678756887,0.0290258749557412,0.455694425782591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,0.00197445052946751,0.00264980564929379,-0.00321916854314832,0.00716806960208335,0.456203850614573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40030,0.00148895098763585,0.00199899255548795,-0.00242907442112052,0.00540697639639223,0.456372811454333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00305291574849946,0.00410227061312456,-0.00498753465322468,0.0110933661502236,0.456767878019865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,39546,0.00524356374413402,0.00705562758947909,-0.008585466331245,0.019072593819513,0.457387063565859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37437,0.00367595731267245,0.00495419554826119,-0.00603426596191949,0.0133861805872644,0.458106993009965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.00210407379614588,0.00284131218123112,-0.00767304567135887,0.00346489807906711,0.458992000712147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39489,0.00401648421976861,0.00545042980703649,-0.00666635820202291,0.0146993266415601,0.461187252322882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00332694967837833,0.0045509280631332,-0.0122467686821194,0.00559286932536274,0.464762470733138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.00204070809091613,0.00279478290257763,-0.00751848257996829,0.00343706639813603,0.465288087461197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,39587,0.00202708329855493,0.00278687505695122,-0.00343519181306946,0.00748935841017932,0.467011475595583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIM,Vimentin,39585,-0.00830890987418323,0.0114335872537903,-0.0307187408916122,0.0141009211432457,0.467414031971691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00365189235339856,0.00503209451090801,-0.0135147975947783,0.00621101288798115,0.468023236799155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.00725307635554515,0.0100306794914056,-0.0269132081587,0.0124070554476097,0.469637891252789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.00418642429483924,0.00579033155646749,-0.0155354741455155,0.00716262555583703,0.469689089103186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00374170944367044,0.00518335159926257,-0.0139010785782251,0.0064176596908842,0.470386683071705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37445,-0.00181037815256213,0.00250924684224915,-0.00672850196337045,0.0031077456582462,0.470625005880628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.00501925988158636,0.00696197820105144,-0.0186647371556472,0.00862621739247446,0.470951148887792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,39866,0.00395630111126954,0.00549825398870713,-0.00682027670659643,0.0147328789291355,0.471808977001297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,0.00307724339756671,0.00428824490661274,-0.00532771661939427,0.0114822034145277,0.473014593919318
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.00410112859207208,0.00573162348834632,-0.0153351106292309,0.00713285344508672,0.47429643769461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00203868642514131,0.00286403356071731,-0.00357481935386462,0.00765219220414724,0.476584326965066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37039,-0.00468481561895808,0.00659510398694696,-0.0176112194333741,0.00824158819545797,0.477501241122038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00346906182573877,0.00489604268787422,-0.0130653054939722,0.00612718184249469,0.47862001060962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.00336649047515283,0.00475200716816859,-0.0126804245247633,0.00594744357445761,0.478685366226219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00359318684799686,0.00507362334372059,-0.0135374886016892,0.0063511149056955,0.478827881561147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.00434650991713457,0.00614444511223655,-0.00769660250284907,0.0163896223371182,0.479337624739272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,0.00252997002956073,0.00358618606655033,-0.00449895466087792,0.00955889471999937,0.480526231162202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.0017240119473825,0.00244701046342702,-0.00652015245569945,0.00307212856093445,0.481110082371639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00277898295904794,0.00395086618571248,-0.0105226806830444,0.00496471476494851,0.481827829827486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.0015645856817918,0.00222521339401635,-0.00592600393406385,0.00279683257048025,0.481995049037946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37169,0.00243821802100509,0.00347177208092086,-0.00436645525759981,0.00924289129960998,0.482505724357417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00510707229060803,0.00728542277800818,-0.0193865009355041,0.009172356354288,0.483314237101336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.00496580771319501,0.0070970050356968,-0.0188759375831607,0.00894432215677071,0.484121885313447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37056,0.00434257343462411,0.00623703853971739,-0.00788202210322196,0.0165671689724702,0.486280993823216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00193176351800592,0.00277969821981907,-0.0073799720288513,0.00351644499283946,0.48709583043343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.00407179720941858,0.00586386139941635,-0.0155649655522746,0.00742137113343746,0.487450992000833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,39587,0.00351799418805346,0.00506940621254456,-0.00641804198853388,0.0134540303646408,0.487713950004854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,39657,0.00716098615216368,0.0103198239949934,-0.0130658688780234,0.0273878411823507,0.487751463512264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.00179398062080004,0.00260872628012656,-0.00690708412984809,0.00331912288824801,0.491663225095217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.00212344550077868,0.00308849250235622,-0.00817689080539686,0.00392999980383951,0.491755870641704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.00319849915349482,0.00468387431363664,-0.0123788928082226,0.00598189450123299,0.494696095972005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.00590340976125133,0.00864926102309429,-0.0228559613665161,0.0110491418440135,0.494911767979097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,-0.0050985230417003,0.00747740009837867,-0.0197542272345225,0.00955718115112189,0.495340570755191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37124,0.00383431941292583,0.00563055828432526,-0.00720157482435168,0.0148702136502033,0.495893579851678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.00278574084944351,0.00410581344338788,-0.0108331351984838,0.00526165349959673,0.497474790739602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.0026480711550211,0.00390397658192433,-0.0102998652555928,0.00500372294555059,0.497592828075194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.00447578360053656,0.00662091288322157,-0.0174527728516508,0.00850120565057772,0.499045952694737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,39788,-0.00276383640629867,0.0040980698204218,-0.0107960532543254,0.00526838044172805,0.500051613035991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.00474284890008868,0.00703637736973031,-0.0185341485447601,0.00904845074458273,0.500293153933364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,0.00479551010829035,0.00711643425954361,-0.00915270104041513,0.0187437212569958,0.500409530912357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00340868946843555,0.00506205441185606,-0.00651293717880234,0.0133303161156734,0.500717538782885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00270020623955156,0.00401047528186138,-0.00516032531289673,0.0105607377919999,0.500775406086218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00236152875545358,0.00350989746162103,-0.00451787026932365,0.0092409277802308,0.501073691485388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.00444633275379305,0.00661084521893246,-0.0174035893829007,0.00851092387531456,0.501225312446719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37411,0.00250894041415,0.00373884753817578,-0.00481920076067453,0.00983708158897453,0.502202368747791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.00396845836971349,0.00591500805062795,-0.0076249574095173,0.0155618741489443,0.502287419546819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.00270554544253716,0.0040537632096341,-0.00523983044834568,0.01065092133342,0.504518274444349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,39913,0.00190996397652206,0.00287116458048604,-0.00371751860123059,0.00753744655427471,0.505917593170045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.00742765465316152,0.0111851072692661,-0.029350464900923,0.0144951555946,0.506659094507542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,39931,-0.00293860324780551,0.00443065734906905,-0.0116226916519808,0.00574548515636983,0.507184336775107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.00307635955819724,0.00464102703097488,-0.012172772538908,0.00602005342251353,0.507428863317419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,0.00384122074772631,0.00580361254154714,-0.00753385983370608,0.0152163013291587,0.508067797323363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,0.00405728452752024,0.0061341116686579,-0.00796557434304925,0.0160801433980897,0.508347973377904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00540655719580645,0.00817491947494278,-0.0214293993666943,0.0106162849750814,0.508393693394464
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39489,-0.00391633876050248,0.00592762544634164,-0.0155344846353321,0.00770180711432713,0.508819155012346
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.00971027635835296,0.0147061841858477,-0.0385343973626145,0.0191138446459086,0.509080278018181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00411756664050374,0.00624173022606173,-0.00811622460257726,0.0163513578835847,0.509468480167431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.00616810786128155,0.00937318231163325,-0.0245395451920827,0.0122033294695196,0.510511580148022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00343664551826837,0.00528643874264225,-0.00692477441731044,0.0137980654538472,0.515647348005766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.00294778756318884,0.00453653298017677,-0.0118393922043353,0.00594381707795762,0.515838319716468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0075944804635881,0.0117475788656669,-0.0154307741131191,0.0306197350402953,0.517983243732091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,39984,0.00388983195411871,0.00602048240773772,-0.00791031356504721,0.0156899774732846,0.518223976616871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37169,0.00180266870261087,0.00279443710237305,-0.0036744280180403,0.00727976542326205,0.518878760986328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37056,-0.00275096500957426,0.00426971040431182,-0.0111195974020254,0.0056176673828769,0.519393542328438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,0.00479421317819665,0.00746976128287055,-0.00984651893622963,0.0194349452926229,0.521002017325496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39315,-0.00217259023295886,0.003392625998129,-0.0088221371892917,0.00447695672337398,0.521931168467616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.00293715546226475,0.00459988340223689,-0.00607861600611956,0.0119529269306491,0.523139379866571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,36991,-0.0048452255176439,0.00758866111045002,-0.0197190012941259,0.0100285502588381,0.523170931818358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.00241614442824449,0.00378527244093537,-0.00500298955598884,0.00983527841247781,0.52328835699378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37368,0.00327049422263394,0.0051374653698342,-0.0067989379022411,0.013339926347509,0.524398270789709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,0.00187058179685239,0.00295292283901053,-0.00391714696760825,0.00765831056131302,0.526437282412742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.00663957566328321,0.0105005609386724,-0.0272206751030811,0.0139415237765147,0.527195521555248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.00310040905419164,0.00490870238913522,-0.0065206476285134,0.0127214657368967,0.527649635818759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00284360587933021,0.00451143598515723,-0.00599880865157797,0.0116860204102384,0.528502057775442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00284278533504,0.00452290022857826,-0.0060220991129734,0.0117076697830534,0.529666764322063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00776927602764689,0.0123915577586975,-0.0165181771794001,0.0320567292346939,0.5306806038032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00184222146380903,0.00293942009358062,-0.00760348484722705,0.00391904191960898,0.530847081235074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00479689066990279,0.00765923273539124,-0.0198089868312696,0.010215205491464,0.531136464500727
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00343363581520825,0.00550441312968018,-0.0073550139189649,0.0142222855493814,0.532771815383611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.0029746187933132,0.00477762861617649,-0.0123387708810191,0.00638953329439271,0.533548999289482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.00177185580750522,0.00285420648004841,-0.00382238889338966,0.0073661005084001,0.534749845952767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37351,0.00304336296482276,0.00492463524885594,-0.00660892212293488,0.0126956480525804,0.536594018402968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.00518269237483856,0.00839594246570676,-0.0112733548579467,0.0216387396076238,0.537057081305333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.00482669736793173,0.00784063115927586,-0.0201943344401124,0.010540939704249,0.538168789942568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37056,0.00281961018416252,0.00458442531104863,-0.0061658634254928,0.0118050837938178,0.538538155144942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.00368976706780899,0.00600788679924406,-0.0154652251943273,0.00808569105870937,0.539123928349223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.00604009392765645,0.00983507944837389,-0.0132366617911564,0.0253168496464693,0.539134880966585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.00270471031692756,0.00442730541295096,-0.0113822289263114,0.00597280829245632,0.5412641566893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00323536907989631,0.00532830829974147,-0.0136788533473896,0.00720811518759698,0.54372618910767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37056,0.00241794838576207,0.00398386154614307,-0.00539042024467834,0.0102263170162025,0.5439039288997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.00137221819739089,0.00226922995603159,-0.00581990891121282,0.00307547251643103,0.545382484152784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00307281757535007,0.00508714675790454,-0.013043625220843,0.00689799007014283,0.545830291553111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00241000748551999,0.00399828561603515,-0.0054266323219089,0.0102466472929489,0.5466786515849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00401299555492368,0.00666112169726385,-0.00904280297171347,0.0170687940815608,0.546884621520261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,37453,0.0011330447287333,0.00189189110854714,-0.0025750618440191,0.00484115130148569,0.549252673476862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2,Complement C2,39908,0.0013821698696781,0.00231020852188482,-0.00314583883321614,0.00591017857257234,0.549656273713561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39477,0.0054725634765325,0.00917934782648047,-0.0125189582633692,0.0234640852164342,0.551062178483044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.00141658300230137,0.00239646719810168,-0.00611365871058067,0.00328049270597793,0.554454514389443
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00372622124239406,0.00630928641288637,-0.0160924226116513,0.00863998012686321,0.554801605351592
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0084242518894303,0.0142659476299966,-0.019537005465363,0.0363855092442236,0.554855497266202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00293151264391244,0.0049809123272711,-0.00683107551753891,0.0126941008053638,0.556173728801965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.00143790468429353,0.00244820590064677,-0.00336057888097414,0.0062363882495612,0.556990380923881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00356525317235121,0.00607128260610388,-0.0154649670803148,0.0083344607356124,0.557055929961325
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.00476707832213606,0.00812817701888891,-0.0206983052791583,0.0111641486348862,0.557555890885625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00196734179610683,0.00335903149469909,-0.00855104352571706,0.00461635993350339,0.558094191570596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00281913717879275,0.00483220584134873,-0.00665198627025076,0.0122902606278363,0.559628535863892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.00303731698070711,0.00523017778917355,-0.0132884654474873,0.00721383148607304,0.561432664404324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.00266855744973737,0.0046037720502849,-0.00635483576882104,0.0116919506682958,0.562161815715104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,39868,0.00651652337754045,0.0112529515808845,-0.0155392617209932,0.0285723084760741,0.562533498734875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37382,0.0020184824897089,0.00351564216957508,-0.00487217616265825,0.00890914114207606,0.565880366585237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,0.00241431772280532,0.00421249297733674,-0.00584216851277469,0.0106708039583853,0.566563003299857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00272167830457399,0.00475429483041758,-0.00659673956304445,0.0120400961721924,0.567015258731844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.00329682206461549,0.00576735205624148,-0.0146008320948488,0.00800718796561781,0.567578724004669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,0.00203206721933406,0.00356023285002522,-0.00494598916671537,0.00901012360538349,0.568166366759105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.00335552188046628,0.00588468831753028,-0.0148895109828256,0.00817846722189307,0.568541618103205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00375946828729227,0.00667808565490284,-0.00932957959631728,0.0168485161709018,0.573474432610157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,0.00528860901355755,0.00941668711858044,-0.0131680977388601,0.0237453157659752,0.574383870532331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.0032363743137798,0.0057645024966284,-0.0145347992071715,0.00806205057961188,0.574512874613735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.00383753230077507,0.00683991517137397,-0.017243766036668,0.0095687014351179,0.57477170559214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,39998,0.00222083242980166,0.00399732417736904,-0.00561392295784166,0.010055587817445,0.578505868615098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37368,-0.00204475735775651,0.003680425345472,-0.00925839103488162,0.0051688763193686,0.578509689101379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.0026722230989734,0.00481444643251517,-0.0121085381067031,0.00676409190875632,0.578874922339559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00285306374486658,0.00514028026806644,-0.00722188558054365,0.0129280130702768,0.578876118390821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.00255579179883851,0.00460731928787558,-0.00647455400539763,0.0115861376030746,0.579092704035217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.00314045391256326,0.00570582831424175,-0.0143238774084771,0.00804296958335056,0.582056950934275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.00270685557933233,0.00492392658977433,-0.01235775169529,0.00694404053662536,0.582510348833833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.00345717339624512,0.00633459511939909,-0.0089586330377771,0.0158729798302673,0.58523965515497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39524,0.00249060075176166,0.00457254976144122,-0.00647159678066314,0.0114527982841865,0.58597771374745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,0.00260595363863112,0.00478648577513627,-0.00677555848063596,0.0119874657578982,0.586146386335466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.00451490947385312,0.00830916205382512,-0.0208008670993503,0.0117710481516441,0.586886138879628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.00306273018680236,0.00563762521310197,-0.00798701523087752,0.0141124756044822,0.586954413390628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40009,0.00158795303473508,0.0029231941604097,-0.00414150751966794,0.0073174135891381,0.586982184557652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37021,0.00323344885967908,0.00597698113445586,-0.00848143416385441,0.0149483318832126,0.588528032453377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.00205954687341822,0.00382374709372722,-0.00955409117712358,0.00543499743028714,0.590158155504199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00337293936216945,0.00629568544192763,-0.0157124828283476,0.00896660410400869,0.592137541363616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,-0.00419920120013688,0.00787445353088086,-0.0196331301206634,0.0112347277203896,0.593856495681707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37039,0.00163488617817817,0.00306750417014106,-0.00437742199529831,0.00764719435165464,0.594063676903062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.00400052589176458,0.00752626764698526,-0.0107509586963265,0.0187520104798557,0.595052371144315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37169,0.00296608266507264,0.00561450731098955,-0.00803835166446687,0.0139705169946122,0.597307547393986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,36991,-0.00273288920812901,0.00521107653231026,-0.0129465992114571,0.00748082079519909,0.599982430635158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,0.00141182080616168,0.00269467593486972,-0.00386974402618297,0.00669338563850633,0.60033597034115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00261396236383785,0.00498977113611892,-0.00716598906295523,0.0123939137906309,0.600381733526601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39477,-0.00378141783202619,0.00722749368581719,-0.0179473054562279,0.0103844697921755,0.600843165373895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.00485324745692426,0.00928315778421885,-0.0230482367139932,0.0133417418001447,0.601119769167068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00172421205758257,0.00330160127401692,-0.00819535055465574,0.0047469264394906,0.60151543056458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37056,0.00322652984279926,0.00618199359085578,-0.00889017759527807,0.0153432372808766,0.601732117900715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00144517339244795,0.00277353354331683,-0.00399095235245304,0.00688129913734893,0.602333262656955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00377841022463419,0.00727451382693774,-0.0104796368761638,0.0180364573254322,0.603487809763267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00189316178191472,0.00368410750953424,-0.00911401250060183,0.00532768893677239,0.60734830824215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.00302851305809675,0.00593807555606737,-0.0146671411479888,0.0086101150317953,0.610048795847528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37039,-0.00297670016675297,0.00587106626103244,-0.0144839900383766,0.00853058970487061,0.612154986919863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.0022280243942463,0.00443024495022171,-0.0109113044966808,0.00645525570818825,0.615034177228908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.00213365497585149,0.00424736814419312,-0.01045849653847,0.00619118658676703,0.615431450024326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,0.00555342792897797,0.0110659683909392,-0.0161358701172628,0.0272427259752188,0.615783168179811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00568937699918742,0.0113579211594198,-0.0279509024716503,0.0165721484732754,0.616437840134889
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00315343690018142,0.00631817276498176,-0.0155370555195457,0.00923018171918283,0.617713157276871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.00275042971919886,0.00552638082277218,-0.0135821361318323,0.00808127669343461,0.618710203246124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.00128876098044899,0.00260162545552823,-0.00381042491238635,0.00638794687328433,0.62034891166769
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,39866,0.00309673496083599,0.00626285663064828,-0.00917846403523463,0.0153719339569066,0.62098781147752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00239449474439517,0.00484418861482843,-0.0118891044294589,0.00710011494066855,0.621100769265228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37124,-0.00451706628055362,0.00916521503275543,-0.0224808877447543,0.013446755183647,0.622127503998932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,36991,-0.00435568820002818,0.00886531863756433,-0.0217317127296543,0.0130203363295979,0.623209955680906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00253678029314922,0.00516635599741346,-0.00758927746178116,0.0126628380480796,0.62342103215191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0036468653150215,0.00743278226593027,-0.0182151185562448,0.0109213879262018,0.623684766662528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,39846,-0.00182110585876855,0.00373802712263135,-0.009147639019126,0.0055054273015889,0.62613484037924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.00456697254520334,0.00938946842030992,-0.0229703306490108,0.0138363855586041,0.62669516126397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,37453,0.00086820460734914,0.00178602174316647,-0.00263239800925715,0.00436880722395543,0.62689638714884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,0.00224662019550522,0.00462352080017781,-0.00681548057284329,0.0113087209638537,0.627036997464237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.000773401077730468,0.00159349785753447,-0.00389665687849804,0.0023498547230371,0.627437298699747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00101437692803605,0.00209289620703409,-0.00308769963775077,0.00511645349382286,0.627913920197989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.00320068186081968,0.00664685215670919,-0.00982714836633033,0.0162285120879697,0.630145384772768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00218329218832061,0.00453752124966266,-0.00671024946101819,0.0110768338376594,0.630406414680389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,36962,-0.00285881785495769,0.00597346018789473,-0.0145667998232314,0.00884916411331597,0.63224075650723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00275755308928697,0.00577160822551592,-0.0140699052112982,0.00855479903272423,0.63281545864138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.00307054996418046,0.00643322240383165,-0.00953856594732957,0.0156796658756905,0.633159434698486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37056,0.00268270282677458,0.00562084248119164,-0.00833414843636103,0.0136995540899102,0.633172285627586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.00278032880238273,0.00582789824147732,-0.0142030093556783,0.00864235175091281,0.633317087998224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.00108361113079349,0.00227351828649673,-0.0033724847107401,0.00553970697232709,0.633637043533481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40011,-0.00143041105955449,0.00300507135679021,-0.00732035091886331,0.00445952879975432,0.634081505288093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.00403902902870847,0.0084944905471603,-0.0126101724437257,0.0206882305011427,0.634447051981954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,0.00166847059653277,0.00351530631552931,-0.00522152978190467,0.00855847097497021,0.635057155523472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.00257867600476818,0.00546302792067061,-0.0132862107292826,0.00812885871974621,0.636916595841846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,39866,-0.00300171402774894,0.00637380297905464,-0.015494367866696,0.00949093981119816,0.63768605058268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.00162345404194528,0.00345970807201567,-0.00840448186309599,0.00515757377920543,0.638901662778035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,39587,0.00142257809983239,0.00304317586791312,-0.00454204660127733,0.00738720280094211,0.640173729410991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.00136840475570157,0.00292903997889424,-0.00437251360293114,0.00710932311433427,0.640373746198532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37021,0.00275265443429556,0.00590226011567095,-0.0088157753924195,0.0143210842610106,0.640956292426463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.00432058518619489,0.00927310079832556,-0.022495862750913,0.0138546923785232,0.641274368403997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.00299431786432594,0.00645028190666468,-0.0156368704013887,0.00964823467273682,0.642501355562498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.00167260279123736,0.00360976054334988,-0.00874773345620313,0.0054025278737284,0.643117144371358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37056,0.00132270495572911,0.00286166198011757,-0.00428615252530132,0.00693156243675954,0.643934300919304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,-0.00386321572058817,0.00836195014067367,-0.0202526379963086,0.0125262065551322,0.6440894242275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37056,-0.00236453620940838,0.0051299287084901,-0.012419196478049,0.00769012405923222,0.644856679642987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.00211559831958596,0.0046129776218419,-0.0111570344583961,0.00692583781922417,0.646515279745764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.00181672574198881,0.00396909500557439,-0.00959615195291461,0.00596270046893699,0.647161372499703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39489,-0.00130093785853866,0.0028490058383595,-0.00688498930172328,0.00428311358464597,0.647944285998439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.00374468746279976,0.00822902340550551,-0.0198735733375906,0.012384198411991,0.649073215643572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0023317484662206,0.00514340773576933,-0.00774933069588728,0.0124128276283285,0.650306176390655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00130684178380901,0.00290858066850147,-0.00439397632645386,0.00700765989407189,0.653218547675965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.00200002475000035,0.00445276133688465,-0.0107274369702943,0.00672738747029356,0.6533197959522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.00262058771376463,0.00583655932287351,-0.00881906855906746,0.0140602439865967,0.65344247205288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.00160362261547451,0.00357240294195376,-0.00860553238170388,0.00539828715075486,0.653515851304036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00368745217556775,0.00822867663746413,-0.0124407540338619,0.0198156583849974,0.654072417578893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.000838527523167763,0.00188028338744199,-0.00284682791621855,0.00452388296255407,0.655633598504216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.00185179454275621,0.00415507213868249,-0.0099957359345739,0.00629214684906147,0.655841025495271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00289489461335078,0.00651054608053494,-0.0098657757044977,0.0156555649311993,0.656582239862333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.00330814822923814,0.00746622783353289,-0.0179419547829626,0.0113256583244863,0.657712672230573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,39788,-0.00359049829259634,0.00811825209315858,-0.0195022723951872,0.0123212758099945,0.658296371754623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,0.0019955305791572,0.00452293951489923,-0.00686943087004529,0.0108604920283597,0.659073833401117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,-0.0015231740243264,0.00346320879271085,-0.00831106325803966,0.00526471520938686,0.660076448012606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,36962,0.00394849491518008,0.00903109103891045,-0.0137524435210844,0.0216494333514446,0.661965332469482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.00340610262527047,0.0077936395334501,-0.0186816361108327,0.0118694308602917,0.66209229600306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37039,0.00257086423963097,0.00590501503923804,-0.00900296523727558,0.0141446937165375,0.6633012773452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.00179045902771163,0.0041261736398279,-0.00987775936177431,0.00629684130635105,0.6643482206394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00201811165848609,0.0046612856933182,-0.00711800830041757,0.0111542316173898,0.665056939660059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37411,0.00293868128591279,0.00678887012601806,-0.0103675041610826,0.0162448667329082,0.665117916053452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37368,0.00250530378356095,0.00581829080478068,-0.00889854619380918,0.0139091537609311,0.666772640402985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,39782,-0.00171508974047259,0.0040282605876731,-0.00961048049231187,0.00618030101136668,0.670285323293304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00280243468563107,0.00662256235149092,-0.0101777875232911,0.0157826568945533,0.672182005849326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39415,0.00124782427877196,0.00295413720101523,-0.0045422846352179,0.00703793319276181,0.67273972522299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00102469973424926,0.00242642906009561,-0.00578050069203665,0.00373110122353813,0.672807104211319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,39868,0.00316223342970546,0.00751168690136891,-0.0115606728969776,0.0178851397563885,0.67377888824861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,0.00192801256778521,0.0045805752814669,-0.00704991498388992,0.0109059401194603,0.673826176177669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.00264670789173879,0.00635233871342013,-0.0150972917700422,0.00980387598656467,0.676940343651418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0036249011542942,0.00876638374317303,-0.0135572109823249,0.0208070132909133,0.679246884006135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.00160577791497294,0.0038920033977381,-0.00923410457453962,0.00602254874459374,0.679918224419957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00204553088472669,0.00496669712125313,-0.00768919547292944,0.0117802572423828,0.680456510919561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,39687,0.00230247718573777,0.00561824435845392,-0.00870928175683191,0.0133142361283074,0.681942458876088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37039,0.00301151875542784,0.00735048015691323,-0.0113954223521221,0.0174184598629778,0.682029990594406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00194507542286432,0.00478725744790029,-0.00743794917502024,0.0113281000207489,0.684527017527196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.00133549240611003,0.00331539098258683,-0.00783365873198021,0.00516267391976016,0.68708909832432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0017971113723159,0.00450759858483801,-0.00703778185396659,0.0106320045985984,0.690131707308492
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37039,-0.00137026402232156,0.00343933618169495,-0.00811136293844367,0.00537083489380055,0.690334850335951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,39585,0.00274378613013283,0.00695261687266367,-0.010883342940288,0.0163709152005536,0.693113366963253
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37039,0.002281193665688,0.00580139213627397,-0.00908953492140899,0.013651922252785,0.694167146842666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00170903983724263,0.00435133471467878,-0.00681957620352777,0.010237655878013,0.694501479547886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0013151173269656,0.00334972070670939,-0.00525033525818481,0.00788056991211601,0.694616516318494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.00255288498348827,0.00654353204286469,-0.0102724378205265,0.0153782077875031,0.696440263355587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39489,0.0026286294605751,0.00676400318116556,-0.0106288167745094,0.0158860756956596,0.697562285082398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.00330659766909849,0.00863584254152115,-0.0202328490504799,0.013619653712283,0.70180575161669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,-0.00187324439189945,0.00490589760225161,-0.0114888036923126,0.00774231490851371,0.702589800100093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,0.00121168442590003,0.00319035734008354,-0.00504141596066371,0.00746478481246376,0.704102013552638
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37287,-0.00370982559961377,0.00977528336285089,-0.0228693809908015,0.015449729791574,0.704314588388813
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,36991,-0.00412942794983479,0.0109155835735664,-0.025523971754025,0.0172651158543554,0.705209595414975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.00265545209005866,0.00702515849022355,-0.0111138585507795,0.0164247627308968,0.705442804017134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37056,0.00144652282198741,0.00382843251271143,-0.006057204902927,0.00895025054690181,0.705557885564552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,39858,0.00696004746222728,0.018465319625265,-0.0292319790032921,0.0431520739277467,0.706234065140237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,-0.00190486920901444,0.00505551459803457,-0.0118136778211622,0.00800393940313332,0.706335473388274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.0010980284899777,0.0029161610145398,-0.0068137040784757,0.0046176470985203,0.706527185143298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,39587,0.00143851970887573,0.00382273227592522,-0.0060540355519377,0.00893107496968917,0.706693986540343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40030,-0.000988651743953061,0.0026303832050981,-0.00614420282594534,0.00416689933803922,0.707027065050797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,39585,-0.00169623142123259,0.00454044226709398,-0.0105954982647368,0.00720303542227161,0.70871972188014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.00223159067973518,0.00603208297569606,-0.0140544733120995,0.0095912919526291,0.711422849991644
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.00216363917580555,0.00585549142416912,-0.013640402367177,0.00931312401556592,0.711755453370057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40052,0.0026109809021289,0.00713766539395393,-0.0113788432700208,0.0166008050742786,0.714516704234359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.00177515386920682,0.00491123544452035,-0.0114011753404667,0.00785086760205307,0.717769755248302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37333,-0.00122768534153406,0.00340742517116221,-0.00790623867701199,0.00545086799394386,0.718630630214678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.00234074841712672,0.0065137139355178,-0.0151076277307416,0.0104261308964882,0.719333659161854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.00110023564910591,0.00306227370826146,-0.00490182081908654,0.00710229211729836,0.719385130156501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,0.0020950637221829,0.00587262116314623,-0.00941527375758371,0.0136054012019495,0.721283744761319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.00133589683179742,0.00375790652995281,-0.00602959996691009,0.00870139363050493,0.722228488373664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.00270122561324539,0.00760427457207595,-0.0122031525480235,0.0176056037745143,0.722426999786104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00226896365611528,0.00643283979057753,-0.0103394023334167,0.0148773296456472,0.724307165805348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,0.00136339953750067,0.00386686004814861,-0.00621564615687061,0.00894244523187195,0.724403817935379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.00166440771944293,0.00477138110629761,-0.0110163146877862,0.00768749924890038,0.727220449872343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00155851545710135,0.00446980252142164,-0.0103193283990878,0.00720229748488506,0.727337691155849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.00195429330323073,0.00564010572967623,-0.0130089005333961,0.00910031392693468,0.728972992434768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00113160829738644,0.00328060175833378,-0.00529837114894777,0.00756158774372065,0.730145398551229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37380,0.00157670107543426,0.004573339237865,-0.00738704383078113,0.0105404459816497,0.730280721862379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00163816099852013,0.00477573387597845,-0.00772227739839763,0.0109985993954379,0.731590521824986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.000804356259417418,0.00235143965747271,-0.00541317798806394,0.0038044654692291,0.732302961507399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,39585,-0.00167942888157172,0.00491335424703499,-0.0113096032057603,0.00795074544261687,0.732499176146106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.00202429669830364,0.00601268169294018,-0.0138091528164664,0.00976055941985911,0.736369999871487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,0.00416279431063836,0.0123898025411582,-0.0201212186700317,0.0284468072913084,0.736887096510788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39489,0.00163763724556536,0.00491688851182678,-0.00799946423761513,0.0112747387287459,0.739090641889729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.00166177977432643,0.00500095611429643,-0.0114636537583474,0.00814009420969457,0.739672934054075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,38832,0.00155919276933829,0.0047027401752395,-0.00765817797413113,0.0107765635128077,0.740233838669289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,0.00134342472196286,0.00405689692197424,-0.00660809324510664,0.00929494268903236,0.740538660594316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.00352564844106714,0.0106865984661993,-0.0244713814348178,0.0174200845526835,0.74147086218292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.00217213749308812,0.00659372485188948,-0.0150958382027915,0.0107515632166153,0.741839752644479
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37021,-0.00119984994449398,0.00368094781905663,-0.00841450766984498,0.00601480778085702,0.744458117399123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.0014447700630265,0.00446027925215602,-0.0101869173972523,0.0072973772711993,0.746004345172686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40030,-0.00136688121201774,0.00422479278008369,-0.00964747506098177,0.00691371263694629,0.746291981017205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00146907096692619,0.00454085866216598,-0.0103691539447715,0.00743101201091913,0.746304540632807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37368,-0.00253585909321338,0.00788264368356242,-0.0179858407129957,0.012914122526569,0.747683742606833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.000931466891629383,0.00290296823585701,-0.00662128463390912,0.00475835085065035,0.748316252752739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.000841335204405794,0.00262336339169328,-0.00598312745212463,0.00430045704331304,0.748435490016002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,0.00209591896638241,0.00658633938107334,-0.0108133062205213,0.0150051441532862,0.750320670389099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,39703,-0.00141189940186942,0.00443802690757186,-0.0101104321407103,0.00728663333697142,0.750385410743375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARTN,Artemin,39587,0.00138512914414641,0.00437627859365452,-0.00719237689941646,0.00996263518770928,0.751620814943933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.00119254809501726,0.00377884637555296,-0.00859908699110106,0.00621399080106654,0.75232221134805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.000923663572833573,0.00297645234704132,-0.00675751017303455,0.00491018302736741,0.756318981869006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.00165791535688382,0.0053634614928562,-0.012170299882882,0.00885446916911432,0.757240519640699
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00171759123211918,0.00557370158589113,-0.00920686387622744,0.0126420463404658,0.757964683510415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40058,0.00182703028656466,0.00595346961067764,-0.00984177015036351,0.0134958307234928,0.758934881665183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.00294477025852484,0.00969834814210739,-0.0219535326170553,0.0160639921000056,0.761409687260618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00191443139913645,0.0063178658651511,-0.0142974484948326,0.0104685856965597,0.761880369651165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.00125717306290604,0.00419275733875677,-0.00947497744686931,0.00696063132105723,0.764300899190541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.00208234267347244,0.00698633292081304,-0.015775555198266,0.0116108698513211,0.765662337037682
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37149,-0.000935545437701077,0.00313926880392468,-0.00708851229339345,0.0052174214179913,0.765697287016657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.002606737816926,0.00879395637309217,-0.0146294166743346,0.0198428923081867,0.766911129599992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.000748071066420315,0.00254646774335522,-0.00573914784339655,0.00424300571055592,0.768938917472666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00144211170129821,0.00492614434790005,-0.00821313122058589,0.0110973546231823,0.769720498387692
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.00133125664712007,0.00458553968360617,-0.0103189144269882,0.00765640113274803,0.771578175218775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00222810802514504,0.00768003445688473,-0.0172809755606391,0.012824759510349,0.771731303482251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.00144211716913169,0.00500221251029434,-0.0112464536893086,0.00836221935104522,0.773124100149508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.00173605534470358,0.00605059779821958,-0.013595227029214,0.0101231163398068,0.774175847704947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37039,0.00170216670711571,0.00593543541351455,-0.00993128670337281,0.0133356201176042,0.774284958361475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,36962,-0.0020047352834575,0.00701811667288727,-0.0157602439623165,0.0117507733954015,0.775149600097279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,39779,-0.000809096827359974,0.00283975670199614,-0.0063750199632724,0.00475682630855245,0.775710934085907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.00147250689818055,0.00516852096481128,-0.0116028079892107,0.00865779419284957,0.775725889255372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00135934380112373,0.00478332601969568,-0.0080159751974798,0.0107346627997273,0.776273265594222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.00156336855880229,0.00551868463222584,-0.00925325332036036,0.0123799904379649,0.776961721711444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,0.00167175811606105,0.00591292400750364,-0.00991757293864609,0.0132610891707682,0.7773879128013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.00162957577709628,0.00577120996228912,-0.00968199574899039,0.012941147303183,0.777668847435925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.000975585434273366,0.00345599809095004,-0.00774934169253544,0.00579817082398871,0.777727297881608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,39587,-0.00136700296271724,0.00484840219695075,-0.0108698712687407,0.00813586534330623,0.77798619794929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.00246240221972687,0.00879544596557133,-0.0197014763122467,0.0147766718727929,0.77950927393779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40030,0.00200515805724104,0.00716610546856765,-0.0120404086611516,0.0160507247756336,0.77962577832056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37039,-0.00114177439622749,0.00409980681538797,-0.0091773957543879,0.00689384696193293,0.780637015893286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00314750452602699,0.011318887015679,-0.0253325230767577,0.0190375140247038,0.78095883380416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.000845674456091696,0.00306487350284195,-0.00516147760947853,0.00685282652166192,0.782610184295353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39489,0.00126532456710601,0.00462003155475542,-0.00778993728021462,0.0103205864144266,0.784182070534184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,0.00223172189615063,0.00815318450921029,-0.0137485197419015,0.0182119635342028,0.784301070086387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,36991,0.00129418933775083,0.0047668772273909,-0.00804889002793534,0.010637268703437,0.786013644018538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,0.000958086809579093,0.00354144437571228,-0.00598314416681697,0.00789931778597516,0.786752362770672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,0.00145452190763387,0.00538073500047694,-0.00909171869330093,0.0120007625085687,0.786917977969164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.000685119459354378,0.00254552672795271,-0.00430411292743294,0.0056743518461417,0.787821205778305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,0.00139882846288856,0.00521078719269972,-0.00881431443480288,0.01161197136058,0.788357589657816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0018676370695648,0.00696124253347736,-0.0155116724351804,0.0117763982960508,0.788479614509538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,0.0008450042903429,0.00315241641413776,-0.00533373188136711,0.00702374046205291,0.788665278712164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,0.000924430218182102,0.00346778710104108,-0.00587243249985842,0.00772129293622263,0.789798723767785
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.00146409010978224,0.00552540873409841,-0.0122938912286151,0.00936571100905064,0.79103357722501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40009,-0.000745326858627806,0.00281352988309596,-0.00625984542949588,0.00476919171224027,0.791083638459525
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00236807390558637,0.00894952676659984,-0.0151729985569493,0.0199091463681221,0.791319275181168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40052,-0.00104173244582332,0.00399583165005492,-0.00887356247993095,0.00679009758828432,0.794323488233227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,0.00116178536790545,0.004459313888049,-0.00757846985267059,0.0099020405884815,0.794458243729691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,39587,-0.00229164407016113,0.00881610128186411,-0.0195712025826148,0.0149879144422925,0.794914622114697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.00141613793587874,0.00545288322419162,-0.0121037890552943,0.00927151318353684,0.795095197518787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,0.00120107916511445,0.00462738884853843,-0.00786860297802087,0.0102707613082498,0.795208229674844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.0012020736908148,0.00463843435685099,-0.00788925764861314,0.0102934050302427,0.795519664069456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39520,-0.00226230221989283,0.00872978530608942,-0.0193726814198281,0.0148480769800424,0.795524826689037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,39858,0.000624797263332733,0.00241896581839294,-0.00411637574071744,0.0053659702673829,0.79618560221539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.00135252538306055,0.00525331875805392,-0.0116490301488462,0.00894397938272514,0.796826719762398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,39754,-0.00128793056900857,0.00504600856031437,-0.0111781073472247,0.00860224620920759,0.798542977985839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,0.000660423255894262,0.00258747926285498,-0.00441103609930151,0.00573188261109003,0.798543082374306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37039,0.00114585808506411,0.00452327987059075,-0.00771977046129376,0.010011486631422,0.800021335644677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00066868147565016,0.00266214815780191,-0.0058864918649419,0.00454912891364158,0.801677348210808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37289,-0.00105305070310849,0.00423067243212789,-0.00934516867007915,0.00723906726386217,0.803435298244432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,39788,0.00131097015802183,0.00529346362471549,-0.00906421854642052,0.0116861588624642,0.804401997393996
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.000947638819186806,0.00388865775463907,-0.00856940801827938,0.00667413037990577,0.807472381674024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,0.00103006476034248,0.00431496387639921,-0.00742726443739996,0.00948739395808493,0.811326453539298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.00114205165261526,0.00478429603730611,-0.00823516858050471,0.0105192718857352,0.81133483243662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.00112341456513224,0.00472881854618557,-0.0103918989156559,0.00814506978539147,0.812219993356718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.000659029918666071,0.00277464963004096,-0.00609734319354635,0.0047792833562142,0.812258451759257
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.000859100152278817,0.00366689153757166,-0.00804620756591928,0.00632800726136164,0.814766842296388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0013419025832407,0.00573222113101609,-0.0125770560000322,0.00989325083355083,0.814911711861608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.00109252581327086,0.00468112848583354,-0.0102675376455046,0.00808248601896287,0.815462665829838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.000945708671268086,0.00414472470691285,-0.0071779517542811,0.00906936909681727,0.819516251009628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.00118811497744016,0.00521553971020654,-0.011410572809445,0.00903434285456465,0.819802930321423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C5,Complement C5,37453,0.000339074835506985,0.00148848444166778,-0.00257835467016186,0.00325650434117583,0.819806155904174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,0.000539965287865901,0.00238414966158242,-0.00413296804883563,0.00521289862456743,0.820830002702707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00127606345789265,0.00565724501221239,-0.00981213676604363,0.0123642636818289,0.821545064837674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00070491890785059,0.00312894228482715,-0.00542780797041063,0.0068376457861118,0.82175730865229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,39788,0.000910048160138966,0.00408365794515402,-0.0070939214123629,0.00891401773264084,0.823654159046753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.00181782687374458,0.00816227507446596,-0.0178158860196979,0.0141802322722087,0.823763431121568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.000847753383942883,0.00381655984122351,-0.0066327039048552,0.00832821067274097,0.824219404406749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,0.00084955941093182,0.00383637427195979,-0.00666973416210937,0.00836885298397301,0.824746545633278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,39585,0.00115318565133421,0.00523940871844515,-0.00911605543681829,0.0114224267394867,0.825797351912708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.00078120185647229,0.00356882579886299,-0.00777610042224375,0.00621369670929917,0.826734394477839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.00160072394336207,0.00732790203201355,-0.0159634119261086,0.0127619640393845,0.827087887242235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00114006857106618,0.00527072405720312,-0.0114706877231843,0.00919055058105193,0.828755111626219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00112549731266999,0.00520354753015183,-0.0113244504717676,0.00907345584642761,0.828761753081903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.00091903737348657,0.00425370198222416,-0.00741821851167279,0.00925629325864593,0.828947000827089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,39587,0.00300336327815056,0.0140910522273497,-0.0246150990874548,0.0306218256437559,0.831220727447988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,39829,-0.00138797857125434,0.00653459882132347,-0.0141957922610484,0.0114198351185397,0.831794141511554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37021,-0.00122860988129721,0.00579124529300244,-0.012579450655582,0.0101222308929876,0.831993676524185
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.00159245501093789,0.00764772776935019,-0.0133970914169885,0.0165820014388643,0.835055281895254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.00128868781134428,0.00619919042906807,-0.0134391010523177,0.0108617254296291,0.835325833285333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.00108404779472358,0.00528471551050665,-0.00927399460586946,0.0114420901953166,0.837474505218986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00160255280265355,0.00781681237220158,-0.0169235050521687,0.0137183994468615,0.837564669806722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.00160751752060491,0.00790156638214188,-0.017094587629603,0.0138795525883932,0.838791527917761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,0.000803890943254106,0.00397405995846501,-0.00698526657533731,0.00859304846184552,0.839697397482784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.000611407868369082,0.00306546978330927,-0.00661972864365525,0.00539691290691709,0.841913845171513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000786336977069796,0.00400562276601407,-0.00863735759845738,0.00706468364431778,0.844371895768128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,0.000847235378101177,0.00439118852661114,-0.00775949413405665,0.00945396489025901,0.847008997740303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.000413451027356617,0.00214580275814114,-0.00461922443331325,0.00379232237860002,0.84721330048825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00123467996980335,0.00642298253286309,-0.013823725734215,0.0113543657946083,0.847566195212957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_A,,37411,-0.000604969589621621,0.00316354961093586,-0.0068055268270559,0.00559558764781266,0.84834727572133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.00170142032255111,0.00896918213642556,-0.0192810173099452,0.015878176664843,0.849550070804086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,36962,0.000751260995970414,0.00399488289655183,-0.00707870948127116,0.00858123147321199,0.850835802627183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37043,-0.000324079970972477,0.00174672949840405,-0.00374766978784442,0.00309950984589946,0.852812054581556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39456,-0.000637260521904045,0.00349419607079451,-0.00748588482066129,0.0062113637768532,0.855289351487798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.00184225586120498,0.0101383755756312,-0.0217134719894421,0.0180289602670321,0.855812211619316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.000900616918358601,0.00498100781800567,-0.0106633922416497,0.00886215840493251,0.856519356692581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,0.00105322016674685,0.00584618135887355,-0.0104052952966453,0.012511735630139,0.857033404406639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,0.000773740673960935,0.00429822612130987,-0.00765078252380641,0.00919826387172828,0.857143894392691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.000422276642042517,0.00237350577741758,-0.00507434796578096,0.00422979468169593,0.858793850532242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.00130671450174885,0.00745726204638912,-0.0159229481126715,0.0133095191091738,0.860903418417958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.000345064563025479,0.00197087565623006,-0.00420798084923639,0.00351785172318543,0.861018002947044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.000433691720332843,0.00248110535715933,-0.00442927477969945,0.00529665822036513,0.861241144859188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39173,0.000357010872131182,0.00206511736900112,-0.00369061917111101,0.00440464091537338,0.862750556705268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.000643481530686271,0.00376903330414632,-0.00674382374544052,0.00803078680681306,0.864439778592126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.000707778748522626,0.00415408128596187,-0.00743422057196264,0.00884977806900789,0.864712237048798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37056,-0.00105522665625121,0.00619846336389672,-0.0132042148494888,0.0110937615369864,0.86482397306808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00117557898612483,0.00692375533347557,-0.0123949814674873,0.0147461394397369,0.865178035382267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.00107131551653525,0.00639070058612582,-0.0135970886653419,0.0114544576322714,0.866871306964677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.00152223951562641,0.00916257212767623,-0.0194808808858718,0.016436401854619,0.868051450615243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.00196265628796473,0.0118340612421265,-0.0251574163225327,0.0212321037466032,0.868278642657587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00126514464264339,0.00768886670882331,-0.0138050341066503,0.0163353233919371,0.86930661442325
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.00191678246178583,0.0118109853926427,-0.0212327489077938,0.0250663138313654,0.871081028303239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,39490,0.000656901753640977,0.00412969585846848,-0.00743730212895724,0.0087511056362392,0.873617489608766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.00130144504723129,0.00821232027975238,-0.017397592795546,0.0147947027010834,0.874084797465781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,0.000709555571343003,0.00452384920187536,-0.00815718886433271,0.00957630000701871,0.875366802083482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.0016609365654889,0.0106422039424626,-0.0191977831617378,0.0225196562927156,0.875979741825299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.000357784288457786,0.00237045516413481,-0.00500387641016202,0.00428830783324644,0.880029420462178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00134128824902546,0.008900560729218,-0.0187863872782927,0.0161038107802418,0.880217003429439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,36962,0.000780764116564255,0.00520122929973875,-0.0094136453109237,0.0109751735440522,0.880678990449716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,39585,-0.00039823785819901,0.00266617229822683,-0.0056239355627236,0.00482745984632558,0.881266053878709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.00043077479968133,0.00294409830383465,-0.00533965787583458,0.00620120747519724,0.883672542846082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,36991,-0.000898834722094587,0.00629809543331382,-0.0132431017713897,0.0114454323272005,0.886517204530054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.00162845305414789,0.0114237265278801,-0.024018957048793,0.0207620509404972,0.886647717479944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40009,0.000913105342191338,0.00646142759772181,-0.0117512927493434,0.0135775034337261,0.887621799137617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.000723343438628333,0.00518571738193581,-0.0108873495072225,0.00944066262996586,0.889066583493593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37169,-0.0011905807869754,0.00859419461095426,-0.0180352022244458,0.0156540406504949,0.889821174087116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.000701956079790498,0.00532126899150765,-0.0111316433031455,0.00972773114356449,0.895053390173115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.00240341285366342,0.0182456499338592,-0.0333580610167006,0.0381648867240274,0.895203272950569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,39788,0.00236749764045861,0.0181932532402813,-0.0332912787104928,0.0380262739914101,0.896464801317775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.000337853857675546,0.00260870974287979,-0.00477521723836884,0.00545092495371994,0.896955791054557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.000515925260969982,0.00399471643353229,-0.0073137189487533,0.00834556947069326,0.897239417218068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.000375555283124649,0.00295422137133853,-0.00541471860469887,0.00616582917094817,0.898843077319853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,0.000584079665724755,0.00473755851337181,-0.008701535020484,0.0098696943519335,0.901881666459469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,0.00161842695404693,0.013139574573425,-0.024135139209866,0.0273719931179599,0.901972764358566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.000636548931081376,0.00518043213426434,-0.0107901959142395,0.00951709805207674,0.902207457936681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.000523841965216152,0.0042636544693683,-0.00783292079474571,0.00888060472517802,0.90221807450494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,0.000305519746711725,0.00249442109713351,-0.00458354560366996,0.0051945850970934,0.902519728683911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,36991,-0.000419017463667119,0.00371667228494435,-0.00770369514215805,0.00686566021482381,0.910238447569035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,0.000794068628148639,0.00713326469946213,-0.0131871301827971,0.0147752674390944,0.911364710139739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.000662338447819242,0.00598493102886228,-0.0110681263687508,0.0123928032643893,0.911881518143539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.000521141143728245,0.00475953865427951,-0.00984983690611608,0.00880755461865959,0.912812317258068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.000752519111173418,0.00688776832981812,-0.0142525450376169,0.0127475068152701,0.913002347445773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.000611050973869458,0.00561968579297924,-0.0116256351281088,0.0104035331803699,0.9134148280664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.000706262523226279,0.00664371576934183,-0.0137279454311363,0.0123154203846837,0.915341707987377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRN,Progranulin,39787,0.000251724458482971,0.00240811592031201,-0.00446818274532857,0.00497163166229452,0.916748726872361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.000850939433505246,0.00818544335472835,-0.0168944084087728,0.0151925295417623,0.917204502275388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,0.000263506058917174,0.00260920036709942,-0.00485052666059769,0.00537753877843204,0.91955876186783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37388,0.00094920066355252,0.00942890879025254,-0.0175314605653425,0.0194298618924475,0.919814557267792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,0.000555737018486246,0.00559243071651809,-0.0104054271858892,0.0115169012228617,0.920843292321895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,0.000246335980784075,0.00248020828198251,-0.00461487225190164,0.00510754421346979,0.920884891048523
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.00116847362828865,0.0117722690226209,-0.0242421209126256,0.0219051736560483,0.920935893669125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,39585,0.000502009209760474,0.00505856602570344,-0.00941278020061827,0.0104167986201392,0.920949433622874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37039,0.000213802471897325,0.00221696626821063,-0.00413145141379551,0.00455905635759016,0.923173219835014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.00236938144587827,0.0252852661213106,-0.0471897401518904,0.0519285030436469,0.92534411858764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39123,-0.000252949384499692,0.00274126907412543,-0.00562583676978553,0.00511993800078615,0.926481115133656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.000908991872738529,0.00991405115065625,-0.0203405321280248,0.0185225483825477,0.92694772084025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.000569123252933537,0.00623077062855083,-0.0127814336848932,0.0116431871790261,0.927223237044843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.000603012597208576,0.00673545695461264,-0.0125984830338322,0.0138045082282494,0.928663377707893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.000631442028979259,0.00707832388033899,-0.0145049568344437,0.0132420727764852,0.928918090264361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.000369861585849895,0.00419417828492506,-0.00785072785260322,0.00859045102430301,0.929731362961183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.000323080729611839,0.00370039611552624,-0.00692969565681959,0.00757585711604327,0.930426613998132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.000899658536895301,0.0103114032554785,-0.0211100089176331,0.0193106918438425,0.930475005539703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.000316999400857308,0.00363735077148194,-0.0068122081112473,0.00744620691296191,0.930552678572865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,39788,0.000636693249036008,0.00739804560876487,-0.0138634761441431,0.0151368626422152,0.931417928342073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37056,0.000386980216070069,0.0045630653497884,-0.0085566278695152,0.00933058830165533,0.932416056906585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37124,0.000393995648279448,0.00484243782860722,-0.0090971824957907,0.00988517379234959,0.935154438563144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.000297223594090372,0.00368434768613772,-0.0075185450589203,0.00692409787073955,0.93570402221632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37039,-0.000538029547762118,0.00688540344914514,-0.0140334203080866,0.0129573612125624,0.937717399100754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37021,0.000365964472393948,0.00478107135277517,-0.00900493537904539,0.00973686432383329,0.938987115976819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.000536921660701095,0.00716083348473317,-0.0145721552907781,0.0134983119693759,0.940231488806716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.000557625093230559,0.00749738403405382,-0.015252497799976,0.0141372476135149,0.940712342704541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,0.00047592282947655,0.00642425613026493,-0.0121156191858427,0.0130674648447958,0.940945945376303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.000400625379678088,0.00556456294963063,-0.0113071687609541,0.010505918001598,0.942606140288541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.000292233958037742,0.00417711119411197,-0.00847937189849719,0.00789490398242171,0.94422594370045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.000188263998292109,0.00274123411925968,-0.00556108287204108,0.00518455487545686,0.945246501819752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.000579573332329289,0.00857782495115886,-0.0173921102366006,0.0162329635719421,0.946131748261057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,36962,0.000301951295267497,0.00447257064290733,-0.00846428716483087,0.00906818975536586,0.946175298478078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.000218210859805666,0.00324159528453181,-0.006571737617488,0.00613531589787667,0.946331068108899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.000722487061006307,0.0108496342953831,-0.0219877702799571,0.0205427961579445,0.946908231764093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.000344072447749786,0.00520473367914101,-0.0105453504588662,0.0098572055633666,0.947293163279381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,0.0003648904220996,0.00558526359644668,-0.0105822262269359,0.0113120070711351,0.947911513095469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.000361943691189192,0.00569786141223415,-0.0115297520591681,0.0108058646767897,0.949351080271094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.000247374750932309,0.00396219049986028,-0.00801326813065845,0.00751851862879383,0.95021814945696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40009,-0.000433989055671643,0.0074006757016019,-0.0149393134308114,0.0140713353194681,0.953238129960829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.000242607330468366,0.00427358428326441,-0.0086188325256666,0.00813361786472987,0.954730006349326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.000405490196224634,0.00735167292954454,-0.0148147691381319,0.0140037887456827,0.956014878098352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,39818,-0.000207461575827385,0.00392112627831124,-0.00789286908131741,0.00747794592966264,0.957805338770423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.000192420670431427,0.00367458556789983,-0.00739460838351509,0.00700976704265224,0.958238439219801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.000260251192998143,0.00510539061752492,-0.00974631441735071,0.010266816803347,0.959345597054485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.000418018069028403,0.00821292729423379,-0.0156793194276698,0.0165153555657266,0.959407903041313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,0.000256301330658685,0.00515282874330614,-0.00984324300622135,0.0103558456675387,0.960330269607735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,0.00020253356940354,0.00411062293150103,-0.00785428737633847,0.00825935451514555,0.960704237114518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37411,-0.000201957304850694,0.00438485564198468,-0.00879627436314067,0.00839235975343928,0.963264768691061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.00034300905600862,0.0075076797901798,-0.015058061444761,0.0143720433327438,0.963559705628181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,36991,-0.00020039942894802,0.00458939472988756,-0.00919561309952764,0.0087948142416316,0.965171493182157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.000371349122220586,0.00858914686025414,-0.0172060769683187,0.0164633787238775,0.965515003156369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,36903,0.000141631175524541,0.00336001739710526,-0.00644400292280178,0.00672726527385086,0.966378238091218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.000257839645668192,0.00623800173743329,-0.0119686437597011,0.0124843230510374,0.967030503091835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.00018811075788204,0.00461288869027115,-0.00922937259081349,0.00885315107504941,0.967472287473516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,0.000358810016557926,0.00923903966659367,-0.0177497077299657,0.0184673277630815,0.969021396599772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.000135059739219228,0.00353211760322996,-0.00678789076311149,0.00705801024154994,0.969498796766791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.000439973528263357,0.0115711108182567,-0.0222394036755197,0.0231193507320464,0.969669461331856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.000320024715713544,0.00894462134667785,-0.017211433123775,0.0178514825552021,0.971459540959796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39477,0.000282895923919545,0.00791593693564792,-0.0152323404699504,0.0157981323177895,0.971492112853521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37437,0.000138958138171621,0.00419877039130255,-0.00809063182878138,0.00836854810512463,0.973599348370652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37039,-0.000192139615595547,0.00589189655814335,-0.0117402568695565,0.0113559776383654,0.9739854300754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.000114261672273527,0.00351373670610894,-0.0067726622717,0.00700118561624705,0.974058999485958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,0.000158007546483629,0.005123212454472,-0.0098834888642815,0.0101995039572488,0.975396339369314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.000135963321927904,0.00516103479017287,-0.00997966486681092,0.0102515915106667,0.978983201165539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,0.000252506854266343,0.00969605628654774,-0.0187517634673672,0.0192567771758999,0.979224051926336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.000110302940540577,0.00450595832616313,-0.0089419812598203,0.00872137537873915,0.980470623897571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.000127244087825039,0.00543079940973432,-0.0107716109309043,0.0105171227552542,0.981307562532178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-7.09827047437229e-05,0.00344979760801119,-0.00683258601644565,0.0066906206069582,0.983584273630144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,0.000116499697932116,0.00673891372712426,-0.0130917712072314,0.0133247706030957,0.986207430758426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,0.000125504257502463,0.00869893940911783,-0.0169244169843685,0.0171754254993734,0.988489110176531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,-8.92380962784036e-05,0.00621558528671017,-0.0122717852582303,0.0120933090656735,0.988545263043033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.000136555859030779,0.00954910432816459,-0.0188528003422334,0.0185796886241718,0.988590550011964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,4.64118267365238e-05,0.00328872197519241,-0.00639948324464061,0.00649230689811365,0.988740505393287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37368,0.000143072177482663,0.0107340882588072,-0.0208957408097794,0.0211818851647447,0.989365693119395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-4.82144643720985e-05,0.00384433821320728,-0.00758311736225837,0.00748668843351417,0.98999363811028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,5.85524887882472e-05,0.00497045340590815,-0.00968353618679172,0.00980064116436821,0.990601228700188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39453,-8.28478682601526e-06,0.0033624316075147,-0.00659865073755483,0.00658208116390279,0.998034104005739
